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Abstract 
The molecular events which control haematopoietic development, stem cell commitment 
and self-maintenance are poorly defined and understood. Although many advances have 
been made in recent years with improved stem cell purification and culturing techniques, 
the various limitations attached to these techniques have constrained such study. The use 
of murine totipotential embryonic stem (ES) cells have to an extent surmounted some of 
these limitations. In the appropriate culture conditions ES cells and their differentiated 
3-dimensional aggregates, embryoid bodies, are able to give rise to all haematopoietic 
lineages and have consequently proved particularly useful for studying gene expression and 
regulation. Furthermore the ability to ablate gene function by the generation of null 
alleles (gene knockouts) allows the examination of function, directly. 
Exploiting the ability of ES cells to differentiate toward haematopoietic lineages, the 
project sought to investigate gene expression with a view to identifying novel 
genes/proteins involved in the early stages of ES cell commitment to haematopoietic 
lineages. In the culture system used, it has been shown that under standard differentiation 
conditions 30-50% of embryoid bodies are able to give rise to haematopoietic colonies. This 
level of haematopoietic commitment was modulated with the addition of chemical 
inducers to the differentiation environment of embryoid bodies. Using the CFU-A assay to 
assess haematopoietic commitment and differentiation, we have found that the number of 
CPU-A colonies can be increased 2-fold after treatment of embryoid bodies with 1% DMSO 
during the first 48 hours of differentiation, and conversely reduced to below 5% after 
treatment with 10-8  M all trans-retinoic acid (atRA) for the same period. 
Lineage commitment in untreated, DMSO and atRA treated embryoid bodies was further 
investigated using reverse transcription-polymerase chain reaction techniques. The 
mesoderm marker brachyury was found to be expressed in both DMSO and atRA treated 
samples to similar extents, suggesting neither compound to be exclusively exerting its effect 
by enhancing or inhibiting mesoderm commitment. However, the level of transcripts of 
various haematopoietic markers such as J-globin, PU-i and CD45 were found to be raised 
in DMSO treated embryoid bodies compared to either untreated or atRA treated samples. 
Employing the opposing effects of DMSO and atRA, 2-dimensional protein gel 
electrophoresis of L-[ 35S]-methionine pulse labelled embryoid bodies was used as a 
screening method for the identification of proteins that could be involved in either ES cell 
haematopoietic commitment, or haematopoietic progenitor cell differentiation. After 
analysis of the gels several proteins were found to display an expression profile mirroring 
the CFU-A assay results. That is their expression level was elevated and diminished 
after DMSO and atRA treatment respectively. These proteins therefore serve as strong 
candidates for further identification and analysis for future studies. Furthermore the 
contrasting effects of the two compounds are being investigated for differential cDNA 
library screening. 
It has been clearly demonstrated, that the haematopoietic commitment of ES cells and 
their differentiated aggregates can be successfully modulated by the addition of chemical 
inducers. Consequently these effects will prove a useful means of screening for genes and 
proteins involved in haematopoietic commitment and differentiation. 
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Haematopoiesis is the unidirectional process whereby pluripotential haematopoietic 
stem cells (HSCs) differentiate to give multipotent progenitors, which in turn commit to 
and terminally differentiate towards one of the lineages in the lymphohaematopoietic 
system (Figure 1.1). Crossing interdisciplinary boundaries from immunology and 
haematology to developmental biology, haematopoiesis demonstrates basic biological 
principles such as homeostasis and biological plasticity; exemplifies a complete model 
intergrating stem cell biology, cellular commitment, differentiation, growth factor 
biology, cellular signalling, transcriptional control, cell death and survival; and provides 
insights not only into normal but disease and malignant states. 
Although much remains elusive about this intricate process, numerous advances have been 
made in recent years through improved tissue culture and molecular biological techniques. 
An overview of some of these findings is outlined in the following sections. 
1.1.1 Haematopoietic stem cells. 
Haematopoietic stem cells (HSCs) are defined as the population of cells with the dual 
capacity of self-maintenance, and differentiation into an expanded population of 
progenitor cells. It has been proposed that HSCs persist throughout an animal's life, 
continually replenishing the terminally differentiated blood cell compartments which 
have limited lifespans (Keller and Snodgrass, 1990; Jordan et a! 1990). It is thought that 
during steady state most HSCs are in the C0 phase of the cell cycle, and due to this 
quiesence are able to maintain their genetic integrity over long periods of time (Lajtha, 
1979). While proliferating however, HSCs display a diminished stem cell activity 
(Fleming et a!, 1993) 
In the adult, HSCs reside in the bone marrow and have been estimated by various studies 
to constitute no more than 1 per 10000 of nucleated marrow cells in the mouse (Micklem e t 
a!, 1987; Harrison et a!, 1988). Due to their rarity it has proved difficult to isolate and 
characterise these cells. Isolation would not only facilitate the study of the growth and 
differentiation of HSCs, but would also be beneficial for the purposes of gene therapy and 
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cell/organ transplantation. The definitive assay for the detection of HSCs utilises their 
unique ability to provide long-term repopulation of all lineages of the haematopoietic 
system, usually of lethally irradiated recipients (Till and McCulloch, 1968). 
Using cell surface marker expression patterns Spangrude et al (1988) have shown that bone 
marrow cells which express high levels of stem cell antigen-1 (Sca-1), low levels of the 
cell surface differentiation antigen Thy-1 and display either low levels or complete 
absence of specific cell surface markers for erythroid (e.g. B220), myeloid (e.g. Mac-1) and 
lymphoid lineages (e.g. CD4CD8) (collectively reffered to as Lin), to be a rich source of 
stem cells. Although these cells were later shown to be more heterogeneous than 
previously thought, consisting not only of long- but also short-term repopulating cells 
(Smith et a!, 1991a), Sca-1 Thy-i'° Lin cells still remain a useful starting population for 
further HSC enrichment. 
Some enrichment techniques applied include: i) separation of cells on the basis of size and 
density (Jones et a!, 1990; Ploemacher and Brons, 1989); 2) low uptake of fluorescent dyes 
e.g. rhodamine 123 which is taken up by the mitochondrial membrane (Spangrude and 
Johnson, 1990) and Hoechst 33342 which binds DNA (Neben et a!, 1991); 3) resistance to 
cytotoxic agents such as 5-fluorouracil which do not affect quiescent HSCs (Hodgson and 
Bradley, 1979); 4) adherence to plastic tissue culture flasks (Kiefer et al, 1991). 
Although some of these procedures have yielded highly enriched populations of HSCs 
their separation from the more mature spleen colony forming cells (CFU-S) with only 
short-term repopulating ability has proved difficult (Jones et a!, 1989). There are 
furthermore two types of CPU-S cells: those which form the characteristic nodules an the 
spleens of recipients 8 days after injection (CFU-S8), and a slightly more primitive cell 
type which form nodules after 12 days (CFU-S12) (Till and McCulloch, 1968) 
Recently Morrison et a! (1995) have identified a cell subset from the liver of day 13.5 p.c. 
foetuses which display typical characteristics of HSCs, that is they provide long-term 
multineage haematopoietic reconstitution when as few as 6 cells are injected into lethally 
irradiated recipients. However it has been argued that in principle it is never possible to 
isolate true stem cells unequivocally, since in order to be defined they must be exposed to 
experimental manipulation, such as those described, which may in turn affect the 
properties of the cells (Potten and Loeffler 1990). 
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Various models for the commitment and differentiation of HSCs have been proposed two of 
which predominate. In both models haematopoietic growth factors and cytokines play 
key roles. Although much of the evidence for these models has been derived from in vitro 
cultures some of the findings have been found to have physiological relevance. The first 
model suggests that self-maintenance and commitment of HSCs and multipotent stem cells 
is stochastic in nature and growth factors act to promote the survival and expansion of cells 
which become commited to a particular lineage (Ogawa, 1993). This hypothesis is 
thought to be supported by the fact that multilineages can be derived from colonies of 
single cell origin, and by findings which suggest that haematopoietic growth factors 
suppress apoptotic cell death (Kinoshita et al, 1995; Abrahamson et al, 1995). 
The second model proposes a more instructive system in which stromal cells in the 
haematopoietic microenvironment direct every stage of haematopoietic cell development 
via cytokine release (Uchida et a!, 1993). The bone marrow consists of a heterogenous 
population of cells. Excluding haematopoietic cells these comprise endothelial cells, 
fibroblasts and adipocytes amongst others, and are thought to influence and regulate the 
commitment of pluripotent and multipotent haematopoietic cells (Perkins and Fleischman, 
1988). This model is supported by the results of long-term bone marrow culture (LT-BMC) 
experiments, first described by Dexter et al (1977), where growth of immature 
haematopoietic cells and the sustenance of the colonies thereafter, take place and have 
been shown to be dependent on direct physical contact with the stromal layer. This direct 
contact is thought to mimic the in vivo circumstances. However a recently isolated mouse 
stromal cell line has been shown to support haematopoietic growth without direct cell-
cell contact via a putative diffusible growth factor(s) (Burroughs et a!, 1994). 
In an attempt to show the relevance of the microenvironment directed haematopoiesis 
model to the in vivo sitution Friedrich et al (1996) have isolated a large number of 
conditionally immortalised stromal cell lines from mouse bone marrow and foetal liver. 
These cell lines do not express haemtaopoietic related cell surface markers, but resemble 
epithelial and fibroblastic cells and preferentially support either lymphoid or myeloid 
differentiation of primitive haematopoietic cells respectively. Although there is 
mounting evidence in favour of the microenvironment directed model (just et al 1991; 
Morrison and Weissman, 1994), both the stochastic and instructive systems probably 
contribute to in vivo haematopoiesis 
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1.1.2 Haematopoietic growth factors. 
Haematopoietic growth factors are soluble molecules originally isolated from LT-BMC 
systems, some of which are now used clinically for the treatment of leukaemias and other 
disorders (reviewed in Sachs, 1996). A variety of cytokines and interleukins (IL) have 
since been isolated and shown to have a wide range of functions in the 
immunohaematopoietic system, from the maintenance of HSCs, e.g. stem cell factor (SCF) 
(Tsuji et a!, 1991), to initiating an immune response e.g. interferon y (IFN-y). 
Some cytokines can act in a lineage specific manner, such as erythropoietin (Epo) and 
granulocyte-colony stimulating factor (G-CSF), which support the growth of erythroid 
and granulocytic lineages respectively. The great majority of cytokines however, display 
functional pleiotropy such as IL-3 and IL-6. The former supports the growth of erythroid, 
myeloid and megakaryocytic lineages while the latter not only induces the maturation of 
B-cells into antibody producing plasma cells but effects T-cell and monocytic growth. One 
of the consequences of pleiotropy is functional overlap and hence redundancy. For instance 
several other factors such as IL-2 and IL-4 are also able to induce antibody production in B - 
cells. Redundancy in the system is particularly well demonstrated with gene 'knock-out' 
experiments in mice, where the introduction of mutations into a specific gene can render 
that gene disfunctional. For example in the case of IL-2 which was thought to be essential 
for T-cell development, the knock-out mice have in fact proved to be normal with this 
respect (Schorle, 1991). 
Despite this redundancy there does appear to be a hierachy for cytokines and some do 
play a more crucial role than others. In the case of SCF which is thought to be involved in 
the cycling of stem cells, mice harboring a homozygous mutation in the gene suffer from 
severe anaemia detectable in foetuses from as early as 13 days gestation (Chui et al 1976), 
and the cytokine continues to play an important role in foetal and adult erythropopiesis 
(Chui et a! 1978). 
Another emerging characteristic of cytokines is their pleiotropy not only in the 
immunohaematopoietic system but in multiple cell types. Cytokines such as leukaemia 
inhibitory factor (LIF) and IL-6 have been found to exert an influence on a variety of cell 
types. For instance, LIF can stimulate the differentiation of sensory neurones from mouse 
neural crest cultures (Murphy et al, 1991), and both LIT and IL-6 have been found to 
stimulate the expression of acute phase plasma proteins from hepatocytes (Baumann and 
Schendel, 1991). 
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Not all cytokines support the proliferation of haematopoietic cells. Some, such as 
macrophage inflammatory factor-la (MIP-lcx) (Dunlop et al, 1992), transforming growth 
factor 13  (TGF-13) (Ottman and Pelus, 1988) and more recently IFN-y (Selleri et al 1996) 
have all been shown to have inhibitory effects. Although the effects of TGF-f3 are likely 
to be more complex since mice bearing a knock-out mutation for this gene display impaired 
haematopoiesis and vasculogenesis (Dickinson et al, 1995). These findings will be 
discussed in more detail in section 1.2. 
1.1.3 Haematopoietic growth factor receptors. 
Haematopoietic growth factor receptors can be classified into several different families. 
The majority of haematopoietic cytokines, and some non-haematopoietic factors such as 
prolactin and growth hormone, exert their effects through a distinct family of membrane 
bound receptors termed the cytokine receptor superfamily (reviewed in Bazan, 1990). This 
family is further sub-divided into Types I and II according to their structural 
characteristics. One of the main features of cytokine/receptor association is the subsequent 
dimerisation of the receptor which appears to be a key step in the initiation of signal 
transduction. In the case of cytokine receptors which consist of a single chain such as those 
for Epo and G-CSF, two receptors homodimerise in response to ligand. Most receptors 
however share a common membrane bound chain which heterodimerises with single or 
multiple ligand specific chains, such as the common 13 (13) chain which heterodimerises 
with the IL-3, IL-5 and GM-CSF receptors upon ligand binding. 
Another family of receptors which a growing number of haematopoietic cytokines have 
been found to exert their effects through, e.g. macrophage colony stimulating factor (M-
CSF) and SCF (Sherr et al, 1985; Chabot et a!, 1988), is the receptor tyrosine kinase 
receptor superfamily. The membrane bound tyrosine kinase receptors are a large family of 
proteins which mediate a variety of cellular signals in response to growth factor ligands. 
Many of these are also retrovirally encoded and can act as transforming oncogenes. Some 
members of this family, such as c-kit the receptor for SCF, have been shown to play an 
important role in murine haematopoiesis. In fact one characteristic feature of populations 
of haematopoietic cells containing HSCs is c-kit expression (Ikuta and Weissman, 1992). 
The extracellular amino terminus of receptor tyrosine kinases consists of five 
immunoglobulin domains, thought to be essential for ligand binding while the 
intracellular segment is a highly conserved catalytic kinase. Like cytokine receptors, 
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receptor tyrosine kinases dimerise upon ligand binding followed by autophosphorylation 
which is an essential step in the signal transduction cascade. Cytokine receptors which 
lack an intrinsic kinase activity achieve this phosphorylation step by associating with 
cytoplasmic tyrosine kinases such as the Janus kinases Oaks) which phosphorylate the 
receptors after dimerisation. 
1.1.4 Signal transduction in haematopoietic cells. 
Signal transduction across the cytoplasm is dependent on a series of protein kinases most of 
which are tyrosine kinases although some such as the mitogen activated protein (MAP) 
kinases have the ability to phosphorylate other amino acid residues (Rossmando et a!, 
1992). To date eight distinct families of protein tyrosine kinases have been identified 
including the Src and Jak families, many of which have been implicated in 
haematopoietic cell signal transduction. Tyrosine kinases interact with and can become 
activated by both cytokine and tyrosine kinase receptors, while a particular type of 
receptor can be associated with members of more than one family of tyrosine kinases. The 
IL-2 receptor for instance has been found to associate with both Src (Torigoe et a! 1992) and 
Jak family of kinases (Johnston et al, 1994). 
After ligand binding and receptor dimerisation, it is thought protein kinases come in close 
contact with receptors and become activated. The signal is then relayed across the 
cytoplasm via a series of protein kinases and adaptor proteins until it results in the 
activation of transcription factors. Due to their complexity much of the detail of signal 
transduction pathways triggered by specific cytokines remains unclear. However advances 
have been made and the MAP kinase pathway which is triggered by some receptors 
including the M-CSF receptor, c-fins is now reasonably well elucidated (Lioubin et a!, 
1994). 
Tyrosine phosphorylation, which sets in motion the process of cell growth and 
differentiation must be regulated in order to avoid aberrant cell growth. One way in which 
this is achieved is through the opposing catalytic activity of protein tyrosine 
phosphatases. These are a growing family of proteins which can be either membrane 
bound, like CD45, or intracellular enzymes such as haematopoietic cellular phosphatase 
(HCP). Recent data suggests that intracellular phosphatases associate with receptor 
complexes in a similar way to kinases and negatively regulate activated receptors (Yi e t 
a!, 1993). 
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The role of HCP in the regulation of haematopoiesis is further emphasised by the 
spontaneous occurence of autosomal recessive mutations in the HCP gene in the C57BL/6J 
strain of mice. Homozygous motheaten viable ( m ev) and motheaten (me) mice display 
reduced and no HCP activity respectively (Shultz et al, 1993). In the case of the 
motheaten mutation there is an increased level of a variety of haematopoietic lineages 
including erythrocytes, monocytes/macrophages and granulocytes and the pups die within 
3-9 weeks after birth from systemic autoimmune disease. 
1.1.5 Haematopoietic transcription factors. 
As mentioned signal transduction culminates in the activation of transcription factors 
which bind to their cognate DNA recognition sequences or response elements. Transcription 
factors therefore play a central role in lineage conmiitment and thus much effort has been 
expended in identifying transcription factors that are involved in haematopoietic 
commitment. Consequently a number of transcription factors belonging to different families 
have been shown to be involved in various stages of haematopoietic commitment and 
differentiation. 
Gene knock-out' mutation studies for example have demonstrated that the zinc-finger 
transcription factors GATA-1 and 2 have an important role in haematopoiesis. These 
factors belong to the highly conserved GATA family of transcription proteins, six of which 
have been identified and found to be expressed in a wide range of tissues (Laverriere et al, 
1994). Mice with a null mutation in GATA-1 die of severe anaemia in utero (Pevney et al, 
1991). Further in vitro colony forming assay studies of haematopoietic tissue samples from 
these mice have revealed that the main lineage affected by the GATA-1/ mutation is 
the erythroid lineage where maturation beyond the pro-erythroid stage does not take 
place (Pevney et al, 1995). Lack of GATA-2 however appears to affect a wider range of 
lineages including the lymphoid and myeloid compartments (Tsai et a!, 1994). The role of 
these transcription factors is discussed in more detail in section 2. 
The major family of transcription factors which appear to be specifically involved in the 
commitment and maintenance of the lymphoid lineage are the Ikaros zinc-finger protein. 
Mice homozygous for a mutation in the DNA binding domain of the Ikaros protein, have 
normal erythroid and myeloid cells but lack T- and B-cell progenitors. Furthermore the 
thymus is grossly under developed and the peripheral lymph nodes absent (Georgopoulos 
et al, 1994). Recent studies have also shown that mice heterozygous for the same Ikaros 
mutation die of leukaemia or lymphoma within six months of birth (Winandy et a!, 1995), 
suggesting a role for Ikaros both in the commitment and differentiation of lymphoid 
progenitors, and in the homeostatic control of T-cell proliferation. 
While the intentional disruption of certain genes has helped identify their putative roles 
in haematopoiesis, some transcription factors have been implicated as a consequence of 
chance mutations giving rise to aberrant haematopoietic cell growth. For instance the 
majority of acute myeloid leukaemias arise from chromosomal rearrangements that 
disrupt the AML-1. The disruption of AML-1 in mice has recently confirmed its role in 
regulating commitment and differentiation of all lineages during definitive 
haematopoiesis (Okuda et a!, 1996). 
Similarly over 95% of promyelocytic leukaemias have been attributed to the chromosomal 
translocation t(15;17)(q22;q21). The point of translocation an chromosome 15 encodes the 
PML protein, while that of chromosome 17 encodes the retinoic acid receptor RARa, one of 
the three members of this family of retinoic acid receptors. RARa is a ligand binding 
transcription factor which has been implicated in neutrophilic differentiation (Tsai and 
Collins, 1993). PML protein contains various motifs typical of transcription factors 
including leucine zipper and zinc-finger motifs. Although the exact function of PML is yet 
to be established it has been suggested that under normal conditions it acts as a growth 
suppressor (Mu et al. 1994; Okuda et al, 1994)). 
The identification of transcription factors and their related family members has proved 
an important step in elucidating haematopoietic commitment and differentiation. 
However the rate limiting step remains the identification of their target genes. 
Due to the diversity of the components and processes involved in haematopoietic 
commitment a complete picture of a set of events contributing to any specific pathway has 
yet to be achieved. Gradually however various findings can be pieced together to yield a 
detailed understanding of how this complex process takes place. For example the newly 
identified Stats (signal transducers and activator of transcription) family of transciption 
factors have been found to mainly associate with and be phosphorylated by the Janus 
kinases. Stat 4, the expression of which is resticted to the myeloid lineage has been shown 
to be phosphorylated in response to IL-12 (Jacobson et a!, 1995) and the IL-12 receptor 
appears to activate Jak2 and Iyk2 (Bacon et a!, 1995). The pathway remains to be 
elucidated however since target genes for Stat 4 have yet to be reported. 
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Figurel.2. Showing the cascade of events which may play a part in initiating transcription 
from the c-fins gene, the M-CSF receptor. After binding, GM-CSF causes the dimerisation of its 
receptor which results in the phosphorylation (P) of the receptor chains by a member of the 
Jak tyrosine kinase family OAK). Ras-GTP may then become activated via accesory molecules 
such as Grb-2 and son of sevenless (SOS) which results in the phosphorylation of Raf. AML-1 
is eventually activated by ERK after phosphorylation of 2 serine residues and binds to its 
response element (ER) on the c-fins promoter, possibly as a dimer with C/EBP. 
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Studies of erythropoiesis have similarly revealed that Epo upon binding to its receptor, 
can activate GATA-1, which in turn transactivates the expression of Epo-receptor and its 
own genes thus forming the basis of a self regulating positive feedback loop (Zon et a 1, 
1991; Dalyot et al, 1993). In this example it is the signalling pathway regulating the 
activation of GATA-1 which is poorly understood. 
More recently a clearer pathway for myeloid commitment has emerged (Figure 1.2). It has 
been shown that in mouse fibroblast and IL-3 dependent haematopoietic cell lines, GM-
CSF (granulocyte/macrophage-colony stimulating factor) can directly stimulate the 
expression of c-fins (Heiftenbein et al, 1996). The GM-CSF ligand/receptor interaction can 
set in motion phosphorylation reactions in more than one signalling pathway including 
the Jak/Stats and Raf/MAP-kinase pathway (Okuda et a!, 1992). Protein studies have 
demonstrated that one of the kinases in the Raf/MAP-kinase pathway, extracellular 
signal-regulated kinase (ERK), directly phophorylates AML-1 on two serine residues, 
ERK itself being a substrate for another protein kinase, MEK-1 (Tanaka et a!, 1996). 
Electrophoresis mobility shift assays have identified c-fins as one of the target genes for 
AML-1 (Zhang et a!, 1996). 
Once activated, AML-1 together with C/EBP (CCAAT enhancer binding protein) possibly 
as a heterodimer complex, has been shown to transactivate the expression of the myeloid 
specific receptor, c-fins. PU.1, another transcription factor implicated in myeloid 
commitment and differentiation has also been shown to transactivate the expression of c-
fins (Zhang et al, 1994). Whether PU.1 is activated by the same cascade of events as AML-
1 or by a distinct pathway is unclear. The model outlined here, demonstrates the manner in 
which insights into haematopoietic differentiation can be gained. No doubt pathways 
such as this will grow in complexity as more signalling molecules and target genes are 
identified 
1.2 Haematopoietic development. 
Stem cells are produced and their fate determined during the very early stages of 
development. Due to the inability of adult tissue to produce cells of such paramount 
importance the ontogeny and commitment of stem cells during embryogenesis is of 
particular interest. Various methods and experimental systems have been employed for 
the study of haematopoietic development. 
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Basic principles of developmental biology have been particularly well elucidated in 
Xenopus laevis and the chick, due to the accessibility of the embryos. The mouse model, 
has proved an indispensable source for the study of haematopoiesis and much of the 
technical advances already mentioned in section 1.1 have greatly facilitated this process. 
There are many similarities between murine and human haematopoietic development, and 
most clinical advances made in the treatment of haematopoietic disorders originate from 
studies carried out in the mouse. For this reason the primary focus in the following sections 
will be on the haematopoietic development of the common house mouse Mus musculus. 
Since comparative studies have proved to be an important means of identifying 
evolutionary conserved genes thought to play an important role in any given system 
comparisons and parallels will be drawn from other models where appropriate. 
The embryonic stage of haematopoiesis is referred to as primitive' and from the foetal to 
the adult stages as definitive'. Haematopoietic development is a compartmentalised 
process which in the mouse first appears in the yolk sac and following that, sequentially, 
in the aorta, gonad, mesonephros (AGM) region of the interembryonic mesoderm, liver, 
thymus, omentum, spleen and finally bone marrow. Although many questions remain 
unanswered and the detailed molecular and cellular events which direct this process are 
poorly understood a framework within which these issues can be addressed has emerged. 
Some aspects of this progress are outlined in the following sections. 
1.2.1 Haematopoietic ontogeny. 
In mammals after fertilisation and the cleavages which give rise to the blastula, the 
totipotential cells of the inner cell mass (1CM) separate to form the embryonic and extra-
embryonic epiblasts. The embryonic epiblast gives rise to the ectoderm and endoderm. The 
region of the ectoderm referred to as the primitive streak, containing a population of cells 
thought to have retained their totipotentiality, invaginates and the cells migrate out to 
form the mesoderm layer. The expression of the putative transcription factor brachyury 
(Kispert et al, 1995), at around 6.5 days of gestation in the mouse in all mesodermal tissue 
and is thought to mark the beginning of mesoderm formation (Wilkinson et al, 1990). 
At least five types of mesoderm are derived which go on to form various organs. The 
lateral plate mesoderm gives rise to the haematopoietic system as well as the blood 
vessels and heart. Transcripts for haematopoietic specific genes such as GATA-1 and a-
globin have been detected at around 7 days post coitum (p.c.) in murine embryos (Rich et a!, 
13 
1994). Once commitment has taken place haematopoietic and vascular progenitors migrate 
out to an extra-embryonic location on the yolk sac, the position of which is classified as 
ventral, and give rise to blood islands. 
The derivation of mesoderm in birds is very similar that of mammals. After invagination 
of the primitive streak, the totipotential cells of the epiblast migrate into the area 
pellucida and a proportion of them give rise to the extra-embryonic splanchnoderm which 
is composed of mesoderm and endoderm. Haematopoietic progenitors then migrate out to 
the posterior area opaca and give rise to blood islands which are morphologically 
detectable by the 7 somite stage of chick embryogenesis. GATA-1 and 2 transcripts can be 
detected at the onset of gastrulation in the chick embryo. GATA-1 displays a more 
restricted expression pattern than GATA-2, being largely expressed in the posterior region 
of the embryonic mesoderm, whereas GATA-2 can be detected both in the anterior and 
posterior regions (Leonard et al, 1993). 
Due to the accessibility of the Xeno pus embryo a better understanding of gastrulation and 
hence haematopoietic initiation is being arrived at in this animal system. The Xeno pus 
embryo is conventionally divided into two poles: the animal and the vegetal poles which 
give rise to ectoderm and endoderm respectively. The dorso-ventral axis of the embryo is 
established upon fertilisation, the dorsal region being opposite the point of sperm entry. 
As in the mammalian and avian systems Xeno pus mesoderm is derived from the ectoderm. 
Xenopus embryo explant assays have shown that at the blastula stage, signalling 
molecules from the ectoderm induce the equatorial cells of the ectoderm which are 
believed to have maintained their totipotentiality, to give rise to mesoderm (reviewed by 
Kimelman et al, 1992). The expression of the Xenopus homologue to brachyury, Xbra in the 
marginal zone once again marks the beginning of mesoderm formation. The newly formed 
mesoderm is futher patterned dorso-ventrally by signalling molecules from the Spemann 
organiser and the most ventral region becomes commited to the haematopoietic lineage. 
Ventral blood islands in Xenopus are functionally and positionally equivalent to their 
mammalian and avian counterparts on the yolk sac. 
Various signalling molecules have been implicated in the patterning of the Xeno pus 
embryo including the fibroblast growth factor (FGF), Wnt and TGF-3 families- the TGF-f 
family being further divided into the activin and bone morphogenetic protein (BMP) sub-
families. Evidence from Xeno pus embryo explant assays strongly suggests that such 
signalling molecules create gradients in the embryo, and exert their effects within tight 
threshold boundaries (Gurdon et a!, 1995). 
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Activin and FGF have been shown to be particularly strong candidates for mesoderm 
induction in Xeno pus. Explants of the animal pole of the Xenopus embryo have been found 
to give rise to mesoderm in response to both these molecules and conversely the disruption 
of their receptors has been found to prevent mesoderm induction (Amaya et a!, 1991; 
Hemmati-Brivanlou and Melton, 1992), the disruption of the FGF receptor leading to 
defects in the ventral structures. 
As in the chick, GAlA-i and 2 are expressed very early on in Xeno pus. Both are expressed 
as early as stage 11 of Xenopus development, haematopoiesis not being evident until stage 
32. At stage 11 GATA-1 expresson is restricted to the ventral region, and GATA-2 is 
detected throughout the animal pole. However after gastrulation GATA-2 expression also 
becomes restricted to the ventral and lateral regions (Kelley et al, 1994). 
Using explant assays Walmsley et al (1994) have shown that GATA-2 expression and 
subsequently haematopoiesis, as detected by globin expression, is inhibited in the presense 
of activin and also in response to signals from the Spemann organiser. Therefore it has been 
suggested that in Xeno pus, induction of haematopoietic tissue from mesoderm occurs by 
default, in the absence of inducers. However the injection of BMP-4 mRNA into the animal 
pole of the Xenopus embryo has been shown to both ventralise mesoderm (Dale et a!, 1992) 
and induce erythropoietin expression (Maéno et a!, 1994). Therefore BMP-4 has been 
suggested to be a haematopoietic inducer possibly acting synergistically with other 
factors. This apparent contradiction between the inductive ability of BMP-4 and the 
inhibiting activity of the Spemann organiser has recently become clearer. It has been 
shown that the putative Spemann organiser signal, noggin, binds BMP-4 with high 
affinity and inactivates it, which results in the dorsalisation of the mesoderm tissue 
(Zimmerman et a!, 1996). 
The families of signalling molecules mentioned are also expressed in avian and 
mammalian embryos and implicated in directing various stages of development from 
neural development (Mason et a!, 1994), to limb bud patterning (Francis et al, 1994). In the 
chick embryo FGF-2 has been suggested to have an important role in inducing 
haematopoietic tissue. Gordon-Thomson and Fabian (1994) have shown that 
haematopoiesis, as detected by haemoglobinisation, can be inhibited in the pre-
gastrulation chick embryo by culturing the blastoderm in the presence of polyclonal 
antibody raised against FGF-2. Furthermore this inhibition is shown to be effective only 
during a brief window of time with the anti-sera having little effect an erythropoiesis in 
later stages of embryogenesis. 
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In mice, the disruption of the BMP-4 gene has been shown to severely inhibit mesoderm 
and hence blood island formation. In fact foetuses fail to develop beyond 9.5 days p.c. and 
mesoderm markers such as brachyury fail to be expressed (Winnier et al, 1995). More 
recently, preliminary experiments with murine embryonic stem cell lines have suggested 
that BMP-4 may be more directly involved in inducing haematopoietic lineages (Johansson 
and Wiles, 1996). 
1.2.2 Primitive Haematopoiesis. 
The first physiological sign of haematopoiesis is the appearance of blood islands on the 
visceral yolk sac of most mammals and, birds. In the mouse, blood islands begin to form a t 
around 7.25 days p.c. and are fully manifest by day 8.5. Structurally blood islands are 
aggregates of blood cells encapsulated by a layer of endothelial cells, this structure being 
supported by the visceral yolk sac endoderm. At around 9 days p.c. angiogenesis begins and 
a network of capillaries between the blood islands forms which then become connected 
with the developing heart. By day 9.5 the heart begins to beat and circulation is 
established. 
The close association of the haematopoietic cells with the endothelial and endodermal 
layers has been proposed to be essential for blood island formation, with the endothelial 
and the endodermal layers providing the necessary microenvironment for haematopoiesis 
and vasculogenesis. Several studies support this hypothesis. Murine bone marrow 
progenitors have for instance been found to have a much increased growth and 
proliferative potential when co-cultured with cell lines isolated from the yolk sac 
endoderm (Yoder et al, 1995). Similar results have been reported from experiments 
involving the co-culture of the endothelial layer with yolk sac HSCs (Auerbach et al, 
1996). However using an in vitro culture system Palis et a! (1995) have shown that visceral 
yolk sac explants from day 7.5 embryos can give rise to haematopoietic cells in the absence 
of the endodermal layer, but there is a failure in angiogenesis. 
Various experiments with cytokines and their receptors have further demonstrated the 
importance of the interaction between the endoderm and endothelium with the 
haematopoietic or mesothelial layer. Mice carrying a homozygous mutation in the Flk-1 
tyrosine kinase receptor for instance, fail to produce any mature endothelial cells in the 
yolk sac which is thought to result in the subsequent absence of haematopoietic progenitors 
and hence blood island formation (Shelaby et a!, 1995). Similar results have been obtained 
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with TGF-31 knock-out mice where the yolk sac of the homozygous mutant foetuses 
displays defective endothelial differentiation and a much reduced erythroid population 
(Dickinson et a!, 1995). The mutation was found to have less of a direct effect on the 
endoderm. Taken together these findings suggest that normal blood island haematopoiesis 
is dependent on both a functional endoderm and endothelium. 
Among the transcription factors which have been found to play an important role in 
primitive haematopoiesis is SCL/Tall, a member of the basic helix-loop-helix family of 
transcription factors. Originally identified as one of the genes disrupted by a chromosomal 
translocation in a case of acute leukaemia, scl has been shown to be expressed in mouse 
blood islands at around 7.5 days p.c. with its expression remaining largely restricted to the 
haematopoietic lineages thereafter (Kallianpur et al, 1994). The disruption of the gene in 
mice has further shown that sd i- embryos fail to develop beyond 9.5 days p.c. 
(Shivdasani et al, 1995; Robb et a!, 1995). Detailed analysis of the embryos has shown a 
marked absence of blood island formation and haematopoiesis. The expression of other 
haematopoietic transcription factors such as GATA-1 and PU.1 were also affected, 
although GATA-2 was found to be present, highlighting the importance of the gene during 
primitive haematopoiesis. More recently studies with chimaeric mice, generated by the 
injection of sd / ES cells into wild type blastocysts, have implicated scl in the very early 
stages of stem cell commitment since the mutant cell line fails to contribute to any of the 
haematopoietic lineages of the adult mouse (Porcher et a!, 1996). 
Mammalian primitive haematopoiesis produces a limited range of blood cells. The 
haematopoietic cells in the yolk sac blood islands are mainly nucleated erythroblasts, 
expressing foetal haemoglobin, and do not undergo any further maturation. Small 
populations of monocytes and macrophages are also thought to be present. No other 
lineages have so far been identified in situ. However Palacios and Imhof (1993) have 
reported the ability of yolk sacs of 8-8.5 day old embryos to produce lymphoid precursors. 
In this study yolk sac cells were injected into various haematopoetic organs of sub-lethally 
irradiated CB17 severely combined immuno-deficient (SCID) mice followed by 
fluorescence-activated cell sorter (FACS) analysis of the haematopoietic tissues of the 
recipients. Both T- and B- cell presursors were detected. This study indicates that yolk sac 
HSCs are able to give rise to a wide range of haematopoietic cell types when placed in a 
conducive environment and in response to the appropriate growth factors. This is further 
demonstrated by in vitro colony forming assays in which yolk sac HSCs have been found to 
give rise to both lymphoid and myeloid lineages (Huang et a!, 1994; Liu and Auerbach, 
1991). 
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Erythropoiesis in the murine yolk sac blood islands is thought to be maintained by 
erythropoietin. Preliminary in vitro evidence suggests that embryonic erythroid cells like 
those of the foetus and adult are able to respond to Epo (Rich et a!, 1994). Using blast-
forming unit (CFU-B) and erythroid-colony forming unit (CFU-E) assays, which detect 
early and late erythroid progenitors respectively, a marked increase in erythroid colonies 
were obtained from disaggregated 7.5 and 8.5 day murine embryos after treatment with 
Epo (Rich 1992). This together with the detection of Epo-receptor and ligand transcripts, 
as early as day 6 of gestation in mouse embryos strongly suggests that primitive 
haematopoiesis is also controled by erythropoietin, which may be secreted by the 
endothelial and/or endodermal layers of the yolk sac blood islands (Yasuda et al, 1993). 
In the Xeno pus the ventral blood islands are encapsulated by the hepatic endoderm which 
is also postulated to support primitive haematopoiesis and erythropoiesis by secreting an 
Epo-like factor. Unlike mammalian blood island haematopoiesis however, Xeno pus 
ventral blood island tissue has been shown to contain myeloid and lymphoid progenitors 
(Smith et al, 1989). 
Avian primitive haematopoiesis is very similar to that of the murine system. However in 
the chick the entire yolk sac becomes vascularised and remames haematopoietic almost 
for the duration of gestation. Murine yolk sac blood island haematopoiesis however 
continues until day 12 p.c. by which time definitive haematopoiesis is established. 
1.2.3 Intra-embryonic haematopoiesis. 
Until recently it was believed that murine haematopoietic progenitors from the yolk sac 
migrated to the liver where they established definitive haematopoiesis and thereafter 
relocated to their final destination, the bone marrow. This hypothesis was supported by in 
vitro murine embryo culture assays where day 7 p.c. embryos cultured in the absence of 
their yolk sac lacked circulating blood cells and failed to develop liver haematopoiesis 
(Moore and Metcalf, 1970). However recently a population of haematopoietic progenitors 
in the dorsal region of the intra-embryonic mesoderm, which gives rise to the aorta, 
gonads and mesonephros (ACM), have been identified which are thought to also 
contribute to definitive haematopoiesis (Medvinsky et a!, 1993). 
A similar population of cells in the corresponding region of the avian embryo have long 
been known to exist. The morphologically distinct foci of haematopoietic cells cri the 
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ventral wall of the chick embryo aorta, (which are thought to have delineated from 
endothelial and/or mesenchymal components), have been shown to contribute to definitive 
haematopoiesis by mtra-species (chick/quail) and intra-strain (chick/chick) embryo 
grafting assays (Dierterlen-Lievre, 1975). This population of cells has recently been 
further enriched and characterised and been shown to give rise to erythroid and myeloid 
cells in vitro (Cormier, 1993). 
Similar embryo grafting experiments with Xeno pus embryos have also demonstrated that 
haematopoietic progenitors originating from both the extra- and intra-embryonic 
mesoderm contribute to adult haematopoiesis (Kau and Turpen, 1983). More recently 
however, using two-colour FACS analysis Chen and Turpen (1995) have shown that 
definitive Xeno pus haematopoiesis is predominantly derived from haematopoietic cells 
of the dorsal lip plate which is analogous to the mammalian AGM. 
The murine AGM region derives from the splanchnopleura, which is the ventral segment of 
the lateral mesoderm and is continuous with the yolk sac. AGM haematopoietic 
progenitors are first detected at around day 9 p.c., which is approximately only 12 hours 
prior to the initiation of liver haematopoiesis, and persist until day 11. Unlike yolk sac 
HSCs, those from the AGM region give rise to a wider range of haematopoietic lineages in 
vivo. In contrast to the chick embryo, haematopoietic cells of the mouse ACM do not form 
foci and were thus demonstrated to be present by two similar experimental approaches. 
In the first instance the splanchnopleura from day 8.5-9 p.c. embryos were surgically 
transplanted under the kidney capsule of SCID mice (Godin et a!, 1993). Subsequent FACS 
analysis of the haematopoietic tissue of recipient mice showed the presence of donor 
derived immunoglobulin M (1gM), 1gM secreting plasma cells and the Bla cell subset (CD5 
B cells), which are among the most primitive B-cells. Further maturation of these cells 
was not however detected. In the second study day 9 embryos were dissected and ACM cells 
injected into lethally irradiated recipients (Medvinsky et a!, 1993). Donor derived day 8 
CFU-S colonies, which are among the more commited haematopoietic progenitors, were 
subsequently detected in the recipients. It was furthermore found that as the CFU-S 
population in the ACM region decreased, those of the liver increased in number. 
In a later study similar experiments were performed but with the ACM of day 10 p.c. 
embryos (Muller et a! , 1994). These were found to provide long term repopulation of 
lethally irradiated recipient mice. Moreover the day 10 p.c. ACM cells were found to 
contribute to erythroid, myeloid and lymphoid compartments, and subsequent secondary 
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and tertiary transplantations have proved to have consistent repopulating ability. In 
order to explain the emergence of the more mature CPU-s cell types before the primitive 
long term repopulating HSCs Muller et al have proposed a 'reverse haematopoietic 
hierachy' model in the embryo. However this apparent anomaly could also be explained 
in terms of the Potten and Loeffler's (1990) stem cell theory, where they propose various 
degrees of 'sternness and commitment and that depending on the circumstances, cells may 
either become more commited to differentation or revert to a more pluripotential state. 
In a recent study further dissection of the AGM region of day 10 mouse embryos, into their 
dorsal aorta and uro-genital ridge components, was carried out and each cell population 
assayed for their CFU-5 forming ability (Medvinsky et a!, 1996). It was subsequently 
found that although the frequency of CPU-S is higher in the dorsal aorta segment, the 
highest total number of CPU-s was obtained from the uro-genital portion. At around day 
10 the uro-genital ridges are occupied by primordial germ cells (PGC5). PGCs are an 
ectodermally derived population of cells which can be specifically detected by alkali-
phosphatase staining. Using this assay, PGCs are first detected at about 7 days p.c. At 
around day 8 they begin their migratory rout to the genital ridges via the hindgut 
epithelium. At approximately day 9 p.c. they arrive at the dorsal mesentry and proceed 
to the genital ridges which they colonise by day 11-11.5 p.c. and give rise to the germ 
layers in the prespective gonads. 
The time of their arrival at the dorsal mesentry coincides with the appearance of 
haematopoietic progenitors in this region. Recent studies have further confirmed the 
haematopoietic potential of PGCs (Rich, 1995). In vitro colony forming assays have 
demonstrated that after exposure to cytokines such as IL-3 and LIF, PGCs are able to give 
rise to myeloid and erythroid colonies. Further analysis of the PGC population has shown 
that they express c-kit (Manova and Backvarova, 1991), and their in vitro proliferation 
and survival depend on SCF (Rich, 1995). 
More recently clusters of cells associated with the dorsal aorta of 30-37 days gestation 
human embryos have been found, which test positive for haematopoietic markers and 
have also been shown to give rise to high numbers of clonogenic haematopoietic 
progenitors in vitro (Tavian et a!, 1996). Thus there is increasing evidence to suggest that 
the AGM plays an evolutionary important role in haematopoietic development and makes 
a contribution to definitive haematopoiesis. New models for haematopoietic development 
have therefore been proposed which take this into account. But the degree and manner in 
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which the ACM makes this contribution, or how ACM haematopoiesisis is initiated and 
the factors which control this process remain to be defined. 
1.2.4 Definitive haematopoiesis. 
In the avian model, after para-aortic haematopoiesis, haematopoietic progenitors are 
detected in the thymus, spleen, bursa Fabricius and bone marrow in sequence. A similar 
sequence is seen in the mouse where after the ACM, haematopoiesis is observed in the 
liver, thymus, omentum, spleen and finally bone marrow which remains the main site of 
haematopoiesis throughout adult life. 
At approximately day 9 p.c. the liver begins to form and by day 10.5 enucleated 
erythrocytes expressing adult haemoglobin, B-cells and macrophages are observed which 
mark the onset of definitive haematopoiesis (Barker, 1968). The thymus is also thought to 
be colonised by progenitors at around day 10.5 (Jotereau et al, 1986). Foetal liver 
haematopoiesis continues until around day 16 p.c. with the mid-stages being found to be 
particularly c-Kit dependent, since haematopoietic progenitors from the liver of day 12.5 
p.c. mouse embryos fail to give rise to myeloid and erythroid lineages in vitro in the 
presence of anti-c-Kit monoclonal antibody (Ogawa et a!, 1993a). This is not the case for 
haematopoietic liver progenitors from younger or older embryos. Although 
haematopoiesis shifts to other sites, the liver does not lose its haematopoietic potential 
totally. Thus if bone marrow haematopoiesis is diminished in the adult the liver can be 
found to supplement the system. More recently reconstitution of the haematopoietic system 
of lethally irradiated recipients with cells derived from the adult mouse liver have been 
reported (Taniguchi et a!, 1996; Watanabe et a!, 1996). 
Haematopoiesis has also been observed in the omentum of day 13 p.c. mouse embryos. the 
omentum is a segment of connective tissue which supports the stomach and spleen. It has 
been found to contain lymphoid and erythroid progenitors and remains at least 
lymphopoietic throughout adult life in mice. After transplantation under the kidney 
capsule the omentum of day 13 mouse embryos has been found to reconstitute the 
haematopoietic system of SCID recipients (Solvason and Kearney, 1989). Haematopoietic 
progenitors do not arise de novo in the omentum but the tissue is thought to be colonised by 
cells from other sites possibly while en route to the spleen. 
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In mice the spleen plays an important role in foetal haematopoiesis and remains a site of 
erythropoiesis throughout adult life. However in humans the spleen does not contribute to 
foetal haematopoiesis significantly with studies showing that human foetal spleen is 
mostly occupied by mature erythrocytes and granulocytes (Wilkins et al, 1994). 
Following their finding of haematopoietic activity in the AGM, Muller and Dzierzak 
(1993) have proposed a new model for the ontogeny of definitive haematopoiesis. Two 
waves of foetal liver colonisation by haematopoietic progenitors have been proposed: the 
first by yolk sac progenitors at approximately day 10 and the second by both yolk sac and 
AGM progenitors at around day 11 p.c., with the spleen and bone marrow being colonised by 
cells from the liver thereafter. 
Recent findings however suggest that bone marrow and spleen are colonised by the same 
migrating population of progenitors which populate the liver. By analysing the cells in 
mouse embryo circulation Delassus and Cumano (1996) have found that the population of 
haematopoietic progenitors increases between day 10 and 12 of gestation followed by a 
significant decrease at day 13. A second increase between day 14 and 16 is observed, 
however the progenitors in this wave are more committed. Furthermore they detect the 
presence of HSCs in the bone marrow at day 15 p.c., 24 hours earlier than previously 
reported. Further studies are however required to confirm these findings. 
1.3 Methods for studying haematopoiesis. 
As already discussed in section 1.1.1, the direct study and manipulation of HSCs has 
proved difficult due to the obscure phenotype and rarity of this cell type. In order to 
circumvent these limitations therefore various techniques and methods have been devised 
and adopted for the study of HSCs and haematopoiesis. Some of the methods currently 
used by investigators will be discussed in the following sections. 
1.3.1 Techniques used for the study of HSCs. 
In order to be able to study the molecular events which control haematopoiesis, candidate 
genes must first be identified. As previously pointed out, naturally occuring mutations such 
as those in the c-kit and HCP genes, and chromosomal translocations which give rise to 
leukaemias, such as those disrupting the AML-1 and PML genes have been useful sources of 
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information. However new appoaches must be devised if novel genes, involved in the 
haematopoietic process are to be identified. Various PCR (Brady et a!, 1990; Guimarães e t 
al, 1995) and subtraction library based techniques (Beading et a!, 1993; Jonk et a!, 1994), 
have been described. In order to be useful however, such techniques require an accessible 
cell type. 
Improved tissue culture techniques have greatly aided the in vitro maintenance of HSCs 
for limited periods of time. These techniques have been further facilitated by the 
identification and purification of haematopoietic growth factors which have been used 
either in concert with stromal cell lines (Szilvassy et al, 1996), or added directly to 
haematopoietic cell cultures (Sutherland et al, 1993) for the support of long term 
repopulating HSCs, and/or for encouraging the differentiation of HSCs toward particular 
lineages (Gabbianelli et al, 1995). Attempts have also been made to establish culture 
conditions which can support HSC maintenance and differentiation for prolonged periods 
of time which can then be used to purify and characterise HSC both phenotypically and 
genotypically (Sutherland et a!, 1990). The use of such culture conditions however will 
always be limited by the abundance and availability of the bone marrow source, and the 
need to maintain the haematopoietic progenitors on stromal feeder layers, makes their 
genetic manipulation particularly complex since such cultures give rise to a heterogeneous 
cell population. 
Devising techniques for the enrichment of HSCs, some of which were mentioned in section 
1.1.1, have been particularly important for studying the properties of HSCs. One technique 
which has proved particularly useful has been the genetic marking of haematopoietic 
progenitor cells with retroviruses, by co-culture with infected cell lines (Capel et a!, 1990; 
Jordan and Lemiscka, 1990). The molecular marking does not appear to alter the behaviour 
of the stem cell populations which have been found to provide long-term repopulation, 
contributing to all blood cell compartments of haematopoietic deficient recipients. 
Although retroviral marking allows the behaviour of HSCs to be assessed in vivo, it is not 
particularly informative with respect to the phenotypic and genotypic characteristics of 
HSCs. Thus Jordan et a! (1990a) have devised a method where retroviral marking is 
coupled with cell surface antigen and antibody panning enrichment techniques, resulting in 
the identification of a highly enriched foetal liver stem cell population. 
Enriched HSC populations can be useful for molecular analysis. It is possible for instance, 
to study the effects of gene over-expression in such populations. However due to 
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experimental limitations complete inhibition of gene expression, which is more 
informative about gene function, has proved somewhat more difficult to achieve, either by 
transfection with antisense oligonucleotides or with retroviruses harbouring dominant 
negative transgenes. The function of transcription factors can be sequestered more 
effectively with competitive binding oligonucleotides (Voso et a!, 1994). But molecular 
analysis of this kind carried out with isolated cell populations, does not take the effects of 
the haematopoietic microenvironment into consideration. 
Leukaemic cell lines such as human leukaemia (HL)-60 and murine erythroid leukaemia 
(MEL) cell lines have also been useful sources of study since they can be maintained in 
culture indefinitly, but are not particularly informative with respect to the study of stem 
cell dynamics. One cell line which has proved useful for studying stem cells however, is 
the FDCP-mix A4 population. This cell line, isolated from murine LT-BMC cultures, has 
the capacity to differentiate to multiple haematopoietic lineages in the presence of 
stromal cells or cytokines, and is also capable of self-maintenance in response IL-3 
(Spooncer et al, 1986; Heyworth et a!, 1995). The potential of the cell line to reconstitute 
the haematopoietic system of recipients has, however not been studied. 
Other investigators have attempted to establish immortalised multipotent 
haematopoietic cell lines with the use of viral or retroviral vectors, harboring genes 
which may play key roles in haematopoiesis. One such cell line was established from the 
bone marrow of mice transgenic for a GATA-1 driven temperature sensitive Simian virus 
(SV)-40 construct (Cairns et al, 1994). These cells have been reported to express myeloid 
specific cell surface markers and erythroid specific genes after exposure to Epo or IL-3. 
However detailed analysis of the multipotentiality of these cells with in vitro assays 
were not reported. 
Tsai et a! (1994a) have taken a similar approach in transfecting murine bone marrow cells, 
obtained 5 days after treatment with 5-fluorouracil, with a retroviral vector construct 
carrying a dominant negative RAR(x gene. Using this approach an SCF dependent cell line 
was established and found to have erythroid, myeloid and lymphoid potential in vitro. 
Retroviral transfection of HSCs is difficult to achieve not only because of their small 
numbers, but also since they are a quiesent population with low replicative rate, which 
hinders retroviral integration. Thus in this experiment it is difficult to assess what 
proportion of the targeted cells were true HSCs or more committed progenitors. 
Furthermore the cell types derived from both strategies described, may be biased by the 
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use of vectors carrying genes known to be involved in the differentiation of particular 
haematopoietic lineages. 
The in vivo potential of neither of the above two cell types have been assessed. However 
one immortalised cell line has been established, from day 12 p.c. foetal liver cells, 
transformed by a rearranged retroviral vector carrying the IL-3 gene (Wong et al, 1994), 
and has been shown to have the ability to reconstitute the haematopoietic system of 
lethally irradiated recipients in primary and secondary transplantation experiments. 
Moreover the recipients did not develop any malignancies or blood related abnormalities. 
Despite these findings however it is difficult to extrapolate the behaviour of transformed 
cell lines to normal haematopoietic cells, and their use sheds very little light on processes 
involved in haematopoietic development. In recent years, however, the derivation and use 
of embryonic stem cell lines has changed the course of haematopoietic research. Not only 
are they relatively accessible and easily manipulated, but their use circumvents many of 
the limitations outlined above. 
1.3.2 Embryonic stem cells. 
Totipotential embryonic stem (ES) cells are currently the only untransformed stem cell 
population in culture. The first indication that such a cell line could be obtained in vitro 
came with the observation that when embryos of up to mid-gastrulation stage, or their 
dissected totipotent epiblast cells were transplanted into a well vascularised, non-uterine 
position such as the testes, the host developed tumours (Stevens, 1970). These 
teratocarcinomas of donor origin were found to contain an array of tissue types including 
skin, hair and bone, but no organised structures requiring the interaction of various tissue 
types for their development, such as kidney and heart. A high proportion of the cells in 
the tumours were also found to be proliferating undifferentiated cells referred to as 
embryonic carcinoma (EC) cells. When re-transplanted into hosts EC cells were found to 
once again give rise to teratocarcinomas and more undifferentiated EC cells. After several 
transplantations, in vitro EC cell lines were established from tumours, which could be 
maintained in an undifferentiated state either in the presence or absence of fibroblast 
feeder layers. 
In certain inbred strains of mice teratocarcinomas of germ cell origin arise spontaneously in 
the gonads. Human EC cell lines have also been isolated from spontaneous germ cell 
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tumours (Thompson et al, 1984), however similar transplantation experiments as those 
performed in mice have failed to produce EC cells in other species. 
In vitro, EC cells were found to give rise to all cell types including haematopoietic cells 
(Cudennec and Nicolas, 1977; Miwa et al, 1991). Furthermore, chimaeric mice were 
generated from EC cells after their injection into pre-implantation blastocysts and were 
found to be able to contribute to all three primary tissues (ectoderm, endoderm and 
mesoderm) and at low frequencies to the germ layer (Stewart and Mintz, 1981). These 
chimaeras however were found to be highly prone to developing tumours of EC cell origin 
(Rossarit and McBumey, 1982). It therefore became desirable to establish a totipotent cell 
line which could contribute to the germ layers of chimaeric animals at higher frequencies, 
which is essential for detailed study of developmental and molecular processes. 
Embryonic stem cell lines were thus established from 3.5 day p.c. pre-implantation male 
embryos from the 129 and C57132 strain of mice (Evans and Kaufman, 1981; Martin, 1981). In 
brief the process involves the attachment of embryos to culture dishes which mimics the 
process of implantation, causing the trophectoderm to spread into a monolayer exposing 
the 1CM. The 1CM then proliferates to form a cluster which is disaggregated with trypsin. 
These totipotent cells were subsequently cultured on fibroblast feeder layers without 
which ES cells terminally differentiate. 
Further analysis of the supernatant of the feeder layer showed the undifferentiated state 
of the cells was maintained by the glycoprotein leukaemia inhibitory factor (LIF) 
(Williams et al, 1988), also referred to as differentiation inhibiting activity (Smith et al, 
1988), and that ES cells could be prevented from differentiating with the addition of 
recombinant LIF. The latter technique is preferred since it provides a homogeneous 
population of cells for experimentation. 
Like EC cell lines, when introduced into hosts ES cells can give rise to teratocarcinomas, 
and can also be used to produce chimaeric mice. ES cells however contribute to the germ 
layer at a much higher frequency than EC cells, making them an extremely useful tool for 
transgenic and knock-out' mutation studies. Using compromised tetraploid host blastocysts 
Nagy et a! (1990) have furthermore shown that mice entirely derived from ES cells can be 
generated. 
Several examples of gene 'knockout' mice generated from ES cells, have already been 
mentioned. In brief the technique involves the transfection of a vector construct with a 
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selectable marker, harboring a mutant copy of the gene of interest into ES cells. Upon entry 
into the nucleus the mutated gene recombines with its homologue. The recombinant cells 
are selected and either combined with or injected into pre-implantation host embryos and 
the resulting chimaeras crossed to produce homozygous mutants. Due to their ability to 
differentiate to all cell types ES cells have been used extensively in vitro, particularly for 
the study of haematopoiesis, discussed in the next section. 
Both EC and ES cells terminally differentiate by the removal of LIF, but they can also be 
induced to differentiate by the addition of chemicals such as sodium butyrate (Kosaka e t 
al, 1994) and 6-thioguanine (Edwards et al, 1983). The most commonly used exogenously 
added inducers of differentiation however are retinoic acid and (RA) and dimethyl 
suiphoxide (DMSO). DMSO has been found to induce cardiac and skeletal muscle in EC and 
ES cells (Edwards et al, 1983; Dinsmore et al, 1996). At lower concentrations RA has also 
been found to induce cardiac and skeletal muscle cells from EC cells, whereas at higher 
concentrations of approximately 10 -7 M it induces neural and glial lineages (Edwards et a 1, 
1983). RA also has been found to induce neural and skeletal muscle tissues from ES cells, but 
has been found to inhibit cardiac muscle differentiation (Wobus et al, 1994; Bain et al, 
1995). ES cells in other species such as rat, hamster and pig have also been reported, 
however the only other cell line which has been shown to give rise to chimaeric animals is 
the avian ES cell line (Pain et a!, 1996). Recently sheep 1CM cells have also been isolated 
which is a major step forward in establishing ES cells from this species (Karasiewics et a 1, 
1996). 
1.3.3 Haematopoietic differentiation of embryonic stem cells, in vitro. 
Totipotential embryonic stem cells are a relatively accessible cell type which can, not only 
be easily manipulated, but also give rise to all eight lineages of the 
lymphohaematopoietic system in vitro, with high reproducibility. Most studies of 
haematopoietic differentiation of ES cells have been carried out with their cystic 
aggregates, referred to as embryoid bodies. Such structures are thought to mimic the in 
vivo microenvironment that are able to support haematopoiesis. Embryonic stem cells are 
highly adhesive in nature, interacting with one another and other cell types. This 
property is exploited in vitro to generate embryoid bodies which is generally achieved in 
one of two ways. 
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If LIF, or fibroblast feeder layers, are removed and ES cells cultured in suspension or media 
containing methyl cellulose in non-tissue culture grade dishes, the cells adhere to the 
surface of the dish and to one another, thus forming three dimensional embryoid bodies 
composed of differentiated cells. This method has been adopted in haematopoietic studies 
by growing ES cells on stromal cell lines known to support haematopoietic growth and 
differentiation. Under such conditions the resulting embryoid bodies are surrounded by 
differentiated haematopoietic cells. Alternatively ES cells can be grown in 'hanging drop' 
suspension cultures in the presence of LIF for approximately 48 hours during which time 
they form aggregates. Once formed, embryoid bodies are allowed to differentiate in 
suspension culture. The advantage with the 'hanging-drop' culture method is that it 
generates embryoid bodies of approximately uniform size, and unlike the methyl cellulose 
method where embryoid body formation and differentiation occur simultaneously, it 
provides a synchronised culture system where all aggregates begin differentiation at time 
zero. 
The ability of ES cells/embryoid bodies to differentiate towards haematopoietic lineages 
in vitro was first reported by Doetschman and co-workers (1985) who found that as well as 
giving rise to cardiac muscle, blood islands also formed in these cysts. Analysis of these 
blood islands revealed that they were pockets of nucleated erythrocytes, expressing 
embryonic haemoglobin, encapsulated by endolethial cells. Detailed analysis of these 
blood islands has shown that they form a vascular network, which although not as 
ordered as those of yolk sac blood islands, nevertheless make contact with the surrounding 
endothelial layer and have been reported to contain blood cells in the lumen (Wang et a 1, 
1992). 
Most ES culture systems are supplemented with serum, (typically from bovine calf), and 
embryoid bodies are able to give rise to haematopoietic cells in these conditions without 
additional growth factors. However it has been found that embryoid body differentiation 
towards particular lineages can be encouraged with certain cytokines (Wiles and Keller, 
1991; Bigas et al, 1995). For instance the addition of Epo increases the number of 
erythropoietic cells, whereas recombinant IL-3 increases macrophage and mast cell 
numbers, while GM-CSF has been reported to have little effect. 
The pattern of haematopoietic gene expression in embryoid bodies has also been studied 
extensively (Schmitt et al, 1991, McClanahan et al, 1993). A range of haematopoietic cell 
specific genes have been found to be expressed in embryoid bodies including cell surface 
markers, e.g. Ly6A/E (Sca-1) and CD45, haematopoietic cytokine receptors, e.g. c-kit and 
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Epo-receptor, and transcription factors e.g. GATA-1. Furthermore this pattern of gene 
expression has been reported to be temporally ordered with mesoderm specific genes, such 
as brachyury, and genes associated with primitive haematopoietic cells being expressed 
first, followed by those indicative of more committed cell types. 
Studies of haematopoietic cell types which arise in embryoid bodies have moreover 
confirmed these reports (Keller et al, 1993). Nucleated erythroid cells are the first to be 
observed in embryoid bodies followed by macrophages, enucleated erythroid cells, 
neutrophils, multilineage precursors and finally mast cells. This cell differentiation 
sequence, closely resembles that of normal murine haematopoietic development. 
Lymphoid precursors with the ability to rearrange T- and B- cell receptors, and 
reconstitute the lymphoid compartment of sublethally irradiated SCID mice, have also 
been observed in embryoid bodies (Gutierrez-Ramos et al, 1992; Potocnik et a!, 1994). 
Although progenitor and terminally differentiated haematopoietic cells have been 
derived in vitro, whether ES cells are able to give rise to self-maintaining haematopoietic 
stem cells has been the subject of some debate. Colony forming assays have demonstrated 
that ES cells are able to give rise to primitive haematopoietic cells in vitro (Bigas et a!, 
1995). The primitiveness of such cells has been tested with various in vivo studies. Earlier 
it was shown that ES cell derived livers of 14.5 day chimaeric foetuses, could reconstitute 
lethally irradiated hosts (Forrester et a!, 1991). Furthermore haematopoietic cells from 
these hosts could be used to reconstitute secondary recipients. 
Following this, it was demonstrated that some populations of immortalised 
haematopoietic cells of ES cell origin, could give rise to multiple lineages in lethally 
irradiated recipients (Chen et a!, 1992). These experiments indirectly illustrate that ES 
cells can give rise to haematopoetic cells with reconstituting ability. However in order to 
test whether ES cells are able to give rise to self-maintaining haematopoietic stem cells, 
in vivo reconstitution studies with genetically unaltered ES cells must be carried out. 
Such an experiment performed by Muller and Dzierzak (1993) showed that only the more 
mature CPU-S cell type with limited recontitution ability could be derived from ES cells. 
However recently long-term repopulation of lethally irradiated recipients with 
differentiated ES cells have been reported (Palacios et a!, 1995; Hole et a!, 1996). In the 
former study ES cells were co-cultured with a stromal cell line and cytokines such as IL-3 
and IL-6 added. Following FACS sorting Thy1Lin cell populations were injected into 
lethally irradiated hosts and donor cells found to contribute to all haematopoietic 
FIE 
ES cells 
maintained in LIF 
0 
Hanging drop culture 
300 cells/1 Opi in presence of LIF 
cell aggregates 
harvested after 48 hours 
0000 Iowa 
W Assay J after 2- 10 days differentiation  
. ~'qq 
Suspension culture 
embryoid bodies differentiate 
in absence of LIF 
lineages. In the latter study however embryoid bodies cultured in the absence of 
additional cytokines or stromal cell lines have been shown to reconstitute the 
haematopoietic system of lethally irradiated recipients. 
With reports of the ability of ES cells to reconstitute haematopoietically compromised 
hosts, it is becoming increasingly apparent that the ES cell culture systems provides a 
unique model for studying both primitive and definitive haematopoiesis. Despite its many 
advantages, certain limitations are still imposed by the ES cell culture system, foremost of 
which is that it remains an in vitro model and as such may not be fully representative of in 
vivo haematopoiesis. Furthermore ES cell commitment and differentiation is temporally 
specific and results in the production of multiple cell types and not just haematopoietic 
lineages. Due to these reasons the study of the early developmental events which control 
ES cell haematopoietic commitment remain difficult to elucidate. 
1.3.4 Aims and objectives of the current study. 
As mentioned earlier, the detailed molecular events which control haematopoietic 
commitment and differentiation are poorly understood, since key genes which direct the 
process have yet to be identified. The main aim of this project has been to distinguish and 
isolate such regulatory elements. However in order to identify a relatively small 
population of genes involved in a specific process, requires a panning process whereby the 
larger unrelated pool can be eliminated. One means of achieving this is by altering gene 
expression patterns of the system under study to either enhance or down-regulate the 
expression of the genes of interest, which can in turn be achieved by altering the growth 
conditions of cells. 
The culture system under study, outlined in Figure 1.3, utilises the CFU-A assay (colony 
forming unit-assay) to assess and quantify the haematopoietic differentiation of embryoid 
bodies (Figure 1.4). It has thus been found that approximately 30-50% of 5-7 day old 
embryoid bodies can give rise to CFU-A colonies. Embryoid bodies which have 
differentiated for less than 4 or more than 8 days, give rise to markedly fewer CFU-A 
colonies. This time course of differentiation has been found to be highly reproducible. 
Although few CFU-A colonies are obtained with 4 day embryoid bodies, the reconstituting 
ability reported by Hole et al (1996), appears to be restricted to this time point. 
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This project therefore seeks to modulate embryoid body haematopoietic commitment by 
the addition of exogenous factors to the culture environment of these cystic structures, 
thereby up- or down-regulating haematopoietic gene expression. This strategy could 
thereafter be used to devise a method of identifying genes which are either directly 
involved in ES cell haematopoietic commitment and differentiation, or which could act as 
surrogate markers for potential haematopoietic progenitors. 
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Figure 1.4. CFU-A assay of embryoid bodies. Embryoid bodies were assayed after 6 days 
differentiation in suspension culture, and assays scored after approximately 11 days 
incubation. A typical CFU-A colony is illustrated in the centre of the figure with 
macrophage and monocytes emanating from the central embryoid body. Two non-
haematopoietic embryoid bodies are represented to the right of the colony. 
z 
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2. Materials and Methods. 
All chemicals were of analytical grade and were purchased from the suppliers indicated, the 
addresses for which are given in Apppendix II. All percentages are weight/volume unless 
specified otherwise. 
2.1 	Tissue culture techniques. 
2.1.1 Routine maintenance of cells. 
The embryonic stem (ES) cell line, EFC-1, derived from male embryos of 129J/Ola strain of 
mice were used throughout the course of the study (Nicholls et a 1, 1990). These were routinely 
karyotyped and checked for mycoplasma infection. All procedures were carried out essentially 
as described (Smith, 1991; Hole and Smith, 1994). Cells were thawed rapidly in a 37°C water 
bath and transferred to a 15ml centrifuge tube containing 9.5ml of media [1 x G-MEM (Gibco 
BRL) media supplemented with 10% foetal calf serum (GlobePharm), 1% non-essential amino 
acids (Gibco BRL), 2% L-glutamine/sodium pyruvate (Gibco BRL) (L-glutamine (200mM) and 
sodium pyruvate (100mM) were prepared as stocks in a 1:1 ratio), 1 x 10 M 2-mercaptoethanol 
(Sigma), 0.2% sodium bicarbonate (Gibco BRL)]. The suspension was centrifuged at 140g for 5 
minutes, the media aspirated and lOmi of fresh media added. The cells were then transferred 
to a 25cm 2 plastic flasks coated with 0.1% gelatine (Sigma), 100 U/mi of LIF added and 
incubated at 37°C in a humidified atmosphere of 5% CO2. LIF was obtained from the 
supernatant of Cos-7 cells transfected with an expression vector containing the LIF gene. The 
volume of supernatant which gave a detectable inhibition of ES differentiation was defined 
as 1 unit. After approximately 6 hours incubation the media en the newly thawed cells was 
aspirated and fresh media added. 
Cells were thereafter routinely passaged once every 48 hours being washed with 4-5m1 of PBS 
(Oxoid) and then released into a single cell suspension by trypsinisation at 37°C with 2ml of 
TVP [1% chick serum (Gibco BRL), 1% trypsin (Gibco BRL), 8.4 x 10 M EDTA (MERCK-BDH) 
in PBS] for approximately five minutes. Following physical agitation the cells were 
transferred to a 15m1 centrifuge tube, 8m1 of media added and the suspension spun at lOOg for 5 
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minutes. The supernatant was consequently removed and the pellet re-suspended in lOml of 
fresh media. A sample of the suspension was then used to estimate cell numbers with a 
haemacytometer. This suspension was either used for passaging, passeges being seeded at 
approximately 1 x 106  cells per lOml of media, or generating hanging drop suspensions. Cells of 
more than passage 30 were not used for experiments. 
For the purposes of freezing, cells was trypsinised as described, resuspended in 7m1 of media. 
The suspension was then centrifuged at 100g for 5 minutes, the supernatant aspirated and cells 
resuspended in 1.0ml of 10% DMSO (v/v) in media. 0.5m1 of the suspension was then pipitted 
into a cryo-tube and placed in a -70°C freezer overnight and thereafter transferred to liquid 
nitrogen (BOC). 
2.1.2 'Hanging Drop' method for the generation of ES cell aggregates 
'Hanging drop' cultures for the formation of embryoid bodies were performed essentially as 
described by Rohwedel et al, (1994). Cell suspensions of approximately 3 x 10 cells per ml of 
media in the presence of 100U/ml of LIF were prepared and lOjtl aliquots dispensed on the 
upturned lid of a bacteriological plate. The lid was subsequently replaced on the base of the 
plate, containing 8m1 of sterile water to prevent dehydration of the drops. Plates were then 
incubated at 37°C in a humidified atmosphere containing 5% CO2 for 48 hours after which the 
undifferentiated ES cell aggregates were harvested into universal containers, centrifuged a t 
65g for 3 minutes, the LIT containing supernatant removed by aspiration and the aggregates 
resuspended in an equal volume of differentiation media [1 x G-MEM media supplemented 
with 10% foetal calf serum (Advanced Protein Products), 1% non-essential amino acids, 2% L-
glutamine/sodium pyruvate, 1 x 10 M 2-mercaptoethanol, 0.2% sodium bicarbonate]. 
2.1.3 Culture of embryoid bodies. 
Embryo bodies were cultured in differentiation media in non-tissue culture grade petri dishes, 
50j.tg/ml of streptomycin/50 units penicillin (Gibco BRL) being included in the media during 
the first 48 hours of differentiation, and incubated at 37°C in a humidified atmosphere of 5% 
CO2. Embryoid bodies were routinely harvested once every 48 hours by transfer into universal 
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containers and allowed to settle. The media was then aspirated and embryoid bodies 
resuspended in fresh differentiation media. The volume of media used was dependent on the 
numbers of embryoid bodies cultured, 1500-2000 embryoid bodies being cultured in 20m1 of 
media in 10cm2 dishes and numbers of between 375-500 cultured in lOml of media in 5cm 2 
dishes. 
Chemical inducers were included in the cultures as required. Retinoic acid (Sigma) was 
dissolved in 100% ethanol (Merck-BDH) at a stock concentration of 10-2  M and stored in the 
dark at -20°C; a-tocopherol (Sigma) was dissolved in 100% ethanol at a stock cencentration of 
1M and stored as retinoic acid. Iron (II) sulphate (Sigma) was made fresh in differentiation 
media at a stock concentration of 10 2M and filtered through a 0.2jim syringe filter before 
addition to cultures. After the required period of exposure, embryoid bodies were harvested as 
described and washed once in 10-15m1 of PBS before resuspension in fresh differentiation 
media. 
2.1.4 CFU-A assay for the detection of primitive haematopoietic stem cells. 
Assays were performed essentially as described (Pragnell et a!, 1988; Lorimore et al, 1990). 
The assay is composed of 2 layers, a bottom feeder layer containing conditioned media which 
are a source of cytokines, and a top agar layer which is used to dispense embryoid bodies on the 
feeder layer and also maintains the CFU-A colonies intact. The bottom feeder layer consisting 
of 0.6% Noble agar (Difco), 50% 2 x stock media [50% (v/v) horse serum, 42% (v/v) cx-MEM; 
2% L-glutamine; 0.45% sodium bicarbonate], 1 / 10th of the total volume of conditioned media 
from the rat fibroblast cell line L929 (a source of CSF-1 (M-CSF) (Stanley and Heard, 1977)), 
and 1/20 of the total volume of conditioned media from the malignant histocytosis sarcoma 
virus-transformed cell line AF1-19T (a source of GM-CSF (Franz et a!, 1985)), was prepared 
and imi layers dispensed into 3cm tissue culture grade dishes and allowed to set. Each 
embryoid body sample was assayed in triplicate. 
Embryoid bodies were harvested into universal containers, allowed to settle and their media 
aspirated. The number of embryoid bodies per sample was estimated by placing three 10.tl 
aliquots onto a microscope slide and calculating the mean number per lojil. An aliquot of 
embryoid bodies containing approximately 150 embryoid bodies was then removed and placed 
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into a fresh universal container. These embryoid bodies were then mixed with 3m1 of top agar 
[0.3% agar; 50% 2 x stock media] and dispensed onto the bottom agar layer, imi per plate, 
(approximately 50 embryoid bodies per plate). The plates were then incubated at 37°C in a 
humidified atmosphere with 5% 02  and 10% CO2 for 11 days. CFU-A colonies were quantified 
visually using an inverted light microscope. 
CPU-A colonies are typically defined as those with a diameter of 2mm or more. However, 
since more primitive haematopoietic progenitors can potentially give rise to smaller CFU-A 
colonies (Pragnell et a!, 1988), in order to avoid the exclusion of such a population of cells from 
quantification, CPU-A colinies were defined on the basis of the number of haematopoietic 
cells (typically macrophages and monocyates) surrounding an embryoid body. Therefore, 
embryoid bodies surrounded by 50 or more haematopoietic cells were defined as CFU-A colony 
forming. The same definition was applied for the quantification of CFU-A colonies from 
disrupted embryoid bodies. That is clusters of 50 or more cells were defined as CPU-A colonies. 
2.1.5 Disruption of embryoid bodies. 
Embryo bodies were harvested as described in section 1.3, their supernatant removed, washed 
once with PBS and then resuspended in 0.5ml of PBS per 375-500 embryoid bodies. An equal 
volume of Dispase (Boehringer) was added and the suspension incubated at 37°C for 1 hour 
with gentle agitation. The cell suspension was passed through a 23G needle several times to 
give a single cell suspension and then transferred to a 15m1 centrifuge tube and centrifuged a t 
lOOg for 5 minutes. The supernatant was removed and the pellet re-suspended in imi of PBS 
and the cell number estimated. For CPU-A assays 1.8 x 10 5 cells were assayed in triplicate, 6 x 
104 cells per plate, as described in section 2.1.4. 
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2.2 	Animal dissections. 
2.2.1 Dissection of mouse spleen and thymus, and single cell suspension preparartion. 
Spleen cells were obtained from female 129/01a mice by dissection. Incisions were made 
through the fur and peritoneum, the spleen removed and placed into a petri dish and covered 
with 1-2m1 of PBS. Two 23G needles on lml syringes were bent to a 900  angle. The spleen was 
held in place with one needle while the second needle was used to nick one end of the spleen 
membrane and then gently stroked across the organ to release the cells. Once the majority of 
the cells had been removed the spleen membrane was discarded and the volume was made up 
to lOml with PBS. The spleen preparation was then passed through a 23G needle to make a 
single cell suspension, transferred to a 15ml centrifuge tube and the cell number estimated with 
a haemacytometer. Single cell suspensions from the thymus were obtained using the same 
technique. Spleen cells required for RNA isolation were extracted using a dissection kit that 
was sterilised at 200°C for 4 hours prior to use, 0.1% DEPC treated PBS was used and the cell 
suspension was maintained on ice to minimise RNA degradation. 
2.2.2 Bone marrow single cell suspensions from mouse femur. 
A female 129/01a mouse was skinned to expose the leg and muscle tissue removed from the 
femur. The femur was then removed by incisions at the knee and hip joints and the epiphyses 
removed. Using a imi syringe and 23G needle lml of ice cold 0.1% DEPC treated PBS was 
flushed through the marrow and into a chilled 15m1 centrifuge tube. The bone marrow cell 
preparation was then passed through a 23G needle to make a single cell suspension, the 
volume made up to lOml with PBS and the cell numbers estimated with a haemacytometer. 
2.2.3 Dissection of post coital (p.c.) mouse embryos for RNA extraction. 
Timed matings were set up between 3 female and 1 male CBA/Ca mice and 6.5 days after 
vaginal plugs were observed one female mouse was killed. The uterus was cut away from the 
pubic bone and the uterine horns separated but left attached at the ovaries. The end of one 
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uterine horn was held in place with a pair of forceps and and the membrane cut along the 
length to expose the decidual masses which were then removed and placed in a petri dish 
containing 1-2m1 of 0.1% DEPC treated PBS. With the use of a microscope the decidual masses 
were held in place with a pair of forceps and cut off-centre along the length. The embryo 
proper was teased out by gentle removal of the surrounding maternal and placental tissue. 
Once free, the embryo was removed with a sterilised Pasteur pipette and placed in a 1.5m1 
eppendorf tube and used for RNA extraction. 
For the removal of day 13 p.c. embryos the uterus was once again cut away from the pubic bone 
and the uterine horns separated but left attached at the ovaries, as above. One uterine horn 
was held in place with a pair of forceps and the membrane cut along its length to expose the 
embryos. The embryos were then removed and placed in a petri dish containing 3-4m1 0.1% 
DEPC treated PBS. The allantois was peeled away and removed along with the placenta and 
yolk sac, and the foetal liver removed with a pair of forceps and placed into a 1.5m1 
eppendorf containing 0.5m1 DEPC treated PBS. The foetal liver was then homogenised by 
passage through 18G and 23G needles respectively and then used for RNA extraction. 
2.3 	Molecular biology techniques. 
All procedures were carried out essentially as described by Sambrook et a! (1989) except where 
indicated. All glassware used for RNA work was sterilised at 200°C for 4 hours prior to use and 
all solutions were treated with 0.1% DEPC for 2 hours, or overnight at room temperature, 
before autoclaving. 
2.3.1 Preparation of genomic DNA. 
Blood samples collected from mice were centrifuged at 9500g for 5 minutes, the sera removed 
and 2 volumes of lysis buffer [25mM Tris (Fisons); 75mM sodium chloride (Fisons)), 1/5 of the 
total volume of blood of 10% SIDS (Fisons)] and 1/20 of the volume of proteiriase K (10mg/mi) 
(Boehringer) were added and the cells incubated overnight at 37°C. An equal volume of 
washed phenol (Fisons) was then added and the 2 phases thoroughly mixed for five minutes. 
The suspension was centrifuged for 2 minutes at 9500g, the aqueous layer transfered to a fresh 
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1.5m1 eppendorf and the procedure repeated. An equal volume of chloroform (Fisons): isoamyl 
alcohol (Aldrich Chemical Co. Ltd.) (24:1) was then added and the 2 phases mixed 
thoroughly for 5 minutes. The suspension was centrifuged for 5 minutes at 9500g and the 
aqueous layer transfered into a fresh 1.5m1 eppendorf tube. 1/10 of the total volume of 3 M 
sodium acetate (Fisons) (pH 7.0) and 2 volumes of 100% ethanol were then added and the 
DNA allowed to precipitate at -70°C for 20 minutes after which it was pelleted by 
centrifugation at 9500g for 20 minutes. The pellet was washed once with 70% ethanol, 
centrifuged as above and finally dissolved in an appropriate volume e.g. 200pJ of TE buffer 
(10mM Tris.Cl pH 7.5; 1mM EDTA pH 8.0). 
2.3.2 PCR amplification of ZFY and Myogenin markers. 
The proportion of peripheral blood cells derived from male ES cells was determined by 
polymerase chain reaction (PCR) amplification of the male genomic marker ZFY, essentially 
as described (Koopman et al, 1991) with the exception that separate reactions were prepared 
for ZFY and Myogenin (control reaction). The reaction mixtures consisted of lOpi of genomic 
DNA, 0.3mM of each of dATP, dGTF, dCTP and dTFP (Promega), 1 x PCR buffer [50mM Tris-
HCL pH 9.0, 15mM ammonium sulphate (Fisons), 7mM magnesium chloride (Fisons), 0.05% 
Nonidet P-40 (Merck-BDH)J, lj.tg oligonucleotide mix (Cruachem) (consisting of 1:1 ratio of 3' 
and 5' primers; Table 2.1), and 2.5 units of BIOPROTM polymerase (Bioline) were added in a 
total volume of 50jil. The reactions were briefly centrifuged in a microcentrifuge, overlaid 
with 50j.tl of mineral oil (Sigma) and PCR amplification carried out. The template was 
denatured at 95°C for 5 seconds followed by annealing of primers for 30 seconds at the 
appropriate temperature (Table 2.1) and extension at 72°C for 30 seconds. This procedure was 
caned out for 25 cycles. Upon completion, 2pJ of 6 x DNA gel loading buffer [0.25% 
bromophenol blue (Fisons); 0.25% xylene cyanol FF (Fisons); 30% glycerol in water (Fisons)] 
was added to 10il of each PCR product and products electrophoresed on 2% agarose 
(Boehringer), 0.5 x TEE (0.045M Tris-borate; 0.001M EDTA), 0.5 jig/rrd ethidium bromide 
(Sigma) gels, at 5 v/cm of gel and thereafter photographed. Gels were then denatured in 100-
200m1 of 1.5M sodium chlride/0.5M sodium hydroxide solution and Southern blotted. 
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2.3.3 Purification and [a- 32 P1 dCTP labelling of probe DNA. - 
Probe DNA was either obtained from PCR amplification of the relevant fragment from mouse 
genomic DNA or cDNA, or excised from plasmid vectors by restriction endonuclease digestion. 
Restriction endonuclease reactions typically consisted of approximately 5jtg of plasmid DNA, 
5 units restriction enzyme(s) (Boehringer), 1 x of appropriate reaction buffer, in a total volume 
of 20-50p1 and digested at the required temperature (typically 37°C) for at least 1 hour. PCR 
products and/or restriction endonuclease reaction products were resolved on 1-2% agarose, 0.5% 
TBE, 0.5j.tg/ml ethidium bromide gels. The appropriate band was then cut from the gel and 
placed in a 0.5m1 eppendorf tube which had been pierced once with a 26G needle and plugged 
with siliconised glass wool. DNA was collected into a 1.5m1 eppendorf by centrifugation for 10 
minutes at 2000g in a microcentrifuge. The DNA eluate was extracted twice with 
phenol/chloroform and precipitated with 1/10 volume 3M sodium acetate, pH 7.0, and 2 
volumes of ethanol. 
Once purified the probe DNA was labelled with radioactive [a- 32 P] dCTP (Amersham), using 
the Promega nick translation system according to the manufacturer's instructions. The 
labelling reaction consisted of 180tM dNTP mixture (60MM of each dNTP excluding dCTP), 1 x 
Nick translation buffer (50mM Tris-HC1, pH 7.2; 10mM magnesium sulphate; 0.1mM DTT), 1ig 
probe DNA, 50jiCi [(X-32p]  dCTP, 5pJ Promega Nick Translation Enzyme Mix [1 unit/il of DNA 
polymerase I, 0.2 ng/pJ DNase I in a 50% glycerol in a solution containing 50mM Tris-HO pH 
7.2, 10mM magnesium sulphate, 0.1mM DTF and 0.5mg/mi nuclease free BSA], in a total 
volume of 50.tl. The reaction was incubated at 15°C for 1 hour and subsequently Sjil of stop 
solution (0.25M EDTA pH 8.0, 0.5M sodium phosphate pH 6.8) added and the total volume 
made up to 100l with double distilled water. Unincorporated dNTPs were removed by 
centrifugation of the product through a lml Sephadex G-50 (Pharmacia) column. The columns 
were prepared by filling a lml syringe with Sephadex G-50 and centrifuging for 5 minutes a t 
350g. This was repeated once more and the column washed once with 0.5m1 of 0.1% SDS and 
centrifuged at 350g for 5 minutes. The radioactive labelled probe was then centrifuged through 
the column at 350g for 5 minutes and the eluate collected into a 1.5m1 eppendorf. The double 
stranded DNA probe was denatured by boiling in a water bath for 5 minutes and subsequetly 
chilled rapidly on ice. 
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2.3.4 Extraction of total RNA and agarose/formaldehyde gel electrophoresis. 
Total RNA was extracted from embryoid bodies and/or tissue samples using RNAzo1 B solution 
(Biotecs) according to the manufacturer's instructions. Briefly the embryoid body or 
homogenised tissue sample was washed with DEPC treated PBS at least 3 times and 0.2m1 of 
RNAzo1 B solution per 106  cells was added, each embryo body being estimated to contain an 
average of 5000 cells. The lysate was then passed through a 23G needle several times, 
followed by addition of 1/10 volume of chloroform (Fisons), mixed thoroughly by agitation 
and incubated at 4°C for 5 minutes. The sample was then centrifuged at 4°C at 12000g for 15 
minutes and the upper aqueous phase transferred to a fresh tube. An equal volume of propan-2-
ol (Merck-BDH) was added to precipitate the RNA and the sample incubated at 4°C for at 
least 25 minutes. The RNA was subsequently pelleted by centrifugation at 7500g for 10 minutes 
at 4°C, washed once in 70% ethanol, re-centrifuged and dissolved in an appropriate volume of 
DEPC treated 1mM EDTA, pH 7.0. The absorbance of the RNA samples were measured at 
260nm and 280nm to determine concentration and purity, and samples stored at -20°C. 
Electrophoresis of total RNA extracts on denaturing agarose formaldehyde gels were carried 
out as follows. 1% agarose gel were prepared by dissolving the appropriate amount of agarose 
in DEPC treated water, cooling to 60°C, and adding 1/5 of the total volume of 5 x 
formaldehyde gel running buffer [0.1M MOPS pH 7.0, 40mM sodium acetate (Merck-BDI-1), 
5mM EDTA] and formaldehyde (Merck-BDH) to give a final concentration of 2.2M. The RNA 
samples (3-10j.tg) were then prepared by adding 1/10 of the total volume of 5 x formaldehyde 
gel running buffer, 50% formamide (Merck-BDH) and formaldehyde to give a final 
concentration of 2.2M. The samples were then incubated at 65°C for 15 minutes, chilled on ice 
and 1/10 of the total volume of RNA gel loading buffer [0.25% bromophenol blue; 0.25% xylene 
cyanol FF (Fisons); 1mM EDTA pH8.0; 50% glycerol in DEPC treated water] and 1/100 of the 
total volume of lOmg/ml ethidium bromide added and mixed thoroughly. The formaldehyde 
gel was pre-run in 1 x formaldehyde gel running buffer for 5 minutes at 5 volts/cm of gel, then 
the samples loaded and electrophoresed. The gels were subsequently photographed, washed 
in copious amounts of DEPC treated water with 3-4 changes to remove the formaldehyde and 
blotted on to nitrocellulose membranes as described in section 2.3.5. 
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2.3.5 Southern and Northern transfer and hybridisation with probe DNA. 
Capillary transfer of DNA and RNA onto a solid support was performed essentially as 
described by Southern (1975) and Aiwine (1977) respectively. The capillary transfer 
apparatus was prepared by pouring 20 x SSC (3M sodium chloride; 03M sodium citrate) in to 
large tray and placing a platform support over the tray. A folded sheet of Whatman 3MM 
paper soaked in 20 x SSC was then placed on the support with the overhanging edges imersed 
in 20 x SSC, avoiding the entrapment of air bubbles. The gel was then placed upside down on 
the 3MM paper, once again avoiding air bubbles and a of piece of nitrocellulose filter 
(Boehringer) which had been cut to the size of the gel and pre-soaked in 2 x SSC carefully 
placed over the gel. To assist the transfer two pieces of 3MM Whatman paper were placed 
over the filter and covered with a stack of paper towels and an even weight of approximately 
500 grams balanced on the towels. In order to avoid short circuiting of the transfer the gel was 
surrounded with clingfilm and transfer allowed to take place over night. Once complete, the 
apparatus was dismantled, the filter removed and placed between 2 pieces of Whatmann 
paper and baked at 120°C for 40 minutes. Northern transfer of RNA was carried in the same 
way with the exception that 0.1% DEPC treated SSC was used with baked glass trays and 
platforms. Denaturation of RNA was not necessary since RNA was electrophoresed an 
denaturing gels, (see below). 
Filters were first pre-hybridised in 10-25m1 of Church/Gilbert buffer (0.5M di-sodium 
hydrogen orthophosphate (Fisons); 7% SDS; 1mM EDTA; pH 7.2 with orthophosphoric acid) 
containing 1/100 volume denatured salmon sperm DNA (lOmg/inl) (Boehringer) for up to 1 hour 
at 65°C with rotation, after which the denatured radioactive DNA probe was added and 
hybridisation allowed to take place over night under the same conditions. Following 
hybridisation, unbound and non-specifically bound probe was removed by washing with 30-
50m1 of 5% SDS, 1mM EDTA, 0.04M di-sodium hydrogen orthophosphate and 1% SDS, lmlvI 
EDTA, 0.04M di-sodium hydrogen orthophosphate in sequence, for upto 1 hour in each wash at 
65°C with rotation. The filter was subsequently wrapped in clingfilm and exposed to a 
phosphorscreen over night. The screen was then scanned using a Molecular Dynamics laser 
scanner and analysis performed using Molecular Dynamics software, run on a Macintosh 
computer. 
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GENE 	 5' PRIME SEQUENCE 	 3'PRIME SEQUENCE 	 PRODUCT 	ANNEALING 	MAGNESIUM 	REF 
SIZE (bp) TEMPERATURE CHLORIDE 
fi - ACTIN 5-GFGACGAGGCCCAGAGCAAGAG-3 15, -AGGGGCCGGACrCATCGrACrC-3 934 63°C 2 mM Schmitt et a! (1991) 
FOETAL -fl 5 -AACCCFCATCAATGGCCFGTGG-3 5 -TCAGTGGTAC1FG7GGGACAGC-3 415 63°C 2mM Schmitt et a! (1991) 
GLOBIN 
BRACHYURY 5 -TCCAGG7GCFATATA7I'GCC-3 5 -TGCFGCCFG7GAGTCATAAC-3 947 50°C 4mM Keller et at (1993) 
CD -45 5'-CCFGAGTCFGCATCFAAACCCC-3' 5 -TGCrrGGCCAGTATFCFGCGCA-3 1067 63 °C 4mM Schmitt et a! (1991) 
c-kit receptor 5 CAACAGCAATGGCCFCACGAGT3 5 GTGGTACACCITFGCFCrGCFC3 1069 68 °C 2mM Schmitt et a! (1991) 
GATA - I 5 -ATGCCFGTAATCCCAGCACF- 3'  5 -TCATGGTGGTAGCFGGTAGC-3 581 55°C 1mM Keller eta! (1993) 
HAEMATOPOIETIC 
CELL 5'-CAGGACrGCAGGTrGGCITFAG- 3' 5 -ATGTCAGCFGGGTrFACCCGAG-3'  800 58°C 2mM 
PHOSPHATASE (HCP) 
IL-3 5 -1-rCI-FGCCAGCFCTACCACCAG-3' 5 -ACITI'AGGTGCI'CFGCCFGCrG- 3 522 63°C 2mM 
Ly - 6A/E/ScaI 5 -CCCCFACCCFGATGGAGTCrGT- 3' 5 -GGATFAGAGCACCFACCFACCC-3 450 58°C 2mM 
MIP-I a 299 65°C 2mM 
MYOGENIN 5 -TCACGGTGGAGGATATGTCr-3' 5 -GAGTCAGCFAAATFCCCFCG-3 350 60°C 7mM Koopman et a! (1991) 
ZFY 5'-CCTATFGCATGGACTGCAGCfTATG-3' 5 -GACFAGACATGTCrTAACATCFGTCC-3 180 65°C 7mM Koopman eta! (1991) 
Table 2.1. Deoxyribonucleotide primers and reaction conditions used for the PCR reactions. 
2.3.6 Reverse transcription of RNA and PCR amplification of products. 
The Promega AJvIV reverse transcription system was used to synthesise single stranded cDNA 
from total RNA extracts, according to the manufacturer's instructions. In brief, 1g of total 
RNA extract was reverse transcribed in a reaction containing reverse transcriptase buffer 
[10mM Tris-HC1 (pH 8.0), 50mM potassium chloride, 0.1% Triton X-1001, 1mM of each dNTP, 
lu/1.tl of rRNasin ribonuclease inhibitor, 15u/g of AMV reverse transcriptase, 0.5g/g RNA 
of random primers in a total volume of 20pJ. The reaction mixture incubated at 42°C for 15 
minutes. 
PCR amplification of the cDNA product was carried out in a total volume of 50pJ consisting of 
1il of the reverse transcription product, 1 x ammonium buffer [16mM ammonium sulphate, 
67mM Tris-HC1 pH 8.8, 0.01% Tween-201, 2-5mM magnesium chloride (depending on the 
specific reaction, see Table 2.1), 1jg oligonucleotide mixture (consisting of 1:1 ratio of 3' and 5' 
primers; Table 2.1), 2.5 units BIOPROTM  polymerase and 1mM dNTP mixture (consisting of 
1:1:1:1 ratio of dATP, dCTP, dGTP and dTTP). The reactions were overlaid with 50il mineral 
oil and amplification carried out. The template was denatured at 95°C for 20 seconds, followed 
by annealing of primers for 1 minute at the appropriate temperature (Table 2.1), and extension 
of primers at 72°C for 1 minute. The procedure was repeated for 30 cycles. Upon completion 1/6 
of the total volume of DNA gel loading buffer was then added to lOi.tl of RT-PCR product and 
ran on a 1-2% agarose, 0.5% TBE, 0.5g/ml ethidium bromide gels. If products were not readily 
visible with ethidium bromide staining, they were blotted and hybridised with the relevant 
probe. 
2.4 	Protein isolation and analysis. 
2.4.1 L25S1 methionine labelling of embryoid body proteins. 
Approximately 50-100 embryoid bodies from each sample were washed twice in PBS and 
resuspended in 0.9m1 of CO2 -gassed methionine free-media [1 x D-MEM (Gibco) L-methionine 
and L-glutamine free; 10% dialysed amino-acid free FCS; 1% glutamine; kept at 5% CO2] and 
transferred to a tissue culture grade 24 well plate. 0.1ml of media containing 0.25 mCi of L-[ 35 
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SI methionme was then added to each well and incubated for 1 hour at 37°C in a humidified 
atmosphere of 5% CO2. The embryoid bodies were then transferred to 1.5m1 eppendorf tubes, 
washed once in cold PBS and lOOjil of lysis buffer added [9.9M urea; 4% Nonidet P-40; 2.2% 
ampholytes pH range 3-10 (Sigma); 100mM DTT)]. 
2.4.2 Estimation of protein concentration. 
Protein concentrations in embryoid body lysates was determined using the Lowry method 
(1951) modified by the addition of sodium deoxycholate. 5il of each lysate was made 0.25 M 
with respect to sodium hydroxide and 2% with respect to sodium deoxycholate (Sigma) in a 
total volume of 0.5m1. 2.5m1 of copper alkali reagent [0.05% sodium hydroxide; 2% sodium 
carbonate (Fisons) 0.02% sodium potassium tartrate (Fisons) 0.01% copper sulphate (Sigma)] 
was then added to the protein solution, mixed and incubated at room temperature for 10 
minutes. 0.25 ml of 1.OM Folin-Ciocalteus phenol reagent (Sigma) was then added, mixed 
thoroughly and the colour allowed to develop in the dark for 90 minutes. The absorbance of 
the samples was measured at 660nm against a reagent blank. A standard curve was calculated 
using dilutions of a known BSA solution in the same assay and the protein concentration of the 
embryoid body samples calculated from this curve. 
2.4.3 Two dimensional SDS - polyacrylamide gel electrophoresis (2D-PAGE) and 
staining of gels. 
213-PAGE was carried out essentially as described by O'Farrel (1975). Isoelectric gel mixture 
consisting of 9M urea, 4% acrylamide (Fisons), 0.24% N,N'-methylbisacrylamide (Fisons), 
300-450j.tl ampholines pH range 3-10, 2% Nonidet P-40 (added after degassing the mixture for 
10 minutes), was prepared in a total volume of 15m1 and polymerisation activated by the 
addition of 70.l 10% ammonium persuiphate (Fisons) and lOjiJ of TEMED. The IEF gels were 
then cast to a height of approximately 12cm, in capillary tubes of internal dimensions of 0.15 x 
17cm, by carefully placing the tubes in the gel mixture and overlayering with water. 1 hour 
was allowed for polymerisation after which the gels were prefocussed at 200 volts for 1-2 
hours using 0.085% orthophosphoric acid as the anode electrode buffer and 0.085% sodium 
hydroxide as the cathode electrode buffer. 0.5mg of each protein sample was then loaded onto 
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a gel with a Hamilton syringe under the cathode electrode buffer and isoelectric focusing 
carried out for 10000-12000 volt-hours. Once complete the gels were removed by inserting a 
yellow eppendorf pipette tip attached to a water-filled imi syringe into the cathode end of 
the gel and carefully removing the gel. The gels were equilibriated in equilibriation buffer 
[0.125M Tris-base, pH 6.8 (Sigma); 2% SDS; 10% glycerol; 0.2-0.8% 2-mercaptoethanol added 
just before use] for 15 minutes. If necessary they were frozen at -20°C before equilibration and 
thawed in equilibration buffer just before electrophoresis across the second dimension. 
Resolving gels for SDS-PAGE electrophoresis consisting of 10% acrylamide, 0.27% N,N'-
methylbisacrylamide, 0.38 M Tris (pH 8.8), 0.1% SDS, were prepared in a total volume of 
50ml and the polymerisation reaction was initiated by the addition of 0.5m1 10% ammonium 
persulphate and 20j.tl of TEMED. The gels were cast between sandwiches of glass plates (16 x 
18cm) separated by 0.15cm spacers and overlaid with water saturated butanol. After 
polymerisation the butanol and un-polymerised acrylamide were washed off with distilled 
water and the tube gel laid horizontally across the resolving gel, alongside molecular weight 
markers (Sigma) [mixed with an equal volume of 1% agarose and formed into a tube with the 
aid of a Pasteur pipette] and electrophoresed at 5 volts/cm of gel in Tris-glycine buffer [25mM 
Tris; 250mM glycine (Fisons); 0.1% SDS]. 
After electrophoresis the gels were either Western blotted or stained overnight in Coomasie 
blue stain with shaking [0.5% Coomasie blue (Fisons); 10% glacial acetic acid; 10% ethanol] 
destained in 10% glacial acetic acid/10% ethanol with shaking until the background was 
clear, and dried under vacuum onto Whatmann 3MM paper. L-[ 35S] methionine labelled gels 
were exposed to Kodak film and the autoradiographs scanned on a Molecular Dynamics laser 
densitometer. The images were then analysed using PDQuestTM software (Protein Databases 
Incorporated) run on a Sun Workstation. 
2.4.4 Western transfer and immunological detection of proteins. - 
Western blotting was carried out essentially as described by Towbin (1979). The transfer 
apparatus was prepared by placing 3 sheets of 3MM paper cut to the size of the gels and 
soaked in transfer buffer [39mM glycine; 48mM Tris base; 0.037% SDS; 20% methanol] onto the 
anode side of the transfer cassette. The PVDF (Boehringer) membrane [pre-soaked in 
methanol and washed in water] was then placed onto the 3MM paper, the 2-dimensional 
PAGE gel removed from the glass plates and placed over the membrane, avoiding the 
entrapment of air bubbles. A further 3 sheets of 3MM paper soaked in transfer buffer were then 
placed over the gel and the cathode side of the transfer cassette clipped into place adjusted 
into place. Transfer was carried out over a period of at least 2 hours at 0.65 milliamps/cm 2 of 
gel after which the apparatus was disassembled and the membrane briefly stained with 
Ponceau S (Sigma) to ensure that transfer had taken place and washed in several changes of 
distilled water. The lane containing markers was cut from the membrane and stained with 
Amido black [0.5% amido black, 10% galcial acetic acid; 10% ethanol] and destained in 10% 
glacial acetic acid/10% ethanol until the bands were visible. 
The remainder of the membrane was placed in 0.1ml/cm 2 of membrane of blocking buffer [0.05% 
Tween-20 (Sigma) in PBS; 5% non-fat dried milk] and incubated at room temperature with 
shaking, for 2 hours. The membrane was then washed 4 times in washing buffer (0.05% Tween-
20) for five minutes each time. The primary antibody (1:500 dilution) was added in fresh 
blocking buffer (0.1ml/cm 2 membrane) and the filter incubated as before. Unbound and non-
specifically bound antibody was removed by 4 times in washing buffer. After the last wash 
the membrane was washed in Tris-saline [150mM sodium chloride; 50mM Tri-HC1 (pH7.5)] for 
5 minutes. HRP-conjugated secondary antibody (Law Hospital) (1:200 in Tris-saline/5% non-
fat dried milk) was added to the filter and incubated for 2 hours with shaking. Unbound 
secondary antibody was removed by washing the filter in 4 changes of Tris-saline for 5 minutes 
each time. The chromogenic reagent [0.3% 4-chloronaphthol in methanol] was diluted 1:5 in 
Tris-saline and added to the membrane and the colour allowed to develop. Once at the desired 
intensity the reaction was stopped by washing in water, the filter allowed to dry and scanned 
with an Epson scanner and analysed with Adobe PhotoshopTM software run on a Macintosh 
computer. 
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3. 	Effects of Exogenous Factors on the Haematopoietic 
Differentiation of Embryoid Bodies. 
3.1 	Introduction. 
Work already carried out with the culture system under study, suggests that primitive 
HSCs can be derived from cultured embryoid bodies, in sufficient quantities to be detected 
in vitro by the CFU-A assay and in vivo by reconstitution experiments. It would however 
be useful to increase HSC yields from embryoid bodies, for the purposes of providing a 
larger pool of stem cells for long term repopulation. The ability to modulate 
haematopoiesis would also be beneficial for differential gene expression studies, 
facilitating the identification of genes involved in haematopoietic development. 
One means of modifying the level of embryoid body haematopoiesis would be by the 
addition of cytokines to the culture system. As discussed previously, the addition of 
cytokines to bone marrow and/or spleen haematopoietic precursors in culture can enhance 
cell colony formation (Tsuji et al, 1991), and have also been shown to have an effect on 
embryoid body haematopoiesis during later stages of differentiation (Keller et al, 1993). 
However most cytokines exert their effect in combination, and deciphering the assortment 
of cytokines that may yield the required results can, not only be time consuming but also 
expensive. The presence of foetal calf serum in the culture media with a many unidentified 
growth factors may also mask and/or complicate the effects of any added cytokines. For 
the purposes of this study therefore more accessible chemical inducers, mainly DMSO and 
RA, were used to regulate the haematopoietic differentiation of embryoid bodies. 
Dimethyl suiphoxide is a low molecular weight polar planar molecule which is commonly 
used in tissue culture systems as a cryoprotectant for freezing cells. It is able to induce 
cardiac and skeletal muscle differentiation from EC and ES cell lines (McBurney et al, 
1982; Pari et al, 1991; Dinsmore et a!, 1996), and has also been shown to influence 
haematopoietic cell differentiation. DMSO was the first chemical agent shown to induce 
terminal differentiation of the transformed murine erythroid precursor cell line, MEL 
(Friend et a!, 1971), and the human promyelocytic leukaemia cell line, HL-60 (Collins e t 
a!, 1979). DMSO can also induce the differentiation of other malignancy-derived cell lines 
such as neuroblastomas (Kimihiet al, 1976). Studies regarding the effects of DMSO on ES 
cell haematopoietic differentiation have not been reported to date. 
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Since DMSO is not known to occur naturally in mammalian cells and is required a t 
relatively high concentrations (usually between 1-2%) in order to elicit an effect, it is 
generally believed to act by a non-specific signalling mechanism(s). DMSO is a lipid 
soluble molecule and could therefore enter cells directly without further requirement for 
cell surface proteins/ receptors. However DMSO has been found to inhibit the binding of 
GM-CSF to its receptor in HL-60 cells and is thus thought to inhibit proliferation and 
trigger cell differentiation (Brennan et a!, 1991; Schwartz et a!, 1993). Biochemical studies 
in MEL and EC cell lines have shown that DMSO releases intracellular stores of the 
secondary messenger calcium, by a process which by-passes phosphatidyl inositol 
breakdown (Morley and Whitfield, 1993). Similar studies with the rat neuroblastoma cell 
line N1E-115 however, suggest that DMSO activates the production of lipid second 
messengers including diacylglycerol which is a breakdown product of phosphatidyl 
inositol (Clejan et a!, 1996). Despite such studies the manner in which DMSO exerts its 
effects remains largely elusive. 
Retinoic acid (RA) is a metabolite of retinol (vitamin A), and its involvment in 
embryogenesis and its roles as a teratogen and morphogen are now well documented 
(reviewed by Morriss-Kay, 1993). RA occurs naturally in living systems and the mechanism 
of its action via its nuclear receptors is now well understood (reviewed by Chambon, 1993). 
Both EC and ES cell lines can be induced to differentiate towards neuronal cell lineages in 
response to certain concentrations of RA. Studies of retinoic acid receptors (both RARs and 
RXRs) and retinoic acid-responsive genes in murine and human EC cell lines, have been 
carried out which strongly suggest that retinoic acid directly induces the terminal 
differentiation of these cells via its receptors (Minucci et a!, 1994; Moasser et a!, 1995; Roy 
et al, 1995). 
The involvement of various stereo-isomers of RA, such as all-trans retinoic acid (atRA) 
and 13-cis retinoic acid (13cRA), and their receptors in haematopoiesis have been widely 
reported. Retinoic acid receptors have been found to be expressd in haematopoietic cells of 
both leukaemic and non-leukaemic origin (de The et a!, 1990). Like DMSO, retinoic acid is 
able to induce the in vitro differentiation of HL-60 cells (Brietmann et a!, 1988), and is now 
widely used clinically for the treatment of acute promyelocytic leukaemia (Huang et a!, 
1988). Furthermore gene transfection assays in RA resistant HL-60 cells have shown that 
retinoic acid exerts its effect directly via the RARa receptor (Collins et al, 1990). 13-cis 
retinoic acid has also been used in the induction of promyelocyte differentiation in vitro 
and in vivo, but has been found to be at least ten fold less effective than atRA (Chomienne 
et a!, 1990). 
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The effects of RA can vary depending on the concentration used and the type of retinoid 
administered (Edwards and McBurney, 1983a). The ability of different retinoids to exert 
differential effects is mediated through their receptors which display ligand specificity. 
The RAR receptors for instance have been found to bind both all-trans and 9-cis retinoic 
acid with high affinity, whereas the RXR receptors only bind 9-cis retinoic acid with 
high affinity (Levin et at, 1992). 
Various studies of the effects of retinoic acid on the haematopoiesis of murine and human 
haematopoietic progenitors have been carried out. These in vitro studies on normal 
haematopoietic cells remain inconclusive, with some investigators reporting an 
enhancement of haematopoiesis after RA administration to cultured cells (Douer and 
Koeffler, 1982; Sakashita et at, 1993), while others have reported a marked decrease (van 
Bockstaele et at, 1993; Smeland et at, 1994). Detailed studies of the haematopoietic 
differentiation of ES cells after RA treatment have to date not been published. 
One means by which to modulate haematopoietic commitment, is by influencing mesoderm 
differentiation. A number of specific factors are known to be directly involved at this stage 
of differentiation such as BMP-4, activin-1 and bFGF. The putative roles of BMP-4 and 
bFGF with respect to haematopoietic development have already been outlined in section 
1.2.1. Furthermore bFGF has been reported to directly enhance the differentiation of 
human bone marrow haematopoietic progenitors in vitro (Wilson et at, 1991). Such factors 
could therefore be theoretically used in ES cell cultures to induce mesoderm lineages and 
hence to indirectly influence haematopoiesis. 
The influence of DMSO, atRA, 13cRA, bFGF and activin-1 on the haematopoietic 
differentiation of embryoid bodies was consequently investigated. In order to study the 
effect of these factors on the earliest stages of ES cell commitment to haematopoietic stem 
cells, undifferentiated ES cell aggregates were incubated with one of the above named 
factors in the absence of LIF, immedately after being harvested from 'hanging-drop' 
cultures. Embryoid body formation in the presence of the added factor was allowed to occur 
for the first 48 hours of differentiation. Thereafter embryoid bodies were removed from the 
morphogen/chemical supplemented media and allowed to differentiate in the absence of 
inducer. Subsequently the presence of haematopoietic progenitors in the embryoid bodies 
was detected by the CPU-A assay. Dose-response and time-course studies were performed 
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Figure 3.1A. DMSO dose response curve. Embryoid bodies were treated with 
varying concentrations of DMSO for the first 48 hours of differentiation and 
assayed after a total of 6 days in culture. Each point represents the mean of 
three plates assayed ± standard deviation. The normalised percentage of 
embryoid bodies giving rise to CFU-A colonies is shown on the y-axis. DMSO 
concentration is expressed as percentage (v/v), on a logarithmic scale on the 
x-axis . 
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3.20) Results of studies with DMSO 
DMSO concentration is expressed as a percentage of volume/volume. 
3.2(i) .1 DMSO dose-response experiments. 
The effects of DMSO cn the haematopoietic differentiation of embryoid bodies was 
initially analysed by dose response studies and the effects of the compound assessed by the 
CFU-A assay. Approximately 300-500 undifferentiated embryonic stem cell aggregates 
were incubated either in the absence of DMSO or with increasing concentrations of DMSO 
for the first 48 hours of differentiation, in the absence of LIF. Antibiotics were also 
included in the suspension cultures at this point, since the differentiating aggregates are 
particularly prone to infections during this period. After exposure to the chemical inducer, 
embryoid bodies were washed with PBS and resuspended in unsupplemented 
differentiation media in the absence of antibiotics. Since previous studies have shown that 
the maximum percentage of haematopoietic colonies are obtained with 6 day old embryoid 
bodies, they were allowed to differentiate for a further 4 days, being replenished with 
fresh media once every 48 hours. 
Since the number of CFU-A colonies decrease when large numbers of embryoid bodies are 
plated, due to glucose depletion, no more than 50 embryoid bodies were included in each 
plate. Each sample was assayed in triplicate. The numbers of CFU-A colonies were scored 
after 8-11 days incubation and the percentage of embryoid bodies giving rise to CFU-A 
colonies calculated. Examples of three independent DMSO dose response experiments are 
illustrated in Figure 3.1, where each point represents the mean percentage of CFU-A 
colonies from triplicate dishes. 
The results show a dose dependent response with higher percentages of embryoid bodies 
giving rise to CFU-A colonies as the concentration of DMSO is increased. Concentrations of 
between 0.01-0.2% appear to have little or no effect on the number CFU-A colonies, when 
compared with the untreated control samples. An apparent increase in haematopoiesis is 
observed with 0.5% DMSO treatment. Incubation of embryoid bodies with 1.0% DMSO 
however results in a more than 2 fold increase in the percentage of CFU-A colonies. Further 
experiments have shown that this increase in haematopoiesis is reproducible and can be 
achieved by concentrations of up to 1.4% DMSO, however any further increase in DMSO 
results in a rapid decline in the numbers of CFU-A colonies. In order to minimise 
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Figure 3.1B. CFU-A assay of DMSO treated ernbryoid bodies. Embryoid bodies were 
treated with 1% DMSO for the first 48 hours of differentiation and assayed after a total 
of 6 days, in suspension culture. Macrophages and monocytes are seen to emanate from the 
central embryoid body. 
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any toxic effect the compound may have, subsequent experiments were carried out with 
1.0% DMSO. 
In order to determine whether there was a qualitative difference in the CFU-A colonies 
obtained after DMSO treatment, the size of colonies produced by untreated and 1.0% 
DMSO treated embryoid bodies were compared (Table 3.1). The diameters of CFU-A 
colonies from DMSO treated and untreated samples in three independent experiments, 
were measured with a graticule to the nearest millimetre and the means compared. 
Assuming that the diameter of CPU-A colonies follows a normal distribution a t-test at the 
5% level of significance was carried out on these values. The results show that there is no 
statistically significant increase in the mean diameter of CFU-A colonies after DMSO 
treatment. 
Mean diameter of CFU-A colonies (mm) 
Untreated 1% DMSO Treated 
Experiment 1; n=12 2.6 ± 1.0 2.8 ± 1.2 
Experiment 2; n=12 3.3 ± 1.2 4.2 ± 0.8 
Experiment 3; n=6 4.0 ± 1.1 1 	5.2 ± 0.8 
Table 3.1. CFU-A colony sizes in untreated and DMSO treated embryoid bodies. Colonies 
were measured, to the nearest millimetre, from triplicate assays of each sample. Results 
are from 3 independent experiments. Results are shown as mean diameter of colonies ± 
standard deviation. 
Embryoid bodies also give rise to skeletal and cardiac muscle in culture, these being 
visually distinguishable as they contract and relax in a rhythmic fashion. Approximately 
5-10% of untreated embryoid bodies are seen to 'beat' in this manner in CFU-A assays. In 
DMSO treated samples the percentage of beating embryoid bodies that lack 
haematopoietic colonies decreases to less than 5%. In contrast however, up to 50% of the 
haematopoietic embryoid bodies in these samples are also seen to beat. 
3.20).2 DMSO time-course experiments. 
Previous time course studies with untreated embryoid bodies have shown that the 
maximum percentage of CPU-A colonies are observed at 6 days of differentiation. 
Untreated embryoid bodies and those treated with 1.0% DMSO for the first 48 hours of 
54 
—0-- DMSO Samples 










0 	 2 	 4 	 6 	 8 	 10 
Days of Differentiation 
Figure 3.2. Time course of embryoid body CFU-A differentiation. Untreated and 
1% DMSO treated embryoid bodies were assayed after 2, 4, 6 or 8 days in 
suspension culture. The graphs are means of two independent experiments, a set 
of untreated and DMSO treated samples being cultured and assayed at the same 
time. The normalised percentage of embryoid bodies giving rise to CFU-A 
colonies is shown on the y-axis, and the total number of days of differentiation, 
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Figure 3.3A. Effect of length of exposure to 1% DMSO on embryoid body 
differentiation. Embryoid bodies were exposed to 1.0% DMSO for varying 
lengths of time (x-axis) and assayed after a total of 6 days differentiation. 
Each point represents the mean of 3 plates assayed ± standard deviation. 
Percentage of embryoid bodies (EBs) giving rise to CFU-A colonies is shown on 
the y-axis. 
Figure 3.3B. Mean percentage of embryoid bodies giving rise to CFU-A colonies 
± standard error, after varying lenths of exposure to 1% DMSO, as calculated 
from Figure 3.3A 
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differentiation were assayed after 2, 4, 6 and 8 days of differentiation in order to assess 
whether the treatment affects this time course of CFU-A differentiation. 
Time course experiments in which a set of DMSO treated and untreated embryoid bodies 
were cultured and assayed at the same time, have shown that DMSO treatment does not 
appear to alter the time course of embryoid body haematopoietic differentiation. DMSO 
treated embryoid bodies do however show an elevated level of haematopoiesis compared 
with their untreated counterparts, as shown by Figure 3.2. Furthermore when compared 
statistically, the DMSO treated population of embryoid bodies give rise to a significantly 
higher number of CFU-A colonies than the untreated population, at the 5% level of 
significance. 
3.2(i).3 DMSO timed-exposure experiments. 
By exposing embryoid bodies to chemicals during the first 48 hours of differentiation, it is 
assumed that the very early stages of embryonic stem cell haematopoietic commitment is 
influenced. In order to determine the period of exposure in this time-frame which produces 
the greatest increase in the percentage of CFU-A colonies from embryoid bodies, timed 
DMSO exposure experiments were carried out. Embryoid bodies were exposed to 1% DMSO 
for varying lengths of time and assayed after a total of 6 days differentiation. 
Three independent experiments are illustrated in Figure 3.3A, the mean of which is 
represented by Figure 3.3B. Considered together the graphs suggest that the increase in the 
percentage of CFU-A colonies after DMSO treatment, is cumulative and dependent an the 
length of time of treatment. A slight increase in the percentage of CFU-A colonies is 
observed after approximatey 1-24 hours of exposure, however this increase is not 
statistically significantly higher than the control population, at the 5% level of 
significance. The largest increase is observed with embryoid bodies that have been treated 
with 1.0% DMSO for 48 hours. This increase was found to be significantly higher than the 
untreated population when tested in a t-test at the 5% level of significance. 
3.2(i).4 Experiments with a-tocopherol. 
DMSO is an antioxidant and can therefore acts as a free-radical scavenger. Free radicals 
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Figure 3.4. cc–Tocopherol dose response curve. Embryoid bodies were exposed to 
varying concentrations of a-tocopherol for the first 48 hours of differentiation, 
and assayed after a total of 6 days differentaition. The normalised percentage 
of embryoid bodies giving rise to CFU-A colonies is shown on the y-axis. 
cx-Tocopherol concentration is expressed as volume per volume on the x-axis. 
Each point represents the mean of three plates assayed ± standard deviation. 
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damage and hence cell death. The ability of DMSO to increase the percentage of 
haematopoietic embryoid bodies could in part be attributable to its antioxidant properties. 
DMSO could in theory, prevent the cumulative build-up of free-radicals in cell cultures 
thus reducing cell death, resulting in increased numbers of CFU-A colonies. In order to test 
this hypothesis, the effects of a-tocopherol (vitamin E) a known antioxidant, at the 
haematopoietic differentiation of embryoid bodies was also tested and compared with the 
effects of DMSO. 
Embryoid bodies were treated with varying concentrations of a-tocopherol for the first 48 
hours of differentiation and assayed after a total of 6 days in culture. The results of two 
independent experiments are shown in Figure 3.4. These clearly do not mirror the 
observations made with DMSO; in fact the drug had little or no effect at the percentage of 
CPU-A colonies even at concentrations as high as 5mM. Higher concentrations had severe 
toxic effects causing the disruption of embryoid bodies. 
a-tocopherol is not water soluble and therefore either DMSO or ethanol are usually used 
as carriers for the drug. In these experiments the drug was dissolved in ethanol, and to 
determine whether the use of ethanol affected the haematopoietic differentiation of 
embryoid bodies, embryoid bodies were treated with 0.5% ethanol for the first 48 hours of 
differentiation and assayed; 0.5% being the highest concentration of ethanol embryoid 
bodies were exposed to when cultured with 5mM a-tocopherol. Treatment with this 
concentration of ethanol had no effect on the percentage of CFU-A colonies compared with 
that of untreated control samples (data not shown). 
3.2(u) Results of studies with atRA. 
3.200.1 	atRA dose-response experiments. 
As with DMSO, the initial experiments to be carried out with atRA were dose response 
studies, to assess the the effect of the drug at the early stages of embryoid body 
haematopoietic differentiation, and to determine the concentration at which these effects, 
if any, would be exerted. Embryoid bodies were treated with varying concentration of atRA 
during the first 48 hours of differentiation, in the presence of antibiotics and the absence of 
LIF. After treatment the samples were washed in PBS and allowed to differentiate in the 
absence of antibiotics and morphogen and the media routinely renewed once every 48 hours. 
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Figure 3.5A. atRA dose response curve. Embryoid bodies were exposed to 
various concentrations of atRA (dissolved in 95% ethanol) for the first 48 
hours of differentiation and assayed after a total of 6 days in suspension 
culture. Each point represents the mean of three plates assayed ± standard 
deviation. The normalised percentage of embryoid bodies giving rise to 
CFU-A colonies is shown on the y-axis. The concentration of atRA used is 
shown on the x-axis on a logarithmic scale. 
After a total of 6 days differentiation each sample was assayed in triplicate and 
incubated for 8-11 days subsequent to which the number of CFU-A colonies were scored and 
the percentage of embryoid bodies giving rise to CFU-A colonies calculated. 
Examples of three such experiments are illustrated in Figure 3.5A, where each point 
represents the mean percentage of CPU-A colonies for triplictate plates. As can be seen, the 
treatment of embryoid bodies with gradually increasing concentrations of atRA reduces the 
percentage of CPU-A colonies even with concentrations as low as 10-10  M. A ten fold 
increase in the dose to 10 9 M results in a less than 50% reduction in the number of colonies, 
with 10-8  M atRA reducing the number of CFU-A colonies to below 5% (Figure 3.5B). Any 
further increase in atRA reduces this percentage further to below 1%. The percentage of 
CFU-A colonies from embryoid bodies treated with 10-11  M and 10-12  M atRA, was neither 
increased nor decreased in comparison with the untreated control samples (data not 
shown). Further experiments have shown the observations made with atRA to be highly 
reproducible. 
Retinoic acid is not water soluble and therefore either DMSO or ethanol are usually used 
as carriers for the drug. Ethanol was used as the carrier for atRA throughout the present 
study. To determine whether ethanol affected the haematopoietic differentiation of 
embryoid bodies, samples were treated with 0.01% (v/v) ethanol for the first 48 hours of 
differentiation and assayed; 0.01% being the highest concentration of ethanol embryoid 
bodies were exposed to when cultured with 10-6  M atRA. Treatment with this concentration 
of ethanol had no effect on the percentage of CFU-A colonies compared with that obtained 
for untreated control samples (data not shown). 
The diameter of CPU-A colonies from atRA treated and untreated samples were measured 
as before, to the nearest millimetre, and the mean diameter of CPU-A colonies from 
triplicate plates compared. As can be seen from Table 3.2 there is a gradual decrease in the 
mean diameter of CFU-A colonies as the concentration of atRA increases. In a t-test, this 
decrease was found to be statistically significant (P<0.05) between the untreated and the 
5x10 8 M atRA treated samples. 
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atRA (M) 0 10-10 10 9 5x10 8 
Mean diameter of 
CFU-A colonies 3.2 ± 0.4 2.8 ± 1.5 1.6 ± 1.6 1.2 ± 0.3 
(mm) 
Table 3.2. The mean diameter of CFU-A colonies from untreated and atRA treated 
embryoid bodies. The diameter of colonies were measured, to the nearest millimetre, from 
triplicate assays of each sample. Diameters are expresses as the mean of 6 colonies ± 
standard deviation. 
No significant increase or decrease was observed in the percentage of beating muscle 
embryoid bodies after atRA treatment at any of the concentrations used. In subsequent 
experiments the concentration of atRA was limited to 10-8  M. This concentration not only 
reduces the percentage of CFU-A colonies significantly and reproducibly, but also 
minimises any toxic effects the drug may have at higher concentrations. 
Figure 3.513. CFU-A assay of atRA treated embryoid bodies. Embryoid bodies were treated 
with 10-8  M atRA for the first 48 hours of differentiation and assayed after a total of 6 
days, in suspension culture. Subsequent analysis of assays showed a marked absence of 
CFU-A colonies (see Figure 1.4) 
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Figure 3.6. Time course of differentiation of atRA treated embryoid bodies 
(EBs). Embryoid bodies, untreated and atRA treated for the first 48 hours of 
differentiation, were assayed after 2, 4, 6 and 8 days in suspension culture 
(x-axis). Each point represents the mean of three plates assayed ± standard 
deviation. The percentage of embryoid bodies giving rise to CFU-A colonies is 






3.2(ii).2 	atRA time-course experiment. 
Time course experiments, similar to those carried out with DMSO, were also performed 
with atRA, at three different concentrations. The results are shown in Figure 3.6; each 
point represents the mean percentage of embryoid bodies giving rise to CPU-A colonies, 
calculated from three plates assayed for each sample. The atRA treated embryoid bodies 
follow the same time course of haematopoietic differentiation as the untreated samples, 
however as the concentration of atRA is increased so the percentage of CFU-A colonies 
decreases. 
3.200.3 	atRA timed exposure experiments. 
To determine the minimum length of time of atRA treatment required within the first 48 
hours of differentiation before a decrease in the number of CPU-A colonies is observed, the 
length of time of treatment with 10-8  M atRA was varied and the samples assayed after a 
total of 6 days differentiation. Three such experiments are illustrated in Figure 3.7A the 
mean of which is shown by Figure 3.7B. The percentage of CFU-A colonies is not reduced 
significantly when embryoid bodies are treated for up to 6 hours. The largest decrease in 
the percentage of CPU-A colonies is seen after 16 hours treatment when less than 10% of 
embryoid bodies give rise to CFU-A colonies. This value does not change after 24 hours 
treatment. But after 48 hours in the presence of 10-8  M atRA the percentage of CFU-A 
colonies is reduced further to less than 5%. 
In order to determine if atRA is able to influence the haematopoietic differentiation of 
embryoid bodies, whether positively or negatively, at any other time point during the 6 
days of differentiation, embryoid bodies were treated with 10-8  M atRA for 24 hour periods 
and subsequently assayed after a total of 6 days differentiation in culture. Two such 
experiments are represented by Figure 3.8. 
The results show that atRA reduces the number of CFU-A colonies if embryoid bodies are 
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Figure 3.7A. Effect of length of exposure to atRA on embryoid body 
differentiation. Embryoid bodies (EBs) were exposed to 10-8 M atRA for 
different lengths of time immediately after being removed from LIF 
containing media and assayed after a total of 6 days differentiation. Each 
point represents the mean from three plates assayed ± standard deviation. 
The percentage of embryoid bodies producing CFU-A colonies is shown on the 
y-axis. 
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Figure 3.8. Embryoid bodies (EBs) were treated with 10-8 M atRA for 24 hour 
periods during 6 days differentiation. All samples were allowed to 
differentiate for a total of 6 days. Each bar represents the mean of 3 plates 
assayed ± standard deviation. The percentage of embryoid bodies producing 
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Figure 3.9A. Untreated embryoid bodies and those treated with 1% DMSO or 
10-8 M atRA during the first 48 hours of differentiation, were assayed after a 
total of 6 days in suspension culture. The percentage of intact embryoid 
bodies (EBs) producing CFU-A colonies is shown on the y-axis, and the type 
of treatment on the x-axis. Each column represents the mean of 3 plates 
assayed ± standard deviation. 
Figure 3.9B. The number of CFU-A colonies produced by single cells from 
disrupted embryoid bodies, after 6 days differentiation. Each point is the 
mean of 3 plates assayed ± standard deviation. 
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samples are treated during the first and second 24 hours of differentiation; the number of 
CFU-A colonies obtained after atRA treatment during the third day of differentiation 
increases marginally but remains below 10%. The percentage of CFU-A colonies obtained 
after treatment during the 4th, 5th and 6th days of embryoid body differentiation are 
similar to those observed for untreated samples. Samples treated with 10-8  M atRA for the 
duration of the 6 days, the atRA being renewed once every 48 hours, produced no CFU-A 
colonies as expected. 
3.260.4 	CFU-A assays with disrupted embrvoid bodies. 
The haematopoietic lineages which give CFU-A colonies their distinctive morphological 
appearance, are the mobile macrophages and monocytes which migrate out into the 
surrounding agar, forming a halo around the embryoid bodies. If the surface properties of 
embryoid bodies are altered, thereby preventing the migration of macrophages/ 
monocytes, typical CPU-A colonies will not be observed. 
To test whether the reduction of CFU-A colony numbers after atRA treatment is due to the 
inability of macrophages/monocytes to migrate away from the cystic structures, embryoid 
bodies were cultured with 10-8  M atRA for the first 48 hours of differentiation. After 6 days 
differentiation a sample of embryoid bodies was disrupted into a single cell suspension 
with dispase treatment, and 1.8x10 5 cells were assayed in triplicate as were the remainder 
of intact embryoid bodies. The number of CFU-A colonies formed by either single cells or 
intact embryoid bodies were scored after 8-11 days incubation. Untreated and 1.0% DMSO 
treated embryoid bodies were also cultured at the same time and treated in the same way. 
The results of three independent experiments are shown by Figure 3.9; Figure 3.9A shows 
the number of colonies obtained from disrupted embryoid bodies, and Figure 3.9B, the 
percentage of the corresponding samples of intact embryoid bodies giving rise to CFU-A 
colonies. Each point represents the mean of triplicate plates. As can be seen the 
observations made with intact embryoid bodies are mirrored by the disrupted samples. 
Less than five CFU-A colonies were obtained from the three experiments with disrupted 
atRA treated embryoid bodies. The results from the three experiments were furthermore 
pooled and compared to the untreated samples using a t-test at the 5% level of 
significance. The number of CPU-A colonies obtained from intact and disrupted atRA 
treated embryoid bodies were found to be significantly lower than the control samples. 
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Figure 3.10. Iron (II) sulphate dose response curve. Embryoid bodies were 
treated with various concentrations of iron (II) sulphate for the first 48 hours 
of differentiation and assayed after a total of 6 days in suspension culture. 
Each point represents the mean of three plates assayed ± standard deviation. 
The normalised percentage of embryoid bodies producing CFU-A colonies is 
shown on the y-axis, and the concentration of iron (II) sulphate used on the 
x-axis. 
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Cells from disrupted 1.0% DMSO treated embryoid bodies gave rise to approximately 
twice as many CFU-A colonies as disrupted untreated embryoid bodies. However, in a t - 
test at the 5% level of significance, the number of CFU-A colonies obtained from disrupted 
DMSO treated embryoid bodies was not found to be significantly higher than the 
untreated sample, even though a similar t-test with the intact embryoid bodies showed 
the increase in the number of CFU-A colonies to be significantly higher than the untreated 
population. 
	
3.20i).5 	Experiments with iron (II) sulphate. 
Retinoids have oxidative properties and are therefore capable of causing cellular and 
molecular damage thus inducing cell death. The ability of atRA to reduce the percentage 
of CFU-A colonies from embryoid bodies could in part be attributable to these properties 
whereby through oxidation it causes cell death which ultimately results in the dramatic 
reduction of CPU-A colonies. This hypothesis was tested by comparing the effects of atRA 
with those of iron (II) sulphate which is an oxidant that splits into its constituent ions 
when in solution. Fe2+  ions subsequently promote the production of superoxides, such as 02. 
Embryoid bodies were treated with various concentrations of iron (II) sulphate during the 
first 48 hours of differentiation and assayed after a total of 6 days in culture. The results of 
two independent experiments are shown in Figure 3.10. Although overall there may be a 
small reduction in the percentage of CPU-A colonies these effects are not as marked or 
potent as those observed after atRA treatment during the same phase of differentiation. In 
fact concentrations of iron (II) sulphate as high as 5x10 4 M failed to reproduce the 
observations made with 104  fold less concentrated atRA solutions. 
3.200.6 	Experiments with 13-cis retinoic acid (13cRA). 
Since different retinoids can exert different effects, experiments with 13cRA, were also 
carried out in order to determine whether another retinoid could elicit the same effects as 
atRA. Similar dose-response experiments to those described previously were carried out. 
Embryoid bodies were exposed to different concentrations of 13cRA for the first 48 hours of 
differentiation and subsequently assayed after a total of 6 days differentiation. The 
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Figure 3.11A. 13cRA dose response curve. Embryoid bodies were treated with 
various concentrations of 13cRA during the first 48 hours of differentiation 
and assayed after a total of 6 days in culture. Each point represents the mean 
of 3 plates assayed ± standard deviation. 
Figure 3.11B. The mean of graphs in Figure 3.11A ± standard error. 
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Figure 3.12. Dose response curves for bFGF and activin-1. Embryoid bodies 
were treated with various concentrations of the mesoderm inducers bFGF 
and activin-1 during the first 48 hours of differentiation and assayed after a 
total of 6 days in culture. Each point represents the mean of 3 plates assayed 
± standard deviation. The normalised percentage of embryoid bodies giving 
rise to CFU-A colonies is shown on the y-axis, and the concentration of 
















mean percentage of CPU-A colonies from three plates assayed. The mean for these 
experiments is shown in Figure 3.11B. 
With reference to Figure 3.1113, it can be seen there is a gradual decline in the percentage of 
CPU-A colonies as the concentration of 13cRA is increased, the percentage being reduced to 
less than 5% with 106  M 13cRA. This level of reduction in CFU-A colony numbers however 
was reached with 10-8  M atRA, 100 fold less than the dose necessary to produce the same 
effect with 13cRA. In Figure 3.11A there is a slight increase in the numbers of CFU-A 
colonies at 10-8  M 13cRA, an effect which is more pronounced in experiment 1. However 
since this observation was not reproduced by the other 3 experiments to the same extent, 
the increase at this concentration could be an experimental anomaly. 
3.2(iii) Experiments with mesoderm inducing factors 
To test whether mesoderm inducing factors would have an effect on the haematopoietic 
differentiation of embryoid bodies in this culture system, similar to the effects observed 
with either DMSO or retinoic acid, dose-response experiments were carried out with 
murine basic fibroblast growth factor (bFGF) and activin-1. Embryoid bodies were exposed 
to one of the two factors for the first 48 hours of differentiation and assayed after 6 days 
differentiation. The results for these experiments are shown in Figure 3.12, where each 
point represents the mean percentage of CPU-A colonies calculated from three plates. 
The results for bFGF show that at the concentrations used, this factor may reduce the 
percentage of CFU-A colonies; however to determine whether this reduction is 
reproducible further experiments are required. Activin-1 treatment of embryoid bodies at 
the concentrations used did not appear to alter the number CFU-A colonies in comparison 
with untreated samples. However once again further experiments are required to confirm 
this. The numbers of contracting embryoid bodies also did not increase in comparison to 
untreated samples, as may have been expected. 
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3.3 	Discussion. 
3.30) Discussion of results of studies with DMSO 
Approximately 30-50% of 6 day embryoid bodies are able to give rise to CFU-A colonies. 
After treatment with DMSO for the first 48 hours of differentiation the percentage of 
CFU-A colonies increases; this increase being dependent on the dose of DMSO used. The 
percentage of CFU-A colonies increases gradually as the concentration of DMSO is 
increased. The largest increase of more than 2 fold was obtained with 1.0%-1.4% DMSO 
(160-220 mM). Further increases in DMSO concentration caused a rapid decline in the 
percentage of CFU-A colonies. This 2 fold increase is furthermore reproducible and was 
also observed in assays of single cell suspensions derived from embryoid bodies disrupted 
after 6 days differentiation (Figure 3.9A). In this experiment twice as many CFU-A 
colonies were observed with single cells derived from DMSO treated embryoid bodies than 
from untreated samples. 
In a t-test at the 5% level of significance, the mean diameter of CFU-A colonies produced 
by embryoid bodies after DMSO treatment was not found to be significantly larger than the 
mean diameter of colonies obtained with untreated samples. Treatment with DMSO does 
not appear to alter the time course of embryoid body CFU-A differentiation. Moreover 
morphological assessment of CFU-A colonies produced by DMSO treated embryoid bodies 
has shown that these colonies are not different from those produced by untreated samples 
(Figures 1.4 & 3.113). 
As mentioned in section 3.1, DMSO has been shown to induce the terminal differentiation 
of promyelocytic and other malignancy derived cell lines, in vitro. DMSO can also induce 
EC cells to differentiate toward cardiac and skeletal muscle lineages (McBurney et a!, 
1982). Few studies of the effects of DMSO on ES cells have been published. In a recent 
publication Dinsmore et a! (1996), have found DMSO to induce skeletal muscle cells from 
ES cells. In all these instances the most potent differentiation inducing concentrations of 
DMSO have been found to be between 1.0%-1.4%, with higher concentration being toxic. 
These results are consistent with those shown in Figure 3.1. 
A 2 fold increase in the percentage of CPU-A colonies was observed after treatment of 
embryoid bodies with DMSO during the first 48 hours of differentiation. It is assumed that 
by exposing embryoid bodies to DMSO during this phase of differentiation, the very early 
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stages of ES cell commitment are being influenced, an assumption which is supported by the 
increase in CFU-A colonies after only 24 hours treatment. Timed exposure experiments, 
however, suggest that this effect is cumulative with the percentage of colonies increasing 
as the length of time of treatment is increased. Similar results have been obtained by 
Edwards et al (1983) with EC cells. In the latter study the number of beating muscle EC cell 
aggregates increased gradually as the length of time of exposure to 1.0% DMSO was 
increased, with the largest number of beating aggregates being observed after treatment for 
the first 50 hours of differentiation. 
DMSO was found to influence embryoid bodies early on during differentiation (Figure 3.2). 
Furthermore, the numbers of CPU-A colonies obtained after disruption of embryoid bodies 
to single cell suspensions was found to mirror the proportion of intact DMSO treated 
embryoid bodies producing CFU-A colonies (Figure 3.9A). This suggests that DMSO is 
acting to increase haematopoietic commitment, as opposed to expanding the population of 
committed progenitors. The question of whether DMSO can expand the population of 
committed progenitors could be addressed by experiments which involve the treatment of 
embryoid bodies for 24 hour periods during the standard 6 day differentiation period, as 
carried out with retinoic acid (section 3.2(ii).3). 
DMSO has been found to induce EC and ES cells to differentiate towards skeletal and 
cardiac muscle tissue (McBurney et al, 1982; Edwards et a!, 1983; Pari et a!, 1992; Dinsmore 
et al, 1996), which like haematopoietic tissue is derived from mesoderm. DMSO could 
therefore, be acting essentially as a mesoderm inducer in differentiating EC and ES cell 
aggregates. The culture system used throughout the course of this study is optimised for 
haematopoietic differentiation, providing the right environment for haematopoietic 
differentiation of the possibly DMSO induced mesoderm. Although the culture conditions 
do not support haematopoietic differentiation exclusively, since approximately 50% of the 
embryoid bodies giving rise to CPU-A colonies also contracted, indicating the presence of 
either skeletal or cardiac muscle. 
DMSO has anti-oxidative properties and can therefore act as a free-radical scavenger. 
Since free radicals can cause cellular and molecular damage and thereby cell death 
(reviewed by Parchment, 1993), it was hypothesised that the increase in CFU-A colonies 
after DMSO treatment could in part, be due to fewer free-radicals in the culture media. a-
tocopherol is a known antioxidant the effects of which have been studied in other systems 
such as tumours and lymphocytes (Masotti et a!, 1988; Poulin et al, 1996). Therefore the 
influence of cx-tocopherol on the haematopoietic differentiation of embryoid bodies was 
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assessed, and compared with the observations made with DM50. The results show that a-
tocopherol has little or no effect cn the percentage of CFU-A colonies (Figure 3.4). On the 
basis of this comparison the effect of DMSO as an anti-oxidant in this culture system is 
unlikely to be significant. 
The mechanism of action of DMSO is not understood although various suggestions have 
been made, including the direct influence of the molecule cn the expression of genes 
involved in differentiation (Tanaka et a!, 1975). However there is increasing evidence to 
suggest that DMSO acts indirectly cn gene expression, explaining the requirement for the 
high concentrations necessary to induce differentiation. Studies with various cell lines 
have shown that the drug stimulates the release or production of intracellular secondary 
messengers such as calcium and lipid secondary messengers (Morley and Whitfield, 1993; 
Clejan et al, 1996). 
DMSO has also been shown to bind to the GM-CSF and insulin receptors, and suggested to 
thereby stimulate cell differentiation (Brennan et a!, 1991; Schwartz et a!, 1993). RT-PCR 
studies with extracts from the CCE line of ES cells have shown the transcript for the GM-
CSF receptor to be present, demonstrating that ES cells can express this receptor amongst 
others (McClanahan et a!, 1993). PCR detection for the f'-chain of the GM-CSF receptor 
transcript in EFC-1 cells has been carried out, but it has not been found to be expressed in 
embryoid bodies of less than 6 days. EFC-1 cells have however been shown to express the 
gp130 common subunit required for dimerisation with various interleukin receptors (Hole e t 
a!, 1996). DMSO could therefore be acting via one or more of these receptors to induce 
haematopoietic differentiation. Competitive binding assays between DMSO and ligands 
for the receptors thought to be expressed in EFC-1 cells, could help to clarify this question. 
It has also been suggested that DMSO effects the permeability of the cell membrane 
(Lyman et a!, 1976), and has even been shown to enhance DNA transfection (Kawai and 
Nishizawa, 1984). Edwards et a! (1983) have suggested that in experiments with cultured 
EC cells, DMSO acts as a carrier for retinoids that are present in the serum used in the 
media, implying that the results obtained are not directly due to DMSO. The group 
therefore investigated the effects of DMSO an EC cells in delipidised serum, but found no 
alteration in the results. DMSO could be acting as a carrier for retinoic acid and/or other 
serum factors present in the culture system throughout the present study. However the 
results obtained by Edwards eta!, as discussed above, suggest that this is probably not the 
case, although the only way to ascertain this would be to perform the same experiments 
with delipidised serum. However, the disadvantage with delipidised serum is that many 
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other factors, the combinations of which may be necessary for ES cell/embryoid body 
differentiation and proliferation, could also be removed. 
As with many other cell culture systems, DMSO is used as a cryoprotectant for the freezing 
of the cells used in this study. It is unlikely that the 10% DMSO solution used, could skew 
subsequent differentiation of ES cells, for a number of reasons. When suspended in the 
freezing-solution, the cells are immediately frozen and when thawed the solution is 
diluted and aspirated promptly and the cells washed several times with media before 
culture. Such practices should ensure that DMSO does not have an effect on the cells, 
particularly since exposure times in excess of 24 hours are required before an effect is 
observed (Figure 3.3). However, the only way to determine the effects of DMSO in this 
procedure on ES cells, would be to use an alternative cryoprotectant. 
3.30) Discussion of results of studies with retinoic acid 
Retinoic acid affects the haematopoietic differentiation of embryoid bodies, as detected 
by the CFU-A assay, in a dose dependent fashion. After treatment with atRA during the 
first 48 hours of differentiation, the percentage of CFU-A colonies obtained from 6 day 
embryoid bodies is found to decrease with increasing concentrations of atRA. 
Concentrations of less than 10-10  M have been found not to affect the percentage of CFU-A 
colonies compared to untreated control samples. The first decrease in the percentage of 
colonies is observed with 10-10  M atRA, with any further increase causing a sharp decrease 
in the percentage of CFU-A colonies. Treatment with 10-8  M atRA reduces the percentage of 
CFU-A colonies to below 5%, while higher concentrations reduce the percentage further to 
less than 1%. 
Morphological analysis of the limited CFU-A colonies obtained from embryoid bodies 
treated with lower doses of atRA (10-10  M, iO M) have shown that these colonies do not 
differ from those derived from untreated control samples. Furthermore, time course 
experiments show that like DMSO, atRA is not shifting embryoid body CFU-A 
differentiation to either an earlier or later time point (Figure 3.6). 
In a t-test at the 5% level of significance, the mean diameter of CFU-A colonies produced 
by intact atRA treated embryoid bodies were also found to be significantly smaller than 
those produced by the untreated samples. Assays of single cells derived from disrupted 
atRA treated embryoid bodies also show a marked decrease in the number of CFU-A 
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colonies compared with untreated samples. This could suggests that atRA is acting to 
reduce the number of haematopoietic progenitors capable of forming CPU-A colonies, and 
that the absence of colonies after atRA treatment is not due to the inability of 
macrophages/monocytes to migrate away from intact embryoid bodies. Alternatively 
treatment of embryoid bodies with atRA could be affecting the self-maintenance capacity 
of CPU-A cells, resulting in the smaller colony sizes. 
Retinoic acid is known to induce the differentiation of EC cells (Hogan et al; 1981; Edwards 
and McBurney, 1983a) and reports of its ability to induce ES cell differentition have also 
been published recently. Pew reports regarding its influence on the haematopoietic 
differentiation of either of these cell lines have however been published. Reporter gene 
studies in the human EC cell line NT2, have shown atRA concentrations of 10 -5M and 5x10 7 
M can activate the MHC class I promoter, and immunoprecipitation studies have shown 
the promoter to be bound and activated by the RARI3-RXRP heterodimer (Segars et al, 
1993). atRA has also been found to induce the de novo expression of the transcription factor 
NP-KB, this transcription factor being involved in transactivating the expression of 
several haematopoiesis related genes including IL-2 and its receptor. 
In a brief study, Heuer et a! (1994) reported similar observations to those made in the 
present study. The system used by this group involved the culture of D3 ES cells in hanging 
drops in the presence varying concentrations of atRA and the absence of LIP for 0-3 days. 
The aggregates were then allowed to differentiate for 2 days in suspension culture in the 
absence of atRA. The number of embryoid bodies with blood islands were counted after 
incubation in semi-solid medium supplemented with leucocyte conditioned medium, 
consisting of 3U/ml of Epo. 10 -9 M atRA made little or no difference to the percentage of 
blood islands, but 10-8  M reduced the number by approximately 50%. The percentage of 
embryoid bodies with blood islands was found to be reduced to less than 10% with a ten 
fold increase in atRA to 10-7  M. In the present study however, the number of CPU-A 
colonies was found to be reduced by concentrations of 10-1010-9  M, and a reduction of less 5% 
was achieved with 10-8  M atRA. 
In the same study other cell types were also observed. A decrease in the number of 
myocardial cells was noted with increasing concentrations of atRA. The percentage of 
embryoid bodies producing skeletal muscle was found to increase at 108  M atRA with any 
further increases in concentration reducing this percentage. However, while myocardial, 
skeletal and blood cell types were reduced by 107106  M atRA, concentrations of between 
108106 M induced nerve cell differentiation by almost 100%. Studies by other groups 
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where atRA has been found to induce embryoid bodies to differentiate towards neural 
lineages support these findings (Wobus et a!, 1994; Bain et a!, 1995). Similar findings were 
also reported earlier with EC cell lines (McBurney et al, 1982; Edwards and McBumey, 
1983a; Husmann et a!, 1989). 
Findings by these groups could suggest that the decrease in the percentage of CFU-A 
colonies from embryoid bodies observed in the present study may not be directly due to the 
inhibition of haematopoiesis by atRA per Se, but as a result of the morphogen inducing the 
specific differentiation of embryoid bodies towards one particular cell type, namely neural 
lineages. This hypothesis could be tested with in vitro assays designed for the detection of 
neural differentiation, and by gene expression studies. 
Dose-response experiments with 13cRA show that this retinoid is also able to reduce the 
percentage of CFLJ-A colonies. However, it is found to be almost 100 fold less effective than 
atRA. Other studies with this retinoid have also found it to be less potent than atRA. Not 
only has 13cRA been found to be at least ten fold less effective than atRA in inducing 
differentiation of promyelocytic cells, both in vivo and in vitro (Chomienne et a!, 1990), 
but also less effective on normal primitive human bone marrow haematopoietic progenitors 
(van Bockstaele et al, 1993). 
Various groups have studied the effects of retinoids on normal haematopoiesis using bone 
marrow progenitors. In studies where mixed populations of human bone marrow cells, 
consisting of both primitive and committed haematopoietic cells, were used, together with 
only one colony stimulating factor (GM-CSF) to stimulate clonal proliferation, retinoids 
have been found to increases haematopoietic differentiation (Douer and Koeffler, 1982; 
Sakashita et a!, 1993). However in studies where a purified populations of either 
primitive murine or human bone marrow cell populations, LinSca1 or CD34 cells 
respectively, were analysed, along with more than one colony stimulating factor to 
simulate clonal proliferation, which is thought to be more representative of the in vivo 
haematopoietic microenvironment, retinoids have been found to inhibit haematopoietic 
proliferation (van Bockstaele et a!, 1993; Jacobson et a!, 1994). 
In studies where retinoic acid has been found to have multiple effects, primitive progenitor 
populations are still found to be inhibited whereas more committed progenitors have 
enhanced proliferation in response to retinoic acid, particularly granulocytic progenitors 
(Smeland et a!, 1994; Zauli et a!, 1995). Therefore the effects of retinoic acid on normal 
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haematopoietic cells appear to be dependent on the different culture conditions used as 
well as the cell types analysed. 
These reports together with the findings that retinoic acid is able to stimulate the 
expression of GM-CSF and M-CSF in human bone marrow stromal cell lines (Nakajima e t 
a!, 1994), suggest that retinoic acid has a complicated role in normal haematopoiesis, with 
the response to the molecule probably being cell type dependent. These findings could also 
suggest that atRA may have an inhibitory effect on primitive haematopoietic stem cells 
derived from ES cells, but could also stimulate haematopoiesis in more mature progenitors. 
However treatment of embryoid bodies with retinoic acid during the later stages of 
differentiation does not appear to increase the number of CPU-A colonies (Figure 3.8). 
Results of timed exposure experiments with atRA show that the reduction in the 
percentage of CFU-A colonies is temporally specific. The reduction is only observed if 
embryoid bodies are exposed to 10-8  M atRA between 0-3 days of differentiation, and for no 
less than 16 hours after being removed from LIF containing media (Figure 3.7 & 3.8). The 
percentage of CPU-A colonies are no different from the untreated sample if embryoid 
bodies are treated with atRA outside of this time frame, therefore the drug may be 
affecting a specific, as yet uncharacterised cell type. 
Wobus et a! (1994) have also found that cardiomyocyte differentiation of embryoid bodies 
in their culture system to be markedly reduced if they were treated with atRA (10-910-6 
M) during days 0-2 of differentiation. They suggest that this is due to the sensitivity of ES 
cells to the cytotoxic effects of atRA. The results of the timed exposure experiments in this 
study and the findings reported by Heuer et a! (1994) discussed earlier, do not support this 
hypothesis. Furthermore reports by Chen and Gudas (1996) suggest that ES cells are able to 
tolerate these, and probably higher concentrations of exogenous retinoic acid since not only 
do the cells metabolise the drug within the first 2 hours of exposure, a function which 
appears to be part of their normal metabolism, but the molecule accumulates inside the 
differentiating cells bound to retinoid binding proteins. 
Foetal calf serum (FCS), used for the culture of ES cells in this experimental system and 
others, contain retinoids as do the sera of other mammals. Although the retinoid content of 
FCS will vary from batch to batch the concentration has generally been found to be between 
10-8 and 10 M (Fuchs and Green, 1981; Hagen et a!; 1996). It must be noted that the 
concentrations of atRA used throughout this study are in addition to the serum retinoid 
levels and so the observations reported cannot be said to be representative of the normal' 
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effects of retinoids on embryoid body haematopoietic differentiation. If the normal effects 
of retinoids an ES cell/embryoid body differentiation were to be studied, either a serum-
free culture system, such as reported by Johansson and Wiles (1995), or delipidised serum, 
would need to be used. However, this is not the concern of this study, the aims of which are 
to modulate embryoid body haematopoietic differentiation by exogenous factors. 
Retinoids are oxidative agents and can therefore cause cellular and molecular damage and 
hence cell death. In order to test whether the effects observed with atRA were due to its 
oxidative potential the effect of iron (II) sulphate, another oxidative agent, on embryoid 
body differentiation was studied and the results compared with those observed after atRA 
treatment. Iron (II) sulphate was found to have very little or no effect on the percentage of 
embryoid body CFU-A colonies compared with untreated control samples, even a t 
concentrations 1000 fold in excess of those used with atRA. 
As an oxidative agent Fe2+ ions cause the production of superoxide radicals such as 02, and 
iron (II) salts have been shown to cause oxidative DNA damage and lipid peroxidation in 
rat liver nuclei (Shires, 1982). However, the concentration of iron (II) salts used in the 
latter study (1.5 x 10 M and 75 x 10 M), were higher than those used in this study. 
Furthermore Fe2 ions are bound by intracellular ferritin, which was also absent from the 
study by Shires (1982). Both these factors may have contributed to the lack of a marked 
effect on CFU-A numbers after iron (II) sulphate treatment of embryoid bodies. In order to 
determine whether oxidative damage can cause a reduction in the numbers of CFU-A 
colonies from embryoid bodies, the culture system needs to be saturated with iron. But this 
threshold is difficult to ascertain since overloading cells with iron, in turn results in 
apoferritin synthesis (Halliwell and Gutteridge, 1984). 
Clearly however, the concentration of iron (II) sulphate, used in the experiments presented 
here, was far in excess of those of atRA. The potency of atRA at concentrations of 10 M 
and 10-8 M is most likely due to its action through its nuclear receptors and not as a result of 
oxidative damage. Moreover, even though there was a lack of CFU-A colonies, contracting 
muscle embryoid bodies were still observed at concentrations of 10-8  M atRA and above, 
which would not be expected if there was oxidative damage to the embryoid bodies. 
Retinoids are known to exert their effects via their nuclear receptors which are ligand 
binding transcription factors that belong to the hormone nuclear receptor superfamily. 
Both families of retinoid receptors (RARs & RXRs) are not only expressed in EC cells but 
retinoic acid, at the concentrations similar to those used in this study, has also been shown 
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to induce EC cell differentiation through these receptors (Minucci et a!, 1994; Roy et al, 
1995). Detailed expression data for retinoid receptors in ES cells have not been published 
yet, but treatment of ES cells with retinoic acid has been shown to induce the expression of 
the receptors (Leroy et al, 1991; Chen et a!, 1996). Thus it can be said that at the 
concentrations of atRA used in this study, atRA is probably acting via its cognate receptors. 
This assumption could be verified by the use of antibodies against one or more of the 
receptors, which could render them ineffective, or with the use of RARa knock-out ES cell 
lines (Lufkin et al, 1993). 
3.2(iii) Discussion of results of studies with mesoderm inducers. 
Since factors such as bFGF and activin-1 induce mesoderm lineages, their addition to the 
culture media of differentiating ES cell aggregates would in theory indirectly enhance 
haematopoietic differentiation. Therefore, preliminary dose dependent studies with both 
the aforementioned factors were carried out. At the concentrations used, activin-1 appears 
to have very little or no effect on the percentage of CFU-A colonies, and bFGF appeared to 
reduce the percentage of colonies marginally. However, no definite conclusions can be 
drawn from these studies since further experiments are required to ascertain the 
reproducibility of the observations. Further experiments could not be carried out due to the 
limited availability of the factors. 
One of the problems with using these factors in this culture system is the presence of serum 
in the media which consists of various unidentified proteins and growth factors that may 
mask the effects of any exogenous growth factors. In other studies where mesoderm factors, 
such as BMP-4, have been used to induce embryoid body haemaopoietic differentiation, 
defined serum-free media has been used (Johansson and Wiles, 1995). For the purposes of 
future experiments with these inducers it may be useful to use different concentration ranges 
to the ones looked at. Moreover recent studies in Xeno pus have shown that the effects of 
activin-1 and bFGF are dependent on each other and therefore it may be useful to add both 
factors to the differentiating embryoid bodies, in order to induce noticeable effects (Cornell 
and Kimelman, 1994; Lebonne and Whitman, 1994). These experiments should also be 
coupled with gene expression studies to test whether the receptors for these factors are 
expressed in differentiating embryoid bodies. 
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3.4 Summary 
When embryoid bodies are allowed to differentiate for 6 days in this culture system 
approximately 30-50% give rise to CFU-A colonies. In order to modulate this level of 
commitment for reconstitution and gene expression studies embryoid bodies were treated 
with various chemicals and mesoderm inducing factors during the earliest stages of 
differentiation, and the effects of the treatments assessed with the CFU-A assay. It was 
thus found that treatment of embryoid bodies with 1.0-1.4% DMSO increased the 
percentage of CFU-A colonies by more than 2 fold. It was furthermore found that the full 48 
hour exposure was necessary to obtain the optimal effects. The treatment does not appear 
to alter the time course of embryoid body CPU-A differentiation and is also not thought to 
be due to the anti-oxidant properties of DMSO. Assays of disrupted DMSO treated 
embryoid bodies, once again showed a 2 fold increase in the percentage of CFU-A colonies, 
strongly suggesting that DMSO is enhancing haematopoietic commitment. 
Treatment of embryoid bodies with 108  M atRA for the first 48 hours of differentiation 
however, was found to reduce the percentage of CPU-A colonies to less than 5%, an effect 
which is temporally dependent. No reduction in the percentage of CFU-A colonies was 
observed, relative to the untreated control samples, when embryoid bodies were exposed to 
atRA for less than 16 hours after being removed from LIF containing media, or if they were 
treated beyond the third day of differentiation. The drug is therefore not thought to act on 
committed haematopoietic cells. atRA treatment once again did not alter the time course 
of embryoid body CFU-A differentiation and the observations made are not thought to be 
as a result of the oxidative properties of atRA. The effects of DMSO and atRA on embryoid 
body gene expression patterns, over a time course of differentiation, were subsequently 
examined. These are discussed in Chapter 4. 
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4. 	Effects of Exogenous Factors on Gene Expression. 
4.1 	Introduction. 
Results discussed in Chapter 3 clearly demonstrate that the number of CFU-A colonies can 
be modulated by the addition of chemical inducers to the differentiation environment of 
embryoid bodies. CFU-A assays of DMSO treated embryoid bodies, section 3.3(i), strongly 
suggest that the compound is enhancing haematopoietic commitment. The effects of atRA 
on embryoid body haematopoietic differentiation are however, somewhat more difficult 
to interpret, since the marked reduction in the number of CFU-A colonies after atRA 
treatment does not necessarily imply that haematopoiesis is inhibited. 
To make a fuller assessment of the influence of these compounds and how they may be 
affecting embryoid body differentiation, their effects on gene expression was investigated. 
Using RT-PCR and Northern blot analysis the messenger RNA content of 1% DMSO or 10-8 
M atRA treated embryoid bodies, together with untreated control samples were analysed 
over a time course of differentiation. The expression of most genes analysed in this study 
have been investigated by other groups, (Schmitt et at, 1991; Wiles et at, 1991; 
McClanahan et at, 1993; Keller et at, 1993; Hole et at, 1996). 
The genes amplified by RT-PCR included the haematopoietic cell surface markers Sca-1 
(Ly-6A/E) and CD45. Sca-1 is a cysteine rich cell surface protein expressed in primitive 
haematopoietic progenitors (van deRijn et at, 1989; Nishio et al, 1996). CD45 is a 
transmembrane spanning glycoprotein expressed in both mature and primitive 
haematopoietic cells; one of its splice variants gives rise to the B-cell specific marker, 
B220, which was also amplified (Saga et at, 1988; Saga et at, 1990). Other transcripts 
analysed included those for c-kit receptor and foetal -g1obin, both of which have been 
shown to be expressed in embryoid bodies differentiating in this culture system (Hole et at, 
1996). 
RT-PCR reactions were also carried out for the transcripts of the chemokine MIP-lcz and 
the intracellular haematopoietic cell phosphatase, HCP: two proteins implicated in the 
negative regulation of haematopoiesis (Dunlop et at, 1992; Yi et at, 1993), which could be 
up-regulated in embryoid bodies after atRA treatment. RT-PCR of GATA-1, and Northern 
blot analysis of GATA-2 and PU.1, three transcription factors known to be important in 
haematopoiesis were also performed (Pevney et at, 1995; Tsai et al, 1994; McKercher et at, 
1996). The expression pattern of such markers should indicate whether treatment with 
either morphogen is acting to enhance or inhibit ES cell haematopoietic commitment. 
Assuming that DMSO and atRA are acting to increase or decrease ES cell haematopoiesis 
respectively, they could be exerting their influence either at the stage of ES cell 
commitment to mesoderm, and/or mesoderm commitment to haematopoietic lineages. 
Therefore to determine whether DMSO is enhancing, and atRA diminishing mesoderm 
commitment, RT-PCR reactions for the mesoderm marker brachyury (Wilkinson et al, 
1990), were also performed. 
4.2 	Results. 
Total RNA was extracted from untreated embryoid bodies and those treated with 1% 
DMSO or 10-8 M atRA for the first 48 hours of differentiation. 1.xg of each RNA sample 
was reverse transcribed to obtain cDNA. It is assumed that under optimum conditions each 
messenger RNA transcript is reverse transcribed into a single cDNA copy. Since 1/20th of 
the RT products were subsequently used for PCR reactions, approximately 50ng of total 
RNA was used for PCR amplification, of which only 2-3% consists of messenger RNA. 
Before the amplification of RT products, the presence of genomic DNA contamination in 
RNA extracts was tested by PCR amplification of the J3-actin gene, using 50ng of each total 
RNA sample. These PCR products were subsequently electrophoresed on an agarose gel and 
no DNA specific bands were observed. RT reactions were then PCR amplified for the P- 
actin transcript and samples of the reactions electrophoresed on an agarose gel. This gel 
was Southern blotted and hybridised with an [a- 32P]dCTP-labelled 13-actin probe and the 
resulting hybridisation intensities were quantitated using a phosphor-imager. This was 
done to determine the variability between samples when a standard amount (lj.il; 
approximately 50ng) of RT product is used for PCR amplification. The intensity of each 
band was derived by subtracting the background signal from the 3-actin signal. The 
resulting intensities are shown in Table 4.1. 
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No. of days of Intensity (Average 
Sample  
differentiation pixel value) 
Undifferentiated 
EFC-1 0 6.4 
2 5.8 
Untreated embryoid 4 10.2 
bodies 6 7.9 
8 7.0 
2 8.2 
1% DMSO treated 4 6.8 
embryoid bodies 6 11.9 
8 7.9 
2 6.5 
10-8 M atRA treated 4 10.3 
embryoid bodies 6 4.4 
8 1 	 6.9 
Table 4.1. Intensity of -actin RT-PCR products for samples of a time course study. The 
percentages were calculated by subtracting the background intensity from the product 
signals. All PCR reactions were were carried out for 30 cycles. 
The lowest intensity of 4.4 was observed with the 6 day atRA sample, and the highest of 
11.9 with 6 day DMSO treated sample. Assuming that 13-actin gene expression is not 
affected by morphogen treatment, it can be said that the intensity of the samples follow a 
normal distribution with the intensities of most samples falling between 6-8. Given the 
number of variables that can affect any given PCR reaction, such as pipetting accuracy and 
reagent integrity, this level of spread in intensities between samples, in any given 
experiment can be tolerated. It should be noted that the RT-PCR experiments are no more 
than semi-quantitative in nature, and although the expression of one gene can be compared 
between samples, the level of expression of different genes cannot be compared. The results 
of subsequent RT-PCR experiments are summarised in Table 4.2. Gels from some experiments 
are illustrated in Figure 4.1a-c. 
Untreated I 	1% DMSO I 10-8 M atRA 
Time of differentiation (days) 
GENE EFC-1 2 4 6 8 2 4 	6 8 2 4 6 8 
fl-actin +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
brachyury * ± + +++ ± +++ +++ + 	+++ +±+ +++ +++ - +++ 
HCP* +++ +++ +++ + +++ +++ +++ +++ + +++ +++ +++ +++ 
GATA-i + ± - ++ + - - 	+ - + - - - 
Ly-61S ca-i I 	+ - ++ ++ + ± + 	++ +± +++ +++ ± ++ 
c-kit - - - + ++ - + 	++ ++ ++ ++ - + 
13-globin - + - - - - ++ 	+++ +++ - - ++ - 
CD45* - - - - ± - - 	+++ + - - - - 
IL-3 - - - - - - - 	- - - - - - 
MIP-la - - - - - - - 	- - - - - - 
VLI.i - - - - - - - 	- + - - - - 
GATA2 - 
Table 4.2. Summary of RT-PCR (unshaded boxes) and Northern hybridisation (shaded 
boxes) analysis of embryoid body RNA extracts. 10tl of each RT-PCR product was 
electrophoresed on an agarose gel and the bands visualised with ethidium bromide 
staining except for * which were hybridised with the respective radiolabelled probes. 
Total RNA was extracted from 2, 4, 6 and 8 day old embryoid bodies cultured in the absence 
of morphogens or exposed to DMSO or atRA for the first 48 hours of differentiation. RNA 
extracts from undifferentiated ES cells (EFC-1) represents day 0. All PCR reactions were 
performed for 30 cycles. The levels of RT-PCR products were scored by eye using the 
following criterion: -, no signal; ±, trace signal; +, weak signal; ++, strong signal; +++, very 
strong signal. For Northern hybridisation analysis, 5j.ig of total RNA extract was 
electrophoresed on a 1% agarose/formaldehyde denaturing gel and blotted on to 
nitrocellulose membrane as described in section 2.3.4. The blots were consequently 
hybridised overnight with the appropriate [a- 32P]dCTP labelled probe. Bands were 
visualised by phospho-imaging. 
4.2.1 Effects of DMSO on gene expression. 
Results of CFU-A assays discussed in section 3.2, strongly suggest that DMSO is enhancing 
haematopoietic commitment. This effect can be exerted either at the point of ES cell 
commitment to mesoderm, or mesoderm commitment to haematopoietic lineages. In order to 
address this question RT-PCR was used to analyse the expression of the mesoderm marker 
brachyury in embryoid bodies treated with 1% DMSO for the first 48 hours of 
differentiation, over a time course of differentiation. Since no product for the gene was 
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detected after ethidium bromide staining, agarose gels were Southern blotted and 
hybridised with [a-32P]dCTP labelled brachyury cDNA probe. Subsequently brachyury 
transcript was detected in nearly all samples. Only a weak signal was obtained from the 
day 6.5 p.c. mouse embryo sample, possibly due to a poor quality of RNA. At this level of 
analysis no marked increase in the level of brachyury transcription was observed with 
DMSO treated embryoid bodies compared to untreated samples. Total RNA samples were 
also used for Northern blot analysis of a second mesoderm marker, gooscoid, using a 
radioactively labelled genomic done of the gene, containing an intronic sequence. The 
probe however hybridised to the ribosomal RNA fraction making the experiment 
uninformative with respect to gooscoid expression. 
To further investigate the effects of morphogens on embryoid body differentiation several 
haematopoietic markers were also RT-PCR amplified. RT-PCR products of the 
intracellular phosphatase HCP, and the membrane bound phosphatase CD45, were 
analysed using Southern blot hybridisation due to poor visualisation of the products with 
ethidium bromide staining. Fragment of a cDNA clone was used as a probe for HCP, while 
total RNA extract from adult mouse spleen was used to obtain a probe for CD45 by RT-PCR. 
Consequently I-ICP was found to be expressed in all samples, and its level of expression was 
not found to be visibly altered after DMSO treatment of embryoid bodies. PCR 
amplification of the cDNA clone of the gene was used as a control for the reaction. 
CD45 transcription levels were found to be markedly up-regulated post DMSO treatment. 
The CD45 gene is alternatively spliced, two splice variants of which were detected with 
the PCR reaction used in this study. The higher molecular weight band, (Figure 4.3b), 
indicates the transcript encoding the B220 cell surface marker. This product is not detected 
in untreated samples, but is found to be expressed in 6 and 8 day DMSO treated embryoid 
bodies. Similarly, the CD45 transcript was faintly visible in 6 and 8 day untreated 
embryoid bodies, but was found to be present with greater intensity at these time points 
after DMSO treatment. 
Transcripts for the haematopoietic transcription factor GATA-1, were detected by RT-PCR 
in 6 and 8 day untreated embryoid bodies and also in 6 day DMSO treated sample. No 
distinct increase in the transcription level of GATA-1 was detected post DMSO treatment. 
Transcripts for GATA-1 were also detected in the day 13 p.c. mouse foetal liver control 
samples. Northern blot hybridisation of embryoid body total RNA extracts with 
radioactively labelled GATA-2 cDNA, revealed an absence of the transcript from all 
samples. However, after Northern blot hybridisation of total RNA samples with PU.1 
cDNA probe, a signal was detected in 8 day DMSO treated embryoid bodies, but no signal 
was detected with the untreated counterpart. The transcript for PU.1 was also found to be 
expressed in adult mouse bone marrow. 
4.2.2 Effects of atRA on gene expression. 
The CFU-A assay results observed with atRA treated embryoid bodies could be due to the 
inhibition of haematopoietic differentiation by the drug. As explained earlier such an 
effect could be exerted at at least two different stages of differentiation one of which is a t 
the point of ES cell commitment to mesoderm. In order to assess whether atRA treatment 
results in the inhibition of mesoderm commitment, expression of brachyury in embryoid 
bodies treated with 10-8 M atRA for the first 48 hours of differentiation, over a time course 
of differentiation, was investigated. Subsequent to Southern blot analysis of the RT-PCR 
products brachyury transcripts were detected in the atRA treated samples. At this level of 
detection no marked reduction in brachyury transcription was detected post atRA 
treatment compared with the untreated counterparts. Although transcripts for this gene 
were not detected in 6 day atRA treated sample in repeated assays, it should also be 
pointed out that only a weak signal was detected for the transcript in 6 day untreated 
embryoid bodies (Figure 4.1a). 
The intracellular phosphatase HCP and the chemokine MIP-lcz have been implicated in 
haematopoietic inhibition. RT-PCR assays for the transcripts of both genes were carried 
out in order to assess whether either is up-regulated by atRA treatment. After Southern 
blot hybridisation no visible increase in the transcription of HCP was detected in atRA 
treated samples compared to their untreated counterparts. The transcripts were present in 
all samples at similar levels. RT-PCR product for MIP-lcz was not detected in any of the 
reactions by ethidium bromide staining. 
Transcripts for the haematopoietic markers CD45, PU. 1 and GATA-2 were not detected in 
any of the atRA treated samples. PU.1 and GATA-2 were also not detected in untreated 
embryoid bodies after Northern blot hybridisation of total RNA samples. However, the 
B220 transcript variant of the CD45 gene was detected by RT-PCR in 8 day untreated 
embryoid bodies, but was found to be absent post atRA treatment. 
Sca-1, c-kit receptor and GATA-1 transcripts were found to be expressed at distinctly 
higher levels in 2 and 4 day atRA treated embryoid bodies compared with the untreated 
samples of the same time points. GATA-1 was only expressed in 2 day atRA treated 
embryoid bodies and was not detected thereafter. Assessment of foetal -globin transcript 
by RT-PCR showed the messenger RNA to be present in 6 day atRA treated embryoid 
bodies, but was not detected at the same time point in untreated samples. But the 
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Figure 4.1. Results of RT-PCR assays. RT-PCR reactions were carried out with RNA 
extracted from untreated embryoid bodies, and those treated with 1% DMSO or 10-8  M 
atRA for the first 48 hours of differentiation. Embryoid bodies were allowed to 
differentiate for 2, 4, 6 and 8 days before total RNA extraction. Undifferentiated ES cells 
(EFC-1) were used as time zero control samples. 
a.RT-PCR products for the brachyury transcript were Southern hybridised with a 
radioactively labelled cDNA probe of the gene and visualised with phospho- imaging. 
RT-PCR products of the CD45 transcript were hybridised with a radioactively labelled 
probe of the transcript obtained by RT-PCR of adult mouse spleen RNA. The higher 
molecular weight product indicates the B220 splice variant. 
Foetal 3-globin RT-PCR products were resolved on an agarose gel and visualised with 
ethidium bromide staining. 
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4.3 	Discussion 
Results discussed in Chapter 3, showed that the percentage of CFU-A colonies could be 
increased by two fold after treatment of embryoid bodies with 1% DMSO for the first 48 
hours of differentiation. However, treatment with 10-8  M atRA for the same period of 
differentiation reduced the percentage of CPU-A colonies to less than 5%. In order to assess 
whether DMSO and atRA are exerting their effects by enhancing and inhibiting mesoderm 
and/or haematopoietic lineage commitment, respectively, Northern blot and RT-PCR 
techniques were used to study the effects of these compounds on haematopoietic and 
mesoderm marker gene expression. Northern blot analysis is a more quantitative technique 
than RT-PCR since relative transcript numbers can be distorted during PCR amplification. 
RT-PCR was used in the majority of cases however, due to difficulties encountered with 
Northern blot analysis, such as poor detection of rare transcripts (e.g. PU.1), and non-
specific hybridisation of probes to the ribosomal RNA fraction. As mentioned previously, 
results of RT-PCR reactions are not quantitative and therefore comparisons between 
experiments cannot be made. 
Approximately 50ng of total RNA was used for PCR amplification only 2-3% of which 
comprises of messenger RNA. The RT product was initially used to amplify the transcript 
for f-actin to detect the presence of messenger RNA in the extract. These products were 
further blotted on to nitrocellulose filter, hybrised with the appropriate probe and the 
signals quantiated by phospho-imaging, in order to assess the variability in the reactions. 
Quantitation of the signals, showed the spread in percentage intensity between samples to 
be within a small range given the variety of factors that can affect PCR reactions. 
To assess whether DMSO and atRA are influencing embryoid body haematopoiesis 
through the regulation of mesoderm commitment, RT-PCR reactions for the mesoderm 
marker brachyury were performed. Keller et al (1993) have reported the presence of this 
transcript in 4-6 day embryoid bodies. In this study transcripts for the transcription factor 
were detected to some extent in nearly all untreated embryo body samples (2-8 days). Trace 
signals for this transcript were also detected in ES cell RNA extracts which were not 
observed by Keller et a! (1993). Although ES cells cultured in the presence of LIF are 
maintained in a largely undifferentiated state, a degree of differentiation nevertheless 
takes place. Furthermore, in the present study brachyury RT-PCR products were visualised 
by hybridisation with a radiolabelled cDNA probe of the gene. This is a more sensitive 
method of discerning transcripts than ethidium bromide staining used by Keller and co- 
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workers, and could account for the detection of brachyury in embryoid bodies at earlier 
time points as well as the ES cell sample. 
At this level of analysis, transcription levels for brachyury in DMSO and atRA treated 
embryoid bodies were not found to be markedly different from those observed with 
untreated embryoid bodies. Therefore the increase in the number of CFU-A colonies after 
DMSO treatment, and the reduction after atRA treatment cannot be said to be due to either 
a marked enhancement or reduction in mesoderm commitment. This is supported by data 
from Vidricaire et a! (1994) who have also found transcription level of the gene to be 
unaffected by DMSO in EC cell aggregates. 
Transcripts of the putative negative regulator of haematopoiesis, HCP, were also detected 
in all samples, and its transcription levels was not found to be noticeably affected after 
DMSO or atRA treatment of embryoid bodies. The transcripts for HCP were also detected 
in ES cells after hybridisation of the RT-PCR products with a radiolabelled cDNA probe 
of the gene. This would therefore suggest that HCP is not a haematopoietic specific gene. 
It should however be noted that the detection of transcripts in any of these experiments 
does not necessarily indicate the presence of a functional protein. MIP-la and IL-3 
transcripts were not detected in any of the samples by ethidium bromide staining. Further 
analysis by cDNA hybridisation was not performed for either of these samples. Keller e t 
a! (1993) and Schmitt et al (1991) also failed to detect IL-3 transcripts in their 
experiments. 
The expression pattern of Ly-6 (Sca-1) and c-kit receptor were found to be very similar 
during the time course of differentiation (table 4.2). In this study, c-kit receptor was found 
to be expressed in 6 and 8 day old embryoid bodies confirming observations reported by 
Keller et a! (1993). Transcription of either c-kit receptor or Ly-6 were not found to be 
enhanced by DMSO treatment. However both transcripts were found to be elevated in 2 
and 4 day atRA treated embryoid bodies in comparison to untreated samples at the same 
stage of differentiation. Mao et al (1996) have also recently reported the up-regulation of 
the human Ly-6 homologue, after atRA treatment of HL-60 and NB-4 cells, two 
promyelocytic cell lines. 
Elevated levels of Ly-6 and c-kit receptor transcripts in 2 and 4 day atRA treated 
embryoid bodies, followed by a decrease in 6 and 8 day atRA treated samples, relative to 
their untreated counterparts, may suggest the drug is regulating the maturation of certain 
haematopoietic lineages. However, the significance of this hypothesis needs to be 
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determined with more detailed gene expression studies. The detection of transcripts for 
foetal -g1obin in atRA treated samples, suggests the morphogen may not be inhibiting 
haematopoiesis completely. Labayya et al, (1994) have recently shown atRA to inhibit 
erythropoiesis in primitive haematopoietic progenitors. In the present study, atRA 
treatment takes place before haematopoietic progenitors can be detected, which is at day 
4 of embryoid body differentiation. This could explain the difference between the findings 
of these two studies. 
In the untreated embryoid bodies only the 2 day sample was found to express -globin a t 
low levels. This is in accordance with the findings reported by Schmitt et al (1991) who 
also detect low levels of this transcript at this time point. This group found the transcript 
to be expressed at higher levels in ES cells that were allowed to differentiate in excess of 8 
days. The result of this experiment in the present study is however not in accordance with 
those reported by Hole et al, (1996) who found foetal -globin to be expressed at high 
levels in 4-8 day embryoid bodies. This difference in findings could be due to a change in 
culture conditions between the time of the study by Hole and co-workers and the 
experiments presented here. A different batch of foetal calf serum is for instance known to 
have been used in this study. 
The most striking aspect of this experiment however, is the marked increase in the level of 
foetal J3-globin transcription in DMSO treated embryoid bodies. DMSO is known to cause 
globin messenger RNA accumulation in MEL cells (Ross et a!, 1972). More recent studies 
have shown this accumulation to be dependent on haem synthesis (Fukuda et a!, 1993; 
Fukuda et a!, 1994). The ability of DMSO to induce f-globin transcription in embryoid 
bodies could suggest that the compound has some specificity for the erythroid 
differentiation pathway. 
DMSO was also found to up-regulate CD45 and B220 transcript levels. The B220 transcript 
was not found to be expressed in untreated samples, but CD45 was weakly detected in 8 day 
untreated embryoid bodies. The same was reported by Hole et al (1996). Schmitt et a 1 
(1991) have detected both transcripts in ES cells which had differentiated for at least 16 
days, by ethidium bromide staining of RT-PCR products. In the present study PCR products 
were hybridised with the homologous gene probes which may explain the detection of 
CD45 at an earlier time point in untreated samples. Both CD45 and B220 transcripts were 
found to be up-regulated in 6 and 8 day embryoid bodies post DMSO treatment. But neither 
transcript was detected in atRA treated embryoid bodies. 
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Transcripts of the GATA-1 transcription factor, which is known to be involved in erythroid 
differentiation (Pevney et al, 1991), were detected in 6 day DMSO treated samples, and in 
6 and 8 day untreated embryoid bodies. Keller and co-workers have also reported the 
presence of this transcript in embryoid bodies during this stage of differentiation. In the 
atRA treated samples only 2 day embryoid bodies were found to express GATA-l. Labbaya 
et a! (1994), have reported the down-regulation of GATA-1 in primitive human 
haemtopoietic progenitors after their exposure to atRA. GATA-1 transcription was also 
detected in ES cell extracts unlike the observations of Keller et a!, (1993). As previously 
mentioned, ES cells undergo a certain degree of differentiation in the presence of LIF, and 
the culture conditions could furthermore be conducive to the expression genes normaly 
associated with differentiated or differentiating cells. But the detection of transcript does 
not necessarily indicate the presence of functional protein. 
Northern hybridisation of embryoid body total RNA extracts with a radiolabelled cDNA 
GATA-2 probe did not detect transcripts for this gene. This could be due to the rarity of the 
transcript, but also, GATA-2 has been shown to be down regulated by GATA-1 (Weiss et a!, 
1994), the transcript for which was detected in the samples by RT-PCR. PU.1, a member of 
the ets family of transcription factors, has been found to play an important role in myeloid 
lineage differentiation (Zhang et a!, 1994; Celada et a!, 1996; McKercher et al, 1996). 
Therefore the presence of the transcript for this protein was also investigated. Embryoid 
body total RNA extracts were probed with a radiolabelled cDNA PU.1 probe. A weak 
signal was detected in 8 day DMSO treated embryoid bodies, but not in any of the other 
samples. 
The up-regulation of transcripts for haematopoietic markers such as CD45, PU.1 and foetal 
-globin, post DMSO treatment, would strongly suggest that the compound is enhancing 
haematopoietic lineage commitment and differentiation. The detection of the mesoderm 
marker brachyury in atRA treated embryoid bodies suggests that mesoderm 
differentiation in these samples is not inhibited, and it could be inferred that the drug 
affects a later stage of lineage commitment which ultimately results in the absence of 
CFU-A colonies. However whether atRA is inhibiting haematopoietic differentiation per 
Se, is unclear, since foetal 3-globin is found to be expressed. Further detailed gene 




RT-PCR and Northern blot analysis was used to study the effects of DMSO and atRA on 
lineage commitment and haematopoietic gene expression in embryoid bodies. DMSO and 
atRA were not found to neither increase nor decrease the level of brachyury transcription 
in comparison with untreated samples. On the basis of this result it could be assumed that 
neither morphogen is affecting embryoid body haematopoiesis through the regulation of 
mesoderm commitment. Treatment of embryoid bodies with 1% DMSO during the first 48 
hours of differentiation was found to increase foetal 3-g1obin, CD45 and PU.1 transcript 
expression, but did not markedly alter Ly-6, c-kit, HCP, and GATA-1 transcript levels 
compared to untreated control samples. 
Transcripts for PU.1 and CD45 were not detected in embryoid bodies treated with 10-8  M 
atRA for the first 48 hours of differentiaion. But foetal -g1obin transcripts were detected 
in 6 day atRA treated samples. GATA-1, Ly-6 and c-kit receptor were also detected in 
atRA treated embryoid bodies but these were found to be expressed at higher levels earlier 
in the time course compared with the untreated control samples. 
On the basis of these findings it can be concluded that DMSO acts to enhance 
haematopoietic lineage commitment and differentiation. But in order to unequivocally 
determine whether atRA is inhibiting haematopoietic differentiation further gene 
expression studies are required. 
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5. 	Differential Protein Expression Analysis of Embryoid 
Bodies. 
5.1 	Introduction. 
Results discussed in Chapter 3 demonstrated that DMSO can increase the percentage of 
CFU-A colonies from embryoid bodies by approximately 2-fold, this effect being exerted 
within the first 48 hours of differentiation. RT-PCR studies showed that the transcription 
level of various haematopoietic markers are enhanced post DMSO treatment. Although 
atRA treated embryoid bodies were found to express foetal f3-globin, suggesting the drug 
may not be inhibiting haematopoietic commitment, assay results clearly demonstrated 
that atRA is acting to reduce CFU-A differentiation in embryoid bodies treated during the 
first 72 hours of differentiation. 
The contrast in the effects of DMSO and atRA cxi embryoid body CPU-A differentiation 
provides a useful means of studying differential gene expression and could be employed in 
identifying factors that may be involved in ES cell commitment to HSCs, and in the in 
vitro differentiation of HSCs to various haematopoietic lineages. Differential library 
screening of treated and untreated embryoid body cDNA extracts is one method whereby 
the effects of DMSO and atRA can be utilised to this end. However, like RT-PCR and 
Northern blot analysis, this technique only detects the presence of transcripts which may 
not necessarily be translated to functional protein. This shortfall can however be overcome 
by 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) analysis of protein 
extracts, which provides a means of assessing gene transcription and translation. This 
method can also be indicative of the activity of certain proteins, since many proteins are 
activated by translational modifications, such as glycosylation and phosphorylation 
which can be detected by 2D-PAGE analysis. 
Computer assisted 2D-PAGE analysis has in recent years gained popularity and 
facilitated the study of protein expression during cell growth and differentiation. 
Software packages, such as PDQue5tTM  and PhoretixTM allow the quantitative and 
qualitative evaluation of any given protein, and provide a systematic means of comparing 
and contrasting protein expression levels over a time course of differentiation and under 
different growth conditions. 
The ability to assess temporal changes in protein expression has made 2D-PAGE analysis 
a productive method for developmental biology studies (Shi et a!, 1994). The technique 
has been used for studying various aspects of murine embryogenesis including: differential 
protein expression studies of the three primary germ layers (Latham et a!, 1993); the 
transition from maternal to embryonic protein expression (Flach et a/, 1982; Poueymirou e t 
a!, 1987; Latham et al, 1991; Latham et a!, 1992; Latham et al, 1994); and genetic 
imprinting (Latham and Solter, 1991a; Bowden et a!, 1996). 
Conditions in the cell culture environment directly influence protein expression. By 
altering growth conditions and/or exposing cells to various environmental stresses and 
differentiation inducing factors, various groups have adopted computer aided 2D-PAGE 
analysis as a means of studying differential protein expression. These studies include the 
comparison of protein expression patterns between normal and virally transformed human 
keratinocytes (Celis and Olsen, 1994), comparisons of normal murine hepatocytes and those 
exposed to ionising radiation (Giometti et a!, 1992), and differential protein expression 
studies of human germ cell-tumour derived cell lines before and after induction with 
retinoic acid (Damjanov et al, 1993). 
It is apparent from the above examples, that 2D-PAGE analysis provides a useful means of 
studying embryoid body haematopoietic differentiation, a temporally regulated process 
(Schmitt et a!, 1991; Hole et a!, 1996), which can also be influenced by exogenous factors, 
such as DMSO and atRA. Using 2D-PAGE analysis protein expression patterns between 
untreated, DMSO and atRA treated embryoid bodies over a time course of differentiation, 
were studied. The PDQue5tTM software system was employed to identify proteins which 
might play an important role in ES cell haematopoietic commitment and differentiation. 
The details and results of this analysis are outlined in the following sections. 
5.2 	Results 
Untreated embryoid bodies, and those treated with 1% DMSO or 10-8  M atRA for the first 
48 hours of differentiation, were pulse labelled with L-[ 355]methionine and subsequent 2D-
gels were analysed using the PDQue5tTM  software system. In order to minimise 
experimental error, all embryoid body samples were labelled at the same time, and 
protein extracts were resolved on 2D-PAGE gels simultaneously. 
The PDQuestTM software system has been described in detail previously (Garrels, 1989). In 
brief, autoradiographs of the gels were scanned, and images calibrated with the 
calibration strip. Background noise and streaking were removed before spots in both 
dimensions were fitted to a Gaussian distribution. The 2D-gel of 6 day untreated embryoid 
bodies contained the largest number of spots (923). This gel was therefore used as the 
template for the construction of a standard protein map, which contains all spots in the 
matchset (Figure 5.1). Matched spots were manually landmarked to enabled orientation 
and compensation for stretching of gels. Automated spot detection was then carried out, 
followed by manual editing and matching. 
A standard spot number (SSP) was allocated to each spot in the completed standard 
protein map as a means of identification, and the intensity of the spots normalised to parts 
per million (p.p.m.), this being calulated from the amount of radiolabelled cell extract 
loaded on each gel. The molecular weight (Mr) in kilo-Daltons (kDa) and isoelectric point 
(p1) of each spot was calculated with reference to proteins with known Mr and p1. The 
intensity of each spot is expressed in pixel density units (PDU), this being a function of the 
spot intensity, number of pixels covered and the normalisation factor. The software can 
locate proteins which are up- or down-regulated by 5 fold, and those which are switched-
on (present) or -off (absent) between specific gels. Therefore by posing questions that can be 
answered in these terms, Boolean sets containing elements, i.e. proteins, satisfying specific 
parameters, were created and proteins fulfilling certain criteria identified. The accuracy 
of the Boolean set analysis was tested by posing a series of control questions' to which the 
answer was expected to be zero (Table 5.8). 
5.2.1 Protein expression patterns in untreated embryoid bodies. 
Initially comparisons between 2-dimensional protein gels of undifferentiated ES cells and 
2 day embryoid bodies were performed. The data shows a large number of changes in 
protein expression taking place during this early stage of the differentiation programme. 
345 proteins were found to be switched cn during this phase of differentiation. An 
additional 145 spots were up-regulated and only 6 down-regulated. 
Switching-on or -off and up- or down-regulation of protein expression was found to continue 
throughout the time course of embryoid body differentiation (Table 5.1). Such temporal 
changes in protein expression are illustrated by spot number 1403, representing a protein of 
p1 4.4 and Mr 38.2 kDa. The intensity of this protein increases by almost 5 fold, from 15.8 
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PDU in 2 day untreated embryoid bodies, to 74.9 PDU in 8 day untreated embryoid bodies. 
In contrast, after being up-regulated by more than 35 fold from 6.3 PDU in undifferentiated 
ES cells, to 226.3 PDU in 2 day embryoid bodies, spot number 8513 is then steadily down-
regulated across the time course of embryoid body differentiation (Table 5.4). 
Boolean-sets of proteins: 
Number of 
spots in set 
up-regulated from 2C to 4C 21 
up-regulated from 4C to 6C 9 
down-regulated from 6C to 8C 23 
switched-off in EFC-1, on in 2C and up-regulated in 4C 9 
switched-off in 2C, on in 4C and up-regulated from 4C to 6C 1 
switched-on from 4C to 6C and switched-off from 6C to 8C 297 
Table 5.1. Boolean sets of spots created for the analysis of protein expression patterns in 
untreated embryoid bodies. 2-dimensional protein gels of undifferentiated ES cells (EFC-
1), and those for 2, 4, 6 & 8 day untreated control (C) embryoid bodies were compared and 
the number of spots in each of the sets, determined. 
For the purposes of identifying proteins involved in ES cell haematopoietic commitment 
and differentiation, various criteria were considered. During the time course of untreated 
embryoid body differentiation, the number of CFU-A colonies gradually increased, with 
the largest number of CFU-A colonies being detected at around the 6th day of 
differentiation and decreased thereafter. Assuming that the expression pattern of 
haematopoietic related proteins reflects this observation, the CFU-A differentiation 
profile can be used as the basis for identifying proteins of interest. As shown in Table 5.1, 
there are proteins which are up-regulated from 2 to 4 to 6 days, and some which are down-
regulated from 6 to 8 days. But none of these proteins were found to be common between all 4 
sets. However, 297 spots were found to be switched-on in embryoid bodies between days 4 
and 6, and down-regulated between days 6 to 8. 
Proteins such as 1305, which are highly expressed in 6 and 8 day embryoid bodies, may be 
markers of differentiated cells, whereas protein spots which are switched an during the 
first 2 days of differentiation and down-regulated thereafter, (such as spot 3109), or 
switched-off, (such as spot 5005), may be representative of proteins involved in the early 
stages of ES cell commitment, among which proteins required for haematopoietic 


















. .- 5 




Figure 5.1. Standard protein map. The 2D-PAGE gel of 6 day untreated embryoid bodies 
was used to create a standard protein map which is a composite of all the protein gels in 
the matchset and therefore contains all the spots from the 13 gels analysed. The red spots 
indicate the position of proteins of interest, i.e. proteins which fulfil one or more aspect(s) 
of the criteria used to define proteins that could potentially play a role in haematopoietic 
commitment/ differentiation (see main text). The SSP numbers for each protein is given to 
the right of each spot. 
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5.2.2 Embryoid body protein expression is modified by DMSO. 
Protein expression in embryoid bodies treated with 1% DMSO for the first 48 hours of 
differentiation was found to vary over the time course of differentiation. The protein 
expression patterns in these embryoid bodies were also found to differ from that of 
untreated samples; this is demonstrated in Tables 5.2 & 5.3. A larger number of spots were 
found to be switched on from day 2 to day 4 of embryoid body differentiation after DMSO 
treatment, compared with the untreated samples at the same phase of differentiation. 
However, fewer spots were found to be switched on from day 4 to day 6, and from day 6 to 
day 8 in DMSO treated embryoid bodies, compared with the same gels in the untreated 
samples. 
No. of proteins switched-on: Untreated 1% DMSO 
from EFC-1 to 2D 345 210 
from 2Dto4D 21 117 
from 4D to 6D 346 205 
from 6D to 8D 354 203 
Table 5.2. Comparison of the number of proteins being switched-on from EFC-1 to 2, 2 to 4, 4 
to 6, and 6 to 8 days in untreated and 1% DMSO (D) treated embryoid body samples. All 
embryoid body samples were labelled with L-[ 35S] methionine simultaneously. 
Comparison of the protein expression profiles in time course experiments of untreated 
embryoid bodies with those of their DMSO treated counterparts, also shows that not only 
does DMSO up-regulate the expression of some proteins, but it also induces the expression 
of additional proteins, (Table 5.3). Some proteins such as 1217, representing a protein of p1 
4.4 and Mr 27.9 kDa, were found to be consistently up-regulated after DMSO treatment, 
throughout the time course of differentiation (Table 5.4). 
Of the proteins whose expression was switched-on in 2 day embryoid bodies as a result of 
DMSO treatment, 16 were also switched-on in the 4 day samples following DMSO 
treatment (Figure 5.2a). Ten protein-spots were also found to be switched-on in both 6 day 
and 8 day embryoid bodies as a result of DMSO treatment (Figure 5.2b). However, since no 
proteins were found to be common to all four sets, it can be assumed that ES cells do not 
possess genes which are specifically induced by DMSO. Proteins were also found to be 
down-regulated or switched-off as a result of DMSO treatment, as shown in Table 5.3. 
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Switched-on Switched-off Up-regulated Down- 
regulated 
From 2Cto2D 55 130 14 102 
From 4C to 4D 220 120 6 75 
From 6Cto6D 154 385 18 113 
From 8C to 8D 1 	114 1 	130 1 	3 32 
Table 5.3. Numbers of proteins being switched-on/off or up/down-regulated as a result of 
DMSO treatment. 2-dimensional protein gels of untreated control (C) and DMSO (D) 
treated embryoid bodies at various days of differentiation were compared and the numbers 
of protein-spots either up/down-regulated or switched-on/off as result of DMSO treatment 





Figure 5.2. Common proteins shared between sets of proteins switched-on following DMSO 
treatment. The numbers 16 and 10, indicated in (a) and (b) respectively, refer to spots 
shared between the following sets: 
Spots switched-on from 2 day untreated samples to 2 day DMSO treated samples 
Spots switched-on from 4 day untreated samples to 4 day DMSO treated samples 
Spots switched-on from 6 day untreated samples to 6 day DMSO treated samples 
Spots switched-on form 8 day untreated samples to 8 day DMSO treated samples 
For the purposes of identifying proteins involved in ES cell haematopoietic commitment 
and differentiation, similar criteria to those mentioned in section 5.2.1 were considered. 
Since twice as many embryoid bodies have been found to give rise to CFU-A colonies after 
exposure to 1% DMSO during the first 48 hours of differentiation, proteins of interest may 
be among those either up-regulated or switched-on, upon DMSO treatment (Table 5.3). 
If proteins switched-on in the early stages of embryoid body differentaition, and 
switched-off or down-regulated thereafter, are representative of proteins involved in the 
early stages of ES cell haematopoietic commitment, proteins such as 5005 may be of 
particular interest. Spot 5005 is a protein of p1 5.3 and Mr 17.2 kDa. It is switched-off in ES 
cells but switched-on in 2 day untreated embryoid bodies, and is switched-off thereafter. 
In 2 day DMSO treated embryoid bodies the PDU value for this spot is increased by more 
than 2 fold compared with untreated samples (Table 5.4). Other proteins such as 1305, 
which are up-regulated throughout the time course of untreated embryoid body 
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Spot Intensities (PDU)  
Untreated 1% DMSO 10-8 M atR 
SSP p1 Mr EFC-1 2 4 6 8 2 4 6 8 2 4 6 8 
1217 4.4 27.9 349.6 403.1 429.7 383.0 176.3 258.3 1156.7 1451.0 1304.7 1712.7 1345.9 1209.4 791.7 
1305 4.4 33.5 104.3 87.2 170.8 303.0 333.6 28.9 254.9 246.2 373.8 201.1 60.1 47.5 51.7 
1403 4.4 38.2 14.8 15.8 - 60.1 74.9 24.9 42.8 51.9 96.8 - - - - 
2110 4.8 23.5 - - - 49.3 84.8 - 37.1 75.2 97.8 29.6 - - - 
2303 4.7 35.2 - 33.6 - 45.7 168.6 - - 162.0 179.8 - - - - 
2405 4.8 38.5 38.2 70.3 61.2 83.4 - 26.0 - - - 44.7 158.9 55.7 95.5 
2606 4.8 55.2 287 668.9 1129.7 578.6 266 847.9 539.1 325.5 310.6 340.8 1996.5 1146.1 620.9 
3109 5.0 22.3 - 257.7 165.1 132.2 - 165.0 137.9 - - - - 85.7 - 
3312 5.1 32.6 - 36.1 30.3 42.2 44.4 47.5 - - - - 129.4 47.5 76.6 
4112 5.1 23.9 28.7 72.1 32.3 19.7 37.0 437.0 23.0 23.5 42.2 - 171.3 227.8 576.3 
4801 5.1 108.7 - - - 54.6 - - 19.1 61.1 - 238.3 - - - 
5005 5.3 17.2 - 79.4 - - - 199.0 - - - - - 111.7 - 
7404 6.4 42.6 10.9 83.6 225.7 54.3 - 124.4 159.9 - 50.7 - 1 - 74.3 51.7 8513 7.1 47.9 6.3 226.3 287.2 200.7 147.8 130.7 261.7 31.7 152.1 22.7 30.0 199.6 422.8 
Table 5.4 . Protein spots of interest and their intensities. The above table shows some protein-spots which may involved in ES cell haematopoietic 
commitment and/or differentiation, and variations in their expression patterns with respect to time and treatment (see text). The spots are 
identified by their standard spot numbers (SSP). The values for their p1 and Mr (kDa) were calculated with reference to those for known proteins. 
The intensities are expressed in pixel density units (PDU). The samples are undifferentiated ES cells (EFC-1); 2, 4, 6 & 8 embryoid bodies either 
untreated or treated with 1% DMSO or 10-8  M atRA for the first 48 hours of differentiation. (-) denotes: no detectable intensity. 
differentiation, and are further up-regulated post DMSO treatment, could be involved in 
embryoid body haematopoietic differentiation. 
5.2.3 Embryoid body protein expression is modified by atRA. 
Expression patterns of proteins in embryoid bodies treated with 10-8  M atRA during the 
first 48 hours of differentiation, are also found to vary over the time course investigated. 
Protein expression profiles in these embryoid bodies differ not only from that of untreated 
embryoid bodies, but also from DMSO treated samples. Comparisons between 2-
dimensional protein gels of untreated and atRA treated embryoid bodies, show that atRA 
can up- or down-regulate the expression of some proteins while it can switched-on or -off 
the expression of others (Table 5.5). For example, protein spot 2606 (p1 4.8, Mr 55.2 kDa), is 
up-regulated in atRA treated samples compared with untreated counterparts, and 
continues to be up-regulated throughout the time course of differentiation. Spot 1305 is up-
regulated by more than 2-fold in 2 day atRA treated embryoid bodies, compared to 
untreated samples but is down-regulated thereafter during the time course of 
differentiation. In contrast, some protein spots displayed a sharp and temporally specific 
expression pattern in atRA treated embryoid bodies, such as 3109 and 5005, both of which 
are only expressed during the 6th day of differentiation (Table 5.4). 
Switched-on Switched-off 
From EFC-1 to 2A 345 230 
From 2A to 4A 171 398 
From 4A to 6A 261 91 
from 6A to 8A 1 	255 1 	155 
Table 5.5. Changes in protein expression across the time course of atRA (A) treated 
embryoid body differentiation. 2-dimensional gels between undifferentiated ES cells 
(EFC-1) & 2 day, 2 & 4 day, 4 & 6 day, 6 & 8 day embryoid bodies were compared and the 
number of protein spots being switched-on or -off, recorded. 
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Switched-on Switched-off Up-regulated Down- 
regulated 
From 2C to 2A 285 329 108 47 
From 4Cto4A 139 159 113 25 
From 6C to 6A 76 76 46 38 
From 8C to 8A 1 	273 1 	92 1 	131 1 	22 
Table 5.6. Comparison between untreated control (C) and atRA (A) treated embryoid 
bodies. 2-dimensional protein gels between 2, 4,6 & 8 day embryoid bodies were compared 
and the number of protein spots switched-on/off or up/down-regulated between samples 
recorded. 
After treatment with 10-8 M atRA during the first 48 hours of differentiation, the number 
of embryoid bodies giving rise to CFU-A colonies is markedly reduced. Assuming that the 
expression pattern of haematopoietic related proteins reflect the results of CFU-A assays, 
effects of atRA can be used to identify proteins of interest. Therefore protein spots which 
are either down-regulated or switched-off after atRA treatment, in comparison to 
untreated samples, are of particular interest. Examples of such proteins include spot 1305, 
which is gradually down-regulated through the time course in atRA treated embryoid 
bodies, and spot 1403, which is not expressed at any time point in atRA treated samples. 
However, results of CFU-A assays of embryoid bodies after time course experiments show 
that a very small proportion of 6 and 8 day atRA treated embryoid bodies give rise to 
haematopoietic colonies (Figure 3.8). Therefore, proteins that could potentially be 
involved in haematopoiesis may be switched-off or down-regulated in 2 and 4 day atRA 
treated embryoid bodies but could be switched-on or up-regulated in 6 and 8 day samples, 
in comparison to untreated samples. Protein spot 7404 (p1 6.4, Mr 42.6 kDa) fulfils such 
criteria. This protein is not expressed in 2 and 4 day atRA treated embryoid bodies but is 
expressed in 6 and 8 day samples. Furthermore, in untreated samples, 7404 is most highly 
expressed in 4 day embryoid bodies, and down-regulated thereafter, a profile which could 
be indicative of a protein involved in the early stages of ES cell differentiation. 
5.2.4 Use of DMSO and atRA for the selection of haematopoietic related proteins. 
By exploiting the opposing effects of DMSO and atRA an the CFU-A differentiation of 
embryoid bodies, a set of criteria for identifying haematopoietic related proteins from 2-
dimensional gels can be defined. Using this approach the Boolean sets defined in the 
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previous sections were superimposed for further selection of proteins that may be involved 
in the haematopoietic commitment and/or differentiation of ES cells. Two main criteria 
for the selection of such proteins were defined; these are outlined below. 
Data obtained from CFU-A analysis, discussed in chapter 3, show that the number of CFU-
A colonies from untreated and DMSO treated embryoid bodies gradually increases between 
the 2nd and 6th day of differentiation. DMSO treatment increases this number of CFU-A 
colonies by about 2-fold (Figure 3.2). Although the number of CFU-A colonies obtained 
from atRA treated embryoid bodies is markedly reduced in comparison to untreated 
samples, it nevertheless increases marginally over the time course of differentiation 
(Figure 3.6). In theory, the expression pattern of the protein-spots which reflect these 
observations could help identify proteins involved in the differentiation of 
haematopoietic progenitors. Such a criterion is represented by Figure 5.3a. 
a. 	 163 
Figure 5.3. Superimposition of sets to define proteins involved in (a) the differentiation of 
haematopoietic progenitors (shaded) and (b) commitment of ES cells to haematopoietic 
lineages (shaded). The sets are: 
Proteins up-regulated throughout the time course of untreated embryoid body 
differentiation 
Proteins up-regulated with DMSO treatment and up-regulated throughout the 
time course of DMSO treated embryoid body differentiation 
Proteins down-regulated with atRA treatment and up-regulated over the time 
course of atRA treated embryoid body differentiation 
Proteins not expressed in EFC-1 
V. 	Proteins up-regulated throughout the time course of untreated embryoid body 
differentiation 
Proteins up-regulated with DMSO treatment but down-regulated throughout the 
time course of DMSO treated embryoid body differentiation 
Proteins down-regulated with atRA and up-regulated over the time course of atRA 
treated embryoid body differentiaion 
As previously mentioned, proteins which are either switched-off or are expressed at low 
levels in undifferentiated ES cells, but which are expressed during the early stages of 
embryoid body differentiation, and thereafter switched-off or down-regulated, could 
potentially be involved in the early stages of ES cell commitment. In theory proteins 
which could be involved in the early stages of ES cell haematopoietic commitment would 
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also have this profile but in addition they would be up-regulated after DMSO treatment 
and down-regulated after atRA treatment. Such a criterion is represented in Figure 5.3b. 
As demonstrated by Table 5.7, when various Boolean sets are superimposed, the number of 
common spots is rapidly reduced. No protein-spots were found to fulfil either of the 
stringent criteria described in Figure 5.3a or b. But a number of proteins were found which 
displayed an expression profile that satisfied some aspects of these criteria, and which 
warranted further analysis (Table 5.7). Amongst these, are proteins the expression 
patterns of which are outlined in Table 5.4 & Figure 5.4. 
Other sets of proteins which may also be of interest are those which are not expressed in 
atRA treated embryoid bodies, but which are expressed in untreated and DMSO treated 
samples, such as protein spot 2405. Assuming that atRA is inhibiting the differentiation of 
certain haematopoietic lineages, proteins which are only expressed in atRA treated 
embryoid bodies and not expressed or are expressed at low levels, in untreated or DMSO 
treated samples, such as protein spot 4112, could potentially be involved in the inhibition 
of such differentiation. 
Boolean set of proteins: 
Number of spots 
 in set 
up-regulated from 2A to 2D 12 
down-regulated from 2A to 2D 74 
up-regulated from 2A to 2D and present in 2C 12 
up-regulated from 6A to 6D and present in 6C 16 
up-regulated from 2A to 2D and present in 6C 12 
up-regulated from 2A to 2D, present in 4C and up-regulated from 4A to 
1 
4D 
up-regulated from 2A to 2D, present in 4C and up-regulated from 6A to 
0 
6D 
on in 6D and off in 6A 210 
on in 8D and off in 8A 75 
on in 4D,off in 4A and on in 6D, off in 6A 42 
on in 4D, on in 6D, off in 4A, off in 6A and up-regulated from 4D to 6D 
2 
Table 5.7. Sets defined for the identification of haematopoietic related proteins. 2-
dimensional protein gels of 2, 4, 6 & 8 day untreated control (C), DMSO (D), and atRA (A) 
treated embryoid bodies were compared for the identification of haematopoietic related 
proteins. 
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Type of Normalisation 








Figure 5.4. Expression profiles of eight proteins of interest (opposite). The key for 
the graphs is shown above. The PDU value is given on the y-axis and the the 
sample on the x-axis. The samples include undifferentiated ES cells (EFC-1); 2, 4, 
6 & 8 day untreated, 1% DMSO treated and 10 -8 M atRA treated embryoid 






























Boolean sets of proteins: 
switched-off in EFC-1, on in 2C and off in 2C, on in 4C 
switched-off in 2C, on in 2D and on in 2C off in 2A 
switched-off in 8C on in 8D and on in 8C, off in 8D 
switched-on in 4D, off in 4A and off in 4D, on in 4A 
Table 5.8. Control questions posed at intervals during the analysis to check the efficacy of 
the Boolean sets. The expected answer in each case is zero since the sets in each example 
are mutually exclusive. The correct answer was given in each case. 2-dimensional protein 
gels of undifferentiated ES cells (EFC-1), 2, 4, 6 & 8 day untreated control (C), DMSO (D) 
and atRA (A) treated embryoid bodies were compared. 
5.2.5. Identification of -tubu1in by Western blotting 
The estimation of a value for the Mr and p1 of each protein-spot on the standard map, 
should in theory enable the identification of proteins after comparison of these values 
with those of other 2D-PAGE databases. However, a variety of factors affect the 
resolution of proteins in either dimension during electrophoresis, such as electrophoresis 
parameters and IEF gel equilibriation. Due to such variation identification of individual 
proteins by inter-laboratory comparisons of 2-dimensional protein databases, can be 
difficult and may be unreliable. 
Despite these drawbacks, attempts were made to identify developmentally regulated 
protein-spots, by visual comparison of the gels in this matchset with those of 6.5 and 7.5 
day p.c. murine embryos (K. Latham, Temple University School of Medicine, 
Philadelphia, pers. com .). Although it is difficult to accurately identify the counterpart 
of any given protein-spot on other gels, this sort of comparison could be useful for 
determining which spots may be of interest for further study. Spot 2303, for instance, is 
thought to be a protein whose expression is elevated in endoderm relative to ectoderm; 
spot 1305 was identified as being in the region of proteins that have transiently elevated 
expression at the 2-cell stage; and spot 5505 could be a protein that is highly expressed in 
6.5 day embryos and in ectoderm. 
In addition, spot 2606 was thought to have a mobility pattern characteristic of -tubulin. 
In order to ascertain this, Western blot analysis was carried out. The highest PDU value 
for spot 2606 was observed in 4 day atRA treated embryoid bodies while the lowest was in 
8 day untreated embryoid bodies. In order to be able to observe the difference in expression 
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Figure 5.5. Western blot analysis of -tubulin. 0.5mg of protein extract from 
4 day atRA treated (A) and 8 day untreated (B) embryoid bodies were 
electrophoresed in two dimensions and western blotted onto a PVDF 
membranes. The membranes were then probed with monoclonal antibody 
against 13-tubulin. The spots detected have a p1 of approximately 5.7 and 
molecular weight of 55 kDa. 
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levels, 0.5mg of protein extracts from these two samples were resolved on 2D-PAGE gels 
and Western blotted onto PVDF membranes. The membranes were probed with a mouse IgG 
monoclonal anti-3-tubu1in antibody. The secondary antibody against the mouse IgG was 
conjugated to horse radish peroxidase, enabling spot detection with a chromogenic reagent. 
A spot was detected with both 8 day untreated and 4 day atRA treated samples both of 
which were approximately 55 kDa in weight, the same Mr as that calculated for spot 2606 
(Figure 5.5). However, the p1 values were found to be more basic than that of spot 2606. 
Both spots were estimated to have a pI of approximately 5.7, spot 2606 having an 
estimated p1 of 4.8. 13-tubulin is known to have different isoforms with varying p1 values. 
Although the spots detected by Western blot analysis had different p1 to that of spot 2606, 
since the same spot was detected in both samples with a monoclonal-antibody specific for 
3-tubulin, and the spot was found to have the same Mr as spot 2606, it is very likely that 
this represents a 3-tubulin isoform. This experiment does not conclusively identify spot 
2606 as f-tubu1in. Further immunological experiments would be required with another 3-
tubulin specific antibody to ascertain this. 
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5.3 	Discussion 
The molecular mechanisms controlling and contributing to the haematopoietic commitment 
and differentiation of ES cells are poorly understood. One of the first steps in deciphering 
this process is to identify genes which are either switched-on/off and/or up/down-
regulated at various stages of differentiation. Differential cDNA library screening offers 
one means by which such genes can be identified. However as previously mentioned this 
method gives little indication as to whether the transcripts from which cDNA clones are 
derived are actually translated to functional protein. To overcome this, protein expression 
patterns in cells can be analysed directly; however, a means of screening for proteins of 
interest is necessary. 
Since protein expression patterns change over a given period of differentiation, many 
groups have used such temporal changes to identify proteins that regulate such processes 
as embryogenesis (Latham et a!, 1991; Shi et a!, 1994). Alternatively, alterations in tissue 
culture conditions and exposure of cells to environmental stresses can also change protein 
expression patterns. Other groups have used such techniques as viral transformation and 
retinoic acid treatment as ways of assessing qualitative and quantitative changes in 
protein expression patterns, in comparisons with untreated samples (Celis and Olsen, 1994, 
Damjanov et al, 1993). 
CFU-A assay studies have shown that embryoid body haematopoietic differentiation is a 
temporally regulated process (Hole et a!, 1996). Furthermore as shown throughout the 
course of this study, this differentiation can be modulated by DMSO and atRA in 
diametrically opposing ways. Time and morphogen treatment were therefore used as 
means of screening for haematopoietic related proteins. L[ 35S] methionine labelled protein 
extracts from undifferentiated ES cells, untreated embryoid bodies and those treated with 
either DMSO or atRA, over a time course of differentiation were analysed. Total protein 
extracts were resolved in 2-dimensions according to charge and molecular weight and the 
resulting 2D-PAGE gels subjected to analysis with the PDQuestTM  software. 
The analysis demonstrated that protein expression patterns changed over the time course 
of embryoid body differentiation and with respect to treatment. Both DMSO and atRA 
were found to switch-on/off and/or down/up-regulate protein expression (Tables 5.2, 5.3, 
5.5 & 5.6). The ability of atRA to down-regulate or switch-off protein expression is 
particularly interesting, since retinoids and their receptors are most widely associated 
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with transactivation of gene expression, although they are also known to down-regulate 
the expression of a number of genes particularly metalloproteases (Nicholson et al, 1987). 
Based cii the opposing effects of DMSO and atRA on the CFU-A differentiation of 
embryoid bodies, two main criteria were defined for identifying proteins involved either 
in ES cell commitment to haematopoietic progenitors, or the differentiation of 
haematopoietic progenitors to terminally differentiated lineages (Figures 5.3a & b). 
However no proteins were found to fulfil either of these stringent criteria. This could be 
due to several reasons. For example, both criteria assume that atRA is inhibiting 
haematopoiesis, an assumption which may not be strictly true, since RT-PCR data have 
shown atRA treated embryoid bodies can express haematopoietic marker transcripts, 
(Table 4.2). This could be taken into account for the outlining of more detailed, criteria a t 
the expense of creating complicated sets which are difficult to decipher. Also to 
incorporate this into the model for selecting proteins of interest it would be necessary to 
know the manner in which atRA was affecting embryoid body differentiation. 
Not all proteins present in a cell will be represented on a given 2D-PAGE gel, since most but 
not all mature proteins contain methionine residues, unlabelled proteins will consequently 
not be represented on gels. PDU values may also not be representative of actual protein 
expression levels, since some proteins may be highly expressed but have few methionine 
residues, or proteins which are methionine rich may be expressed at low levels. These 
shortfalls could be overcome by using more than one radiolabelled amino acid residue in 
labelling experiments. Another drawback with 2D-PAGE analysis is that it may not be 
sensitive enough to detect proteins which are expressed at low levels, but which are key 
regulators of commitment and differentiation, such as transcription factors. Labelling with 
more than one radiolabelled amino acid would also aid the detection of such proteins on 
gels. An alternative way of representing the total protein content of a cell is by silver 
staining, as used by Burggraf and Lottspeich (1995), for the construction of 213-PAGE 
protein databases from various human cell lines. However once again the technique has 
similar limitations to radiolabelling since some proteins will silver stain more easily than 
others. 
Despite the absence of proteins which fulfilled all the the criteria outlined in Figures 5.3a 
& b, some proteins were found to satisfy aspects of these criteria, either with respect to 
their expression patterns across the time course of differentiation, and/or the way in 
which their expression was affected by either DMSO or atRA treatment (Table 5.4; 
Figures 5.1 & 5.4). For instance spot 3109 could be indicative of a protein involved in the 
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early stages of ES cell commitment to haematopoietic lineages, since it was not expressed 
in undifferentiated ES cells, but was expressed in 2 day untreated and DMSO treated 
embryoid bodies, and thereafter down-regulated over the time course. Spot 2110 however 
could be representative of a protein involved in the differentiation of committed 
haematopoietic progenitors. This protein was not expressed in undifferentiated ES cells, 
but was switched-on in differentiating embryoid bodies and up-regulated throughout the 
time course of both untreated and DMSO treated samples, while it was only expressed in 2 
day atRA treated embryoid bodies. 
In this experiment only 213-PAGE gels of embryoid bodies treated with DMSO or atRA for 
the first 48 hours of differentiation were analysed. For further 'fine-tuning of Boolean sets 
for the identification of haematopoietic related proteins, it would be useful to produce 2D-
PAGE gels from other types of experiments. For example timed morphogen exposure 
experiments, outlined in Figures 3.3,3.7 & 3.8, would also be useful sources of information. 
Since atRA appears to have little effect on the CFU-A differentiation of embryoid bodies 
after 72 hours (Figure 3.8), proteins related to CFU-A differentiation should in theory be 
switched-off during the 1st, 2nd and 3rd day of atRA exposure, but switched-on thereafter. 
Furthermore, timed DMSO exposure experiments suggest that DMSO acts in a cumulative 
fashion (Figure 3.3b), and therefore proteins involved in haematopoietic differentiation 
could also be up-regulated as embryoid bodies were exposed to DMSO for longer periods of 
time. 
As previously mentioned, identification of specific protein spots by inter-laboratory 
comparisons of 2D-PAGE gels are not particularly practical or reliable for various reasons. 
There are many factors which can influence the resolution of proteins in either gel 
direction (Duncan and Hershey, 1984). Although most laboratories follow standard 
protocol procedures, specific practices can alter the outcome of 2-dimensional gels. For 
instance ampholytes from different manufacturers, and different gel electrophoresis times 
between laboratories, will affect the resolution of the gels. Thus a protein such as actin 
may have an apparent p1 of 5.4 under certain electrophoresis conditions but a p1 of 5.5 in 
others. In addition to this the 2D-gel protein-pattern obtained from different cell types 
will inevitably differ, making comparisons and matching of spots difficult. The specific 
post-translational modification that a given protein may be subjected to in different cell 
types could also vary, making its specific identification difficult. Nevertheless, attempts 
were made to compare the gels in the present study with those of other databases, 
particularly those from day 6.5 and 7.5 p.c. murine embryos. Consequently protein-spots 
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such as 2303 and 5505 were suggested to be developmentally regulated (K. Latham, Temple 
University School of Medicine, Philadelphia, pers. corn.). 
The mobility pattern of spot 2606 was also thought to resemble that of 3-tubulin. To 
confirm this, Western blots of 2D-gels of 8 day untreated and 4 day atRA treated embryoid 
bodies were probed with a mouse monoclonal antibody against -tubu1in. These samples 
were chosen since spot 2606 was found to have the lowest and highest PDU values in these 
samples respectively. A spot of approximately 55 kDa was observed with both samples, 
which corresponds to the molecular weight estimated for spot 2606 (Table 5.4; Figure 5.4). 
However the p1 of the spot on both membranes was found to be approximately 5.7, more 
basic than that estimated for spot 2606. However, -tubulin has been shown to have many 
isoforms with different p1 values (Linhartová et al, 1993). This experiment therefore does 
not determine whether spot 2606 is f3-tubulin. But the fact that a monoclonal antibody was 
used, together with the detection of the same spot in both samples strongly suggests that 
the antibody may be detecting a particular isoform of 3-tubulin. The use of another 
antibody specific for 3-tubulin or radio-immunoprecipitation should help clarify this 
question. 
It is interesting to note that the expression of the protein spot thought to be 3-tubulin is up-
regulated after atRA treatment, in comparison with either untreated or DMSO treated 
samples (Table 5.4; Figure 5.4). Studies with atRA have shown that it induces ES cells to 
differentiate towards neural lineages (Wobus et a!, 1994; Bain et a!, 1995). Since class III 
3-tubulin is specifically expressed in neural tissue, it would be interesting to use a 
monoclonal antibody against this particular isoform in order to test whether it would bind 
to spot 2606. Spot 0305 has also been suggested to be a tropomyosin isoform, however 
further studies of this protein spot could not be carried out due to the unavailability of the 
antibody. 
Recently Bowden et a! (1996) have published 213-PAGE gels of two ES cell lines, different 
from the cell line analysed here. Although their database does not include differentiated 
embryoid bodies, it would nevertheless be useful to compare these gels with those from 
this study for the purposes of identifying specific proteins. Ultimately, the only way of 
identifying specific proteins is by physical means as opposed to comparative methods. One 
way of achieving this is by physical removal of the spot of interest from the gel, cleavage 
of the protein by enzymatic digestion or alkylation, and N-terminal sequencing of the 
fragments. These amino acid sequences could then be checked against protein sequence 
databases and homologous or identical sequences distinguished (Merrick et a!, 1994). 
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A more rapid method of identifying proteins from 2D-PAGE gels has been developed in 
recent years which not only eliminates the requirement for N-terminal sequencing but also 
requires only picomolar amounts of protein. This method involves the tryptic digestion of 
protein spots either after removal from gels or directly on a Western blot membrane. The 
masses of the peptide fragments generated are then determined by mass spectrometry. 
Various computer programs have been developed which search protein databases and 
match the peptides derived, with those obtained from a given protein under similar 
cleavage conditions. A number of groups are using this new technology for identifying 
proteins from 213-PAGE gels (Henzel et a!, 1993; Ji et a!, 1994; Arnott et al, 1996). This 
technology coupled with the use of DMSO and atRA as a means of screening, is a 
potentially efficient method of identifying proteins involved in the commitment and 
differentiation of ES cells to haematopoietic lineages. 
Post-translational modification is also known to play an important part in regulating 
protein function (Howlett, 1986). DMSO has been shown to release intracellular calcium 
stores (Morley and Whitfield, 1993), one function of which is the activation of protein 
kinases and phosphatases that modify other proteins, either activating them or 
sequestering their actions. Using 32P-labelling of proteins it would be valuable to 
determine to what extent DMSO influences the phosphorylation or dephosphorylation of 
embryoid body proteins. Other modifications to the present 213-PAGE studies may include 
the extraction and analysis of specific protein fractions such as the cell-membrane, 
cytosolic and nuclear fractions. This kind of analysis can provide a much more detailed 
profile of protein expression patterns. 
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5.4 Summary 
Studies of 2D-PAGE gels of untreated, DMSO or atRA treated embryoid bodies, have 
shown that protein expression patterns can be regulated both temporally and with respect 
to treatment. Following the observations made with CFU-A assays of untreated and 
morphogen treated embryoid bodies, two main criteria were outlined for the identification 
of haematopoietically related proteins. However no proteins were identified which 
fulfilled these stringent criteria. Since some proteins satisfied certain aspects of the 
specifications and these have been designated for future studies. No specific proteins could 
be definitively identified, at this level of analysis, but spots 2606 and 0305 have been 
suggested to be -tubulin and tropomyosin respectively. These studies have therefore 
demonstrated that the opposing effects of DMSO and atRA on embryoid body CFU-A 
differentiation can be used to screen for proteins that may be involved in either the 
haematopoietic commitment of ES cells or differentiation of committed haematopoietic 
progenitors. 
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6. 	Summary of Conclusions. 
The intricate cellular and molecular events which control and contribute to 
haematopoietic commitment and differentiation, during embryogenesis and adult life, 
remain largely elusive. Despite the difficulties in studying such a complex process, a 
variety of different techniques have been employed in an attempt to unravel the 
complexity of this fundamental biological process, some of which have already been 
discussed in Chapter 1. In recent years ES cell lines have in particular proved an important 
and productive in vitro source for studying haematopoiesis. One of the limiting steps in 
understanding the mechanisms of haematopoiesis has been the identification of genes 
involved in directing and controling the process. Using ES cells and their differentiated 
aggregates, the main aim and proposal of this project was to devise a strategy for 
identifying genes that could be involved in the very early stages of haematopoietic 
commitment and differentiation. 
Using the CFU-A assay as a means of studying the haematopoietic potential of embryoid 
bodies, it was found that in the absence of cytokines or stromal cell lines in the culture 
system, approximately 30-40% of embryoid bodies could give rise to CFU-A colonies. For 
the purposes of devising a method of screening for genes involved in haematopoiesis, to the 
exclusion of the much larger pool of unrelated genes, it was deemed desirable to alter and 
modulate this level of haematopoietic commitment. This was achieved by the addition of 
chemical inducers, namely DMSO and atRA, known to affect the differentiation of not 
only ES and EC cell lines but also several leukaemic cell lines in vitro and in vivo. 
It was consequently found that exposure to 1% DMSO during the first 48 hours of 
differentiation increased the number of embryoid bodies giving rise to CFU-A colonies by 2 
fold. Assays of single cell suspensions derived from DMSO treated embryoid bodies were 
also found to produce twice as many CFU-A colonies as their untreated counterparts. These 
findings were furthermore found to be reproducible. This together with the fact that no 
significant difference between the colony sizes of DMSO treated and untreated embryoid 
bodies was observed, indicate that DMSO is acting to enhance haematopoietic 
commitment as opposed to the treatment causing an expansion of committed cell lines. RT-
PCR studies furthermore demonstrated that the expression of various haematopoietic 
related genes, such as foetal 3-globin, PU.1 and CD45, was elevated in DMSO treated 
embryoid bodies. 
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Conversely it was found that treatment with atRA during the first 48 hours of 
differentiation markedly reduced the number of CPU-A colonies from both intact and 
disrupted embryoid bodies. These results were once again found to be highly reproducible. 
This effect however, was only found to be exerted within a specific time frame. The drug 
had the described effect when embryoid bodies were cultured in its presence for longer than 
16 hours, and appeared to have little or no effect beyond 72 hours of differentiation. 
Whether the absence of CPU-A colonies is due to haematopoietic inhibition by atRA 
however remains elusive. The embryoid bodies continue to express the mesoderm marker 
brachyury, along with haematopoietic related genes foetal 3-globin and GATA-1. It would 
be interesting to use other colony forming unit assays such as BFU-E (erythroid burst 
forming unit), to determine whether atRA treated embryoid bodies are able to produce 
haematopoietic colonies under different assay conditions. 
As discussed in Chapter 3, several groups have recently reported atRA to be an inducer of 
neural lineages from ES cell lines (Wobus et al, 1994; Bain et a!, 1995). Consequently the 
absence of CPU-A colonies within the specified time frame could be due to the induction of 
neural lineages and not the direct inhibition of haematopoiesis. Alternatively atRA could 
be acting on a specific cell type, possibly a very primitive haematopoietic cell type, (such 
as those recently described by Kennedy et al (1997)), present within the 16 to 72 hour time 
frame which is atRA sensitive, but after further differentiation becomes more committed 
and is rendered atRA insensitive. 
This hypothesis is corroborated by the finding that reconstitution of haematopoietically 
compromised hosts with ES derived progeny, is best achieved by embryoid bodies that 
have been allowed to differentiate for no longer than 4 days (Hole et a!, 1996). 
Furthermore various workers have shown that atRA does inhibit differentiation of 
primitive haematopoietic cells from the bone marrow. Whatever the manner in which 
atRA is acting to produce the results reported, it is evident from the marked reduction in 
the number CFU-A colonies that it is clearly affecting ES cell haematopoietic 
differentiation at some level, implying that the expression of haematopoietic related 
genes is also affected, this being confirmed to some extent by the RT-PCR experiments 
(Chapter 4). 
Having modulated the level of embryoid body haematopoiesis by the use of exogenous 
factors, which was the initial aim of the project, the findings could then be used for the 
purposes of screening for haematopoietic related genes. By exploiting the opposing effects 
of DMSO and atRA several techniques for screening of genes were feasable. The method 
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adopted upon consideration was that of 2-dimensional protein gel analysis. As discussed in 
Chapter 5, the technique provides both qualitative and quantitative measurements of 
protein expression, and has been utilised by various groups for differential protein 
expression studies in a range of biological systems. Since embryoid body haematopoietic 
differentiation was found to be affected both temporally and by the culture conditions 
used, this method was deemed apt as a means of screening for proteins which could 
potentially be involved not only in the early stages of haematopoietic commitment but 
also in the differentiation of progenitor cells. 
Various criteria based co the results of the tissue culture studies were therefore defined. 
Several proteins were found to satisfy particular aspects of these criteria, such as being up-
regulated or switched-on by DMSO or down-regulated or switched-off by atRA, and 
therefore their physical parameters were determined. The limitation with the use of 2-
dimensional protein gels however is the actual identification of the proteins of interest. 
Antibodies for proteins known to be involved in haematopoiesis could be used for 
immunoprecipitation experiments, however for the purposes of identifying novel proteins 
one of two options are available. N-terminal sequencing of proteins isolated from 
acrylamide gels is one option, however this is somewhat time consuming and slow. The 
technique which is currently being developed by various workers and which would be more 
suitable for large screening projects, involves the enzymatic digestion of protein of interest 
followed by analysis of the fragments by mass spectrometry. Although these options could 
not be explored in this study through lack of time and resources, the protein database 
created, represent a rich source of information and possibilities for future work. 
One of the disadvantages with using 2-dimensional protein gels is that some proteins 
which may play key roles in haematopoiesis, but which are expressed at low levels, such 
as transcription factors, may not be detected. Another option therefore which is currently 
being explored in conjunction with the Beatson Institute in Glasgow is the construction of 
cDNA libraries from DMSO and atRA treated embryoid bodies which could then be used 
for differential library screening. This technique has already been used for generating a 
large number of clones which are differentially expressed between day 3 and 5 embryoid 
bodies. Using these temporal variations alongside the opposing effects of DMSO and atRA 
an efficient screening method could be devised for the identification of haematopoietic 
related genes. 
The main proposals and intentions of the project have been successfuly addressed. The 
basic level of embryoid body haematopoiesis, as detected by the CFU-A assay, was 
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modulated with the use of chemical induction, and these results were then employed to 
devise strategies for screening of haematopoietic related genes/proteins. However, some 
questions concerning the exact nature of the way in which the chemicals are affecting 
haematopoiesis, or the exact cell lineage being affected remain unanswered. 
The data presented in the thesis highlight one of the main disadvantages of using 
potentially pleiotropic inducers such as DMSO and atRA and although much is now known 
about the signalling mechanisms of retinoids, the method of action of DMSO remains 
largely elusive. Regulation of the level of embryoid body haematopoiesis with cytokines 
has also been explored. However, the use of sera in the culture media could at least 
theoretically distort the effects of these, thus requiring the same clarifications about the 
exact nature of any observable effects, as are demanded with the use of chemical inducers. 
Many possibilities and avenues are presented by the results obtained and the techniques 
explored. The use of DMSO and atRA in assisting the isolation and identification of either 
novel cDNA clones or proteins involved in haematopoieis can, not only contribute to 
understanding the key events of the process in vitro, and with the use of the reconstitution 
experiments in vivo; but also in answering the question of how these chemicals regulate 
the complex cascade of biological events that control haematopoiesis. 
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Appendices 
Appendix I - Abbreviations. 
AGM - 	 Aorta, gonads and mesonephros 
AMV - 	 Avian myeloblastosis virus 
atRA - 	 all trans-retinoic acid 
bFGF - 	 Basic fibroblast growth factor 
BSA - 	 Bovine serum albumin 
cDNA - 	 Complementary DNA 
13cRA - 	 13 - cis retinoic acid 
CFU-A - 	 Colony forming unit assay 
CFU-S - 	 Colony forming unit-spleen 
cm - 	 Centimetre 
CPM - 	 Counts per minute 
CSF - 1 - 	 Colony stimulating factor - 1 
dATP - 	 2'-deoxyadenosine 5'-triphosphate 
dCTP - 	 2'-deoxycytidine 5'-triphosphate 
[a-32 P]- dCTP - 	 dCTP labelled with 32-phosphorous at the a—position 
DEPC - 	 Diethyl pyrocarbonate 
DMSO - 	 Dimethyl suiphoxide 
D-MEM - 	 Dulbecco - MEM 
DNA - 	 Deoxyribonucleic acid 
dGTP - 	 2'-deoxyguanosine 5'-triphosphate 
dNTP - 	 2'-deoxynucleotide 5'-triphosphate 
DTT - 	 Dithiothreitol 
dTTP - 	 2'-deoxythymidine 5'-triphophate 
EB/EBs - 	 Embryoid body/Embryoid bodies 
EDTA - 	 Ethylenediaminetetra - acetic acid 
ES - 	 Embryonic stem (cell) 
FCS - 	 Foetal calf serum 
g - 	 Relative centrifugal force 
GM - CSF - 	 Granulocyte/macrophage - colony stimulating factor 
G-MEM - 	 Glasgow - MEM 
HRP - 	 Horseradish peroxidase 
HCP - 	 Haematopoietic cell phosphotase 
HSC/HSCs - 	 Haematopoietic stem cell/haematopoietic stem cells 
1 
1CM Inner cell mass 
IEF 	 - Isoelectric focusing 
kDa 	 - kilo-Dalton 
L-[35S]-methionine 	- L- methionine labelled with35-sulphur 
LD 	 - Lethal Dose 
LIF 	 - Leukaemia inhibitory factor 
MAP 	 - Mitogen activated protein 
MEM 	 - Minimal essential medium 
MIP 	 - Macrophage inhibitory protein 
M 	 - Molar 
mM 	 - Milli-molar 
jiM 	 - Micro-molar 
p.Ci 	 - MicroCurie 
gl - Microlitre 
mCi 	 - MilliCuries 
ml 	 - Millilitre(s) 
MOPS 	 - 4- Morpholinepropanesulphonic acid 
ng 	 - Nanograms 
PAGE 	 - Polyacrylamide gel electrophoresis 
PBS 	 - Phosphate buffered saline 
P.C. 	 - Post coitum 
PCR 	 - Polymerase chain reaction 
PDU 	 - Pixel density unit 
PGCS 	 - Primordial germ cells 
p.p.m 	 - Parts per million 
PVDF 	 - Polyvinylidene difluoride 
RNA 	 - Ribonucleic acid 
RT-PCR 	 - Reverse transcript-PCR 
SCF 	 - Stem cell factor 
s.d. 	 - Standard deviation 
SDS 	 - Sodium dodecyl sulphate 
SSC 	 - Sodium sulphate/Sodium citrate 
TBE 	 - Tris/boric acid/EDTA electrophoresis buffer 
TE 	 - 10mM Tris (pH7.5)/0.lmM EDTA 
TEMED 	 - NNN'N'- Tetramethylethylenediamine 
Tris 	 - Tris (hydroxymethyl)-methylamine 
TVP 	 - Trypsin/varsene (EDTA)/PBS 
11 
Appendix II - Suppliers and Addresses. 
Aldrich Chemical Company, The Old Brickyard, New Road, Gillingham, Dorset, SP8 4JL, 
UK. 
Amersham, Buckinghamshire, UK. 
Advanced Protein Products Ltd, West Midlands, UK. 
Biotecs, Boummouth, UK. 
Bioline, 16 The Edge Business Centre, Humber Road, London, NW2 6EW, UK. 
Bio-Rad Laboratories Ltd., Bio-Rad House, Maylands Avenue, Hemel Hempstead, 
Hertfordshire, HP2 71FD, UK. 
BOC Gases, Leith, Edinburgh, UK. 
Boehringer Mannheim, Bell Lane, Lewes, East Sussex, BN7 11-G, UK. 
Cruachem, Glasgow, UK. 
Difco, East Molesey, Surrey, UK. 
Fisons, Bishops Meadow Road, Loughborough, Leics, LE11 ORG, UK. 
Gibco BRL, Life Technologies Ltd., Trident House, P.O. Box 35, Renfrew Road, Paisley, 
PA3 4AF, UK. 
GlobePharm Ltd., P.O. Box 89c, Esher, Surrey, KT19 9MD, UK. 
Law Hospital, Lanarkshire, UK. 
Merck-BDH, Merck House, Poole, Dorset, BH15 lTD. UK. 
Oxoid, Basingstoke, Hants, UK. 
Pharmacia Biotech AB, Uppsala, Sweden. 
Promega UK Ltd., Delta House, Chilworth Research Centre, Southampton, S016 7NS, 
UK. 
Sigma, Fancy Road, Poole, Dorset, BH17 7NH, UK. 
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